activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650819	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1650819	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1650820	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1650821	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL2801	Homo sapiens	Kd		
	1650822	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1100.0	CHEMBL2801	Homo sapiens	Kd	uM	1.1
Not Active	1650823	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1650824	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1650825	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1650826	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1650827	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL2801	Homo sapiens	Kd		
	1652292	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.5	CHEMBL2801	Homo sapiens	Kd	uM	0.0005
Not Active	1652293	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1652294	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1652295	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1652296	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1652297	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1652298	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1652299	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1652300	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1652301	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL2801	Homo sapiens	Kd		
Not Active	1652302	CHEMBL860893	Average Binding Constant for CAMK2D; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL2801	Homo sapiens	Kd		
	2121872	CHEMBL933473	Inhibition of cloned CaMK2delta	B	C[C@H](Nc1cc(Nc2nccc(-c3cccc(F)c3)n2)ccn1)c1ccccc1		CHEMBL271699	=	IC50	nM	1280.0	CHEMBL2801	Homo sapiens	IC50	uM	1.28
	2121873	CHEMBL933473	Inhibition of cloned CaMK2delta	B	NCCNc1cccc(-c2ccnc(Nc3cccc(Cl)c3)n2)c1		CHEMBL272978	=	IC50	nM	12.0	CHEMBL2801	Homo sapiens	IC50	uM	0.012
	2121874	CHEMBL933473	Inhibition of cloned CaMK2delta	B	Clc1cccc(Nc2nccc(-c3cccc(N4CCCCC4)c3)n2)c1		CHEMBL403053	=	IC50	nM	930.0	CHEMBL2801	Homo sapiens	IC50	uM	0.93
	2121875	CHEMBL933473	Inhibition of cloned CaMK2delta	B	Clc1cccc(Nc2nccc(-c3cccc(N4CCOCC4)c3)n2)c1		CHEMBL403054	=	IC50	nM	240.0	CHEMBL2801	Homo sapiens	IC50	uM	0.24
	2121876	CHEMBL933473	Inhibition of cloned CaMK2delta	B	Nc1cccc(-c2ccnc(Nc3cccc(Cl)c3)n2)c1		CHEMBL273008	=	IC50	nM	660.0	CHEMBL2801	Homo sapiens	IC50	uM	0.66
	2121877	CHEMBL933473	Inhibition of cloned CaMK2delta	B	c1ccc(Nc2nccc(-c3ccc(-c4nnn[nH]4)cc3)n2)cc1		CHEMBL404090	=	IC50	nM	770.0	CHEMBL2801	Homo sapiens	IC50	uM	0.77
	2121878	CHEMBL933473	Inhibition of cloned CaMK2delta	B	O=C(NO)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL255633	=	IC50	nM	290.0	CHEMBL2801	Homo sapiens	IC50	uM	0.29
	2121879	CHEMBL933473	Inhibition of cloned CaMK2delta	B	CNC(=O)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL271067	>	IC50	nM	20000.0	CHEMBL2801	Homo sapiens	IC50	uM	20.0
	2121880	CHEMBL933473	Inhibition of cloned CaMK2delta	B	COC(=O)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL270008	>	IC50	nM	20000.0	CHEMBL2801	Homo sapiens	IC50	uM	20.0
	2121881	CHEMBL933473	Inhibition of cloned CaMK2delta	B	O=C(O)Cc1ccc(-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL256026	>	IC50	nM	20000.0	CHEMBL2801	Homo sapiens	IC50	uM	20.0
	2121882	CHEMBL933473	Inhibition of cloned CaMK2delta	B	O=C(O)c1ccc(-c2ccnc(Nc3cccc(Cl)c3)n2)cc1		CHEMBL271045	=	IC50	nM	42.0	CHEMBL2801	Homo sapiens	IC50	uM	0.042
	2121883	CHEMBL933473	Inhibition of cloned CaMK2delta	B	O=C(O)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL402428	=	IC50	nM	64.0	CHEMBL2801	Homo sapiens	IC50	uM	0.064
	2121884	CHEMBL933473	Inhibition of cloned CaMK2delta	B	O=C(O)c1ccc(-c2ccnc(Nc3ccncc3)n2)cc1		CHEMBL256632	=	IC50	nM	390.0	CHEMBL2801	Homo sapiens	IC50	uM	0.39
	2121885	CHEMBL933473	Inhibition of cloned CaMK2delta	B	Nc1cc(Nc2nccc(-c3ccc(C(=O)O)cc3)n2)ccn1		CHEMBL255617	=	IC50	nM	66.0	CHEMBL2801	Homo sapiens	IC50	uM	0.066
	2121886	CHEMBL933473	Inhibition of cloned CaMK2delta	B	C[C@H](Nc1cc(Nc2nccc(-c3ccc(C(=O)NO)cc3)n2)ccn1)c1ccccc1		CHEMBL402524	=	IC50	nM	170.0	CHEMBL2801	Homo sapiens	IC50	uM	0.17
	2121887	CHEMBL933473	Inhibition of cloned CaMK2delta	B	C[C@H](Nc1cc(Nc2nccc(-c3ccc(-c4nnn[nH]4)cc3)n2)ccn1)c1ccccc1		CHEMBL255641	=	IC50	nM	2260.0	CHEMBL2801	Homo sapiens	IC50	uM	2.26
	2121888	CHEMBL933473	Inhibition of cloned CaMK2delta	B	CNC(=O)c1ccc(-c2ccnc(Nc3ccnc(N[C@@H](C)c4ccccc4)c3)n2)cc1		CHEMBL402741	=	IC50	nM	720.0	CHEMBL2801	Homo sapiens	IC50	uM	0.72
	2121889	CHEMBL933473	Inhibition of cloned CaMK2delta	B	C[C@H](Nc1cc(Nc2nccc(-c3ccc(N(C)C)cc3)n2)ccn1)c1ccccc1		CHEMBL272524	=	IC50	nM	2220.0	CHEMBL2801	Homo sapiens	IC50	uM	2.22
	2121890	CHEMBL933473	Inhibition of cloned CaMK2delta	B	C[C@H](Nc1cc(Nc2nccc(-c3ccc(CC(=O)O)cc3)n2)ccn1)c1ccccc1		CHEMBL403217	=	IC50	nM	3420.0	CHEMBL2801	Homo sapiens	IC50	uM	3.42
	2121891	CHEMBL933473	Inhibition of cloned CaMK2delta	B	C[C@H](Nc1cc(Nc2nccc(-c3cccc(C(=O)O)c3)n2)ccn1)c1ccccc1		CHEMBL272525	=	IC50	nM	12990.0	CHEMBL2801	Homo sapiens	IC50	uM	12.99
	2121892	CHEMBL933473	Inhibition of cloned CaMK2delta	B	C[C@H](Nc1cc(Nc2nccc(-c3ccc(C(=O)O)cc3)n2)ccn1)c1ccccc1		CHEMBL403766	=	IC50	nM	210.0	CHEMBL2801	Homo sapiens	IC50	uM	0.21
	2121893	CHEMBL933473	Inhibition of cloned CaMK2delta	B	COC(=O)c1ccc(-c2ccnc(Nc3ccnc(N[C@@H](C)c4ccccc4)c3)n2)cc1		CHEMBL257454	=	IC50	nM	1690.0	CHEMBL2801	Homo sapiens	IC50	uM	1.69
	2121894	CHEMBL933473	Inhibition of cloned CaMK2delta	B	C[C@H](Nc1cc(Nc2nccc(-c3ccc(Cl)cc3)n2)ccn1)c1ccccc1		CHEMBL271069	=	IC50	nM	2870.0	CHEMBL2801	Homo sapiens	IC50	uM	2.87
	2121895	CHEMBL933473	Inhibition of cloned CaMK2delta	B	Cc1cccc(-c2ccnc(Nc3ccnc(N[C@@H](C)c4ccccc4)c3)n2)c1		CHEMBL271278	=	IC50	nM	920.0	CHEMBL2801	Homo sapiens	IC50	uM	0.92
	2121896	CHEMBL933473	Inhibition of cloned CaMK2delta	B	C[C@H](Nc1cc(Nc2nccc(-c3cccc(-c4ccccc4)c3)n2)ccn1)c1ccccc1		CHEMBL256429	=	IC50	nM	3140.0	CHEMBL2801	Homo sapiens	IC50	uM	3.14
	2121897	CHEMBL934462	Inhibition of CaMK2delta-mediated vimentin phosphorylation in human HL2 cells at 5 uM after 1 hr by ELISA	B	O=C(O)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL402428	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	Inhibition	%	0.0
	2121898	CHEMBL934462	Inhibition of CaMK2delta-mediated vimentin phosphorylation in human HL2 cells at 5 uM after 1 hr by ELISA	B	c1ccc(Nc2nccc(-c3ccc(-c4nnn[nH]4)cc3)n2)cc1		CHEMBL404090	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	Inhibition	%	0.0
	2121899	CHEMBL934462	Inhibition of CaMK2delta-mediated vimentin phosphorylation in human HL2 cells at 5 uM after 1 hr by ELISA	B	O=C(NO)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL255633	=	Inhibition	%	90.0	CHEMBL2801	Homo sapiens	Inhibition	%	90.0
	2121900	CHEMBL934462	Inhibition of CaMK2delta-mediated vimentin phosphorylation in human HL2 cells at 5 uM after 1 hr by ELISA	B	COC(=O)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL270008	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	Inhibition	%	0.0
	2121901	CHEMBL933473	Inhibition of cloned CaMK2delta	B	Clc1cccc(Nc2nccc(-c3cccc(N4CCNCC4)c3)n2)c1		CHEMBL270849	=	IC50	nM	9.0	CHEMBL2801	Homo sapiens	IC50	uM	0.009
	2121902	CHEMBL934463	Inhibition of CaMK2delta-mediated vimentin phosphorylation in human HL2 cells after 1 hr by ELISA	B	Clc1cccc(Nc2nccc(-c3cccc(N4CCNCC4)c3)n2)c1		CHEMBL270849	=	IC50	nM	320.0	CHEMBL2801	Homo sapiens	IC50	uM	0.32
	2121903	CHEMBL934463	Inhibition of CaMK2delta-mediated vimentin phosphorylation in human HL2 cells after 1 hr by ELISA	B	NCCNc1cccc(-c2ccnc(Nc3cccc(Cl)c3)n2)c1		CHEMBL272978	=	IC50	nM	110.0	CHEMBL2801	Homo sapiens	IC50	uM	0.11
	2121904	CHEMBL934462	Inhibition of CaMK2delta-mediated vimentin phosphorylation in human HL2 cells at 5 uM after 1 hr by ELISA	B	O=C(O)c1ccc(-c2ccnc(Nc3cccc(Cl)c3)n2)cc1		CHEMBL271045	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	Inhibition	%	0.0
	2121905	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL270875	=	IC50	nM	380.0	CHEMBL2801	Homo sapiens	IC50	uM	0.38
	2121906	CHEMBL934464	Inhibition of CaMK2delta	B	CN1C(=O)C(c2c[nH]c3ccc(Br)cc23)=C(c2cn(CCCN)c3ccccc23)C1=O		CHEMBL402013	>	IC50	nM	20000.0	CHEMBL2801	Homo sapiens	IC50	uM	20.0
	2121907	CHEMBL934464	Inhibition of CaMK2delta	B	CN1C(=O)C(c2ccccc2)=C(c2cn(CCCN)c3ccccc23)C1=O		CHEMBL402591	=	IC50	nM	15020.0	CHEMBL2801	Homo sapiens	IC50	uM	15.02
	2121908	CHEMBL934464	Inhibition of CaMK2delta	B	CN1C(=O)C(c2csc3ccccc23)=C(c2cn(CCCN)c3ccccc23)C1=O		CHEMBL427724	=	IC50	nM	2320.0	CHEMBL2801	Homo sapiens	IC50	uM	2.32
	2121909	CHEMBL934464	Inhibition of CaMK2delta	B	CC(C)(C)OC(=O)NCCCn1cc(C2=C(c3c[nH]c4ccc(Br)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL411456	=	IC50	nM	7540.0	CHEMBL2801	Homo sapiens	IC50	uM	7.54
	2121910	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3c[nH]c4ccc(Br)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL403446	=	IC50	nM	34.0	CHEMBL2801	Homo sapiens	IC50	uM	0.034
	2121911	CHEMBL934464	Inhibition of CaMK2delta	B	Cc1[nH]c2ccccc2c1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ccccc23)C(=O)NC1=O		CHEMBL257851	=	IC50	nM	7610.0	CHEMBL2801	Homo sapiens	IC50	uM	7.61
	2121912	CHEMBL934464	Inhibition of CaMK2delta	B	Cc1[nH]c2ccccc2c1C1=C(c2cn(CCCN)c3ccccc23)C(=O)NC1=O		CHEMBL256265	=	IC50	nM	750.0	CHEMBL2801	Homo sapiens	IC50	uM	0.75
	2121913	CHEMBL934464	Inhibition of CaMK2delta	B	Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL269264	=	IC50	nM	310.0	CHEMBL2801	Homo sapiens	IC50	uM	0.31
	2121914	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(n3ccc4ccccc43)C(=O)NC2=O)c2ccccc21		CHEMBL446110	=	IC50	nM	4560.0	CHEMBL2801	Homo sapiens	IC50	uM	4.56
	2121915	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3cccc(Oc4ccccc4)c3)C(=O)NC2=O)c2ccccc21		CHEMBL403887	=	IC50	nM	1680.0	CHEMBL2801	Homo sapiens	IC50	uM	1.68
	2121916	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3cccc(-c4ccccc4)c3)C(=O)NC2=O)c2ccccc21		CHEMBL409232	=	IC50	nM	1320.0	CHEMBL2801	Homo sapiens	IC50	uM	1.32
	2121917	CHEMBL934464	Inhibition of CaMK2delta	B	Cc1cccc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c1		CHEMBL408434	=	IC50	nM	280.0	CHEMBL2801	Homo sapiens	IC50	uM	0.28
	2121918	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3cccc(Br)c3)C(=O)NC2=O)c2ccccc21		CHEMBL412302	=	IC50	nM	180.0	CHEMBL2801	Homo sapiens	IC50	uM	0.18
	2121919	CHEMBL934464	Inhibition of CaMK2delta	B	CC(C)(C)OC(=O)NCCCn1cc(C2=C(c3cccs3)C(=O)NC2=O)c2ccccc21		CHEMBL408462	>	IC50	nM	20000.0	CHEMBL2801	Homo sapiens	IC50	uM	20.0
	2121920	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3cccs3)C(=O)NC2=O)c2ccccc21		CHEMBL407666	=	IC50	nM	1190.0	CHEMBL2801	Homo sapiens	IC50	uM	1.19
	2121921	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3ccco3)C(=O)NC2=O)c2ccccc21		CHEMBL410536	=	IC50	nM	1490.0	CHEMBL2801	Homo sapiens	IC50	uM	1.49
	2121922	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3ccncc3)C(=O)NC2=O)c2ccccc21		CHEMBL272295	=	IC50	nM	1600.0	CHEMBL2801	Homo sapiens	IC50	uM	1.6
	2121923	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3cccnc3)C(=O)NC2=O)c2ccccc21		CHEMBL407464	=	IC50	nM	540.0	CHEMBL2801	Homo sapiens	IC50	uM	0.54
	2121924	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3ccccn3)C(=O)NC2=O)c2ccccc21		CHEMBL270662	=	IC50	nM	1580.0	CHEMBL2801	Homo sapiens	IC50	uM	1.58
	2121925	CHEMBL934464	Inhibition of CaMK2delta	B	CC(C)(C)OC(=O)NCCCn1cc(C2=C(c3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL404438	>	IC50	nM	20000.0	CHEMBL2801	Homo sapiens	IC50	uM	20.0
	2121926	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL256827	=	IC50	nM	1350.0	CHEMBL2801	Homo sapiens	IC50	uM	1.35
	2121927	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3ccc4ccccc4n3)C(=O)NC2=O)c2ccccc21		CHEMBL402774	>	IC50	nM	20000.0	CHEMBL2801	Homo sapiens	IC50	uM	20.0
	2121928	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3ccnc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL402775	=	IC50	nM	630.0	CHEMBL2801	Homo sapiens	IC50	uM	0.63
	2121929	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3ccc4ccccc4c3)C(=O)NC2=O)c2ccccc21		CHEMBL409834	=	IC50	nM	500.0	CHEMBL2801	Homo sapiens	IC50	uM	0.5
	2121930	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3cccc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL411253	=	IC50	nM	290.0	CHEMBL2801	Homo sapiens	IC50	uM	0.29
	2121931	CHEMBL934464	Inhibition of CaMK2delta	B	CC(C)(C)OC(=O)NCCCn1cc(C2=C(c3csc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL255178	>	IC50	nM	20000.0	CHEMBL2801	Homo sapiens	IC50	uM	20.0
	2121932	CHEMBL934464	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3csc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL258290	=	IC50	nM	360.0	CHEMBL2801	Homo sapiens	IC50	uM	0.36
	2121933	CHEMBL934464	Inhibition of CaMK2delta	B	CC(C)(C)OC(=O)NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL256259	=	IC50	nM	3810.0	CHEMBL2801	Homo sapiens	IC50	uM	3.81
	2121934	CHEMBL950203	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL270875	=	IC50	nM	380.0	CHEMBL2801	Homo sapiens	IC50	uM	0.38
	2121935	CHEMBL950203	Inhibition of CaMK2delta	B	NCC(O)Cn1cc(C2=C(c3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL404077	=	IC50	nM	450.0	CHEMBL2801	Homo sapiens	IC50	uM	0.45
	2121936	CHEMBL950203	Inhibition of CaMK2delta	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccc5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300549	=	IC50	nM	1870.0	CHEMBL2801	Homo sapiens	IC50	uM	1.87
	2121937	CHEMBL950203	Inhibition of CaMK2delta	B	Cn1cc(C2=C(c3cn(C4CCNCC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL55788	=	IC50	nM	640.0	CHEMBL2801	Homo sapiens	IC50	uM	0.64
	2121938	CHEMBL950203	Inhibition of CaMK2delta	B	Cn1cc(C2=C(c3cn(C4CCCNC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL409856	=	IC50	nM	300.0	CHEMBL2801	Homo sapiens	IC50	uM	0.3
	2121939	CHEMBL950203	Inhibition of CaMK2delta	B	Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL269264	=	IC50	nM	310.0	CHEMBL2801	Homo sapiens	IC50	uM	0.31
	2121940	CHEMBL950203	Inhibition of CaMK2delta	B	CN1CCCC1CCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL218328	=	IC50	nM	1890.0	CHEMBL2801	Homo sapiens	IC50	uM	1.89
	2121941	CHEMBL950203	Inhibition of CaMK2delta	B	O=C1NC(=O)C(c2cn(CCC3CCCCN3)c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL403771	=	IC50	nM	1450.0	CHEMBL2801	Homo sapiens	IC50	uM	1.45
	2121942	CHEMBL950203	Inhibition of CaMK2delta	B	O=C1NC(=O)C(c2cn(CCCN3CCNCC3)c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL446199	=	IC50	nM	2020.0	CHEMBL2801	Homo sapiens	IC50	uM	2.02
	2121943	CHEMBL950203	Inhibition of CaMK2delta	B	CC(C)(C)OC(=O)NCCCn1cc(C2=C(c3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL404438	>	IC50	nM	20000.0	CHEMBL2801	Homo sapiens	IC50	uM	20.0
	2121944	CHEMBL950203	Inhibition of CaMK2delta	B	CC(C)(C)OC(=O)NCCCn1cc(C2=C(c3c[nH]c4ccc(Br)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL411456	=	IC50	nM	7540.0	CHEMBL2801	Homo sapiens	IC50	uM	7.54
	2121945	CHEMBL950203	Inhibition of CaMK2delta	B	CC(C)(C)OC(=O)NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL256259	=	IC50	nM	3810.0	CHEMBL2801	Homo sapiens	IC50	uM	3.81
	2121946	CHEMBL950203	Inhibition of CaMK2delta	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cccc(Br)c1		CHEMBL404368	=	IC50	nM	3530.0	CHEMBL2801	Homo sapiens	IC50	uM	3.53
	2121947	CHEMBL950203	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3cccc(Br)c3)C(=O)NC2=O)c2ccccc21		CHEMBL412302	=	IC50	nM	180.0	CHEMBL2801	Homo sapiens	IC50	uM	0.18
	2121948	CHEMBL950203	Inhibition of CaMK2delta	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1ccccc1		CHEMBL380598	>	IC50	nM	20000.0	CHEMBL2801	Homo sapiens	IC50	uM	20.0
	2121949	CHEMBL950203	Inhibition of CaMK2delta	B	Cn1cc(C2=C(c3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL54425	>	IC50	nM	20000.0	CHEMBL2801	Homo sapiens	IC50	uM	20.0
	2121950	CHEMBL950203	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL256827	=	IC50	nM	1350.0	CHEMBL2801	Homo sapiens	IC50	uM	1.35
	2121951	CHEMBL950203	Inhibition of CaMK2delta	B	Cn1cc(C2=C(c3c[nH]c4ccc(Br)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL256452	=	IC50	nM	870.0	CHEMBL2801	Homo sapiens	IC50	uM	0.87
	2121952	CHEMBL950203	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3c[nH]c4ccc(Br)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL403446	=	IC50	nM	34.0	CHEMBL2801	Homo sapiens	IC50	uM	0.034
	2121953	CHEMBL950203	Inhibition of CaMK2delta	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	IC50	nM	1190.0	CHEMBL2801	Homo sapiens	IC50	uM	1.19
	2121981	CHEMBL950207	Inhibition of CaMK2delta using freshly stock solution of compound	B	NCCCn1cc(C2=C(c3csc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL258290	=	IC50	nM	360.0	CHEMBL2801	Homo sapiens	IC50	uM	0.36
	2121982	CHEMBL950208	Inhibition of CaMK2delta using 3 weeks old stock solution of compound	B	NCCCn1cc(C2=C(c3csc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL258290	<	IC50	nM	39.0	CHEMBL2801	Homo sapiens	IC50	uM	0.039
	2121983	CHEMBL950207	Inhibition of CaMK2delta using freshly stock solution of compound	B	NCCCn1cc(C2=C(c3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL256827	=	IC50	nM	350.0	CHEMBL2801	Homo sapiens	IC50	uM	0.35
	2121984	CHEMBL950208	Inhibition of CaMK2delta using 3 weeks old stock solution of compound	B	NCCCn1cc(C2=C(c3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL256827	=	IC50	nM	230.0	CHEMBL2801	Homo sapiens	IC50	uM	0.23
	2121985	CHEMBL950209	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL270875	=	IC50	nM	380.0	CHEMBL2801	Homo sapiens	IC50	uM	0.38
	2121986	CHEMBL950209	Inhibition of CaMK2delta	B	CNCCc1cn(C2=C(c3c[nH]c4ccc(C(=O)N(C)C)cc34)C(=O)NC2=O)c2ccccc12		CHEMBL255117	=	IC50	nM	11850.0	CHEMBL2801	Homo sapiens	IC50	uM	11.85
	2121987	CHEMBL950209	Inhibition of CaMK2delta	B	CNCCc1cn(C2=C(c3c[nH]c4ccc(C(=O)NC)cc34)C(=O)NC2=O)c2ccccc12		CHEMBL256460	=	IC50	nM	280.0	CHEMBL2801	Homo sapiens	IC50	uM	0.28
	2121988	CHEMBL950209	Inhibition of CaMK2delta	B	CNCCc1cn(C2=C(c3c[nH]c4ccc(C(N)=O)cc34)C(=O)NC2=O)c2ccccc12		CHEMBL271043	=	IC50	nM	190.0	CHEMBL2801	Homo sapiens	IC50	uM	0.19
	2121989	CHEMBL950209	Inhibition of CaMK2delta	B	CNCCc1cn(C2=C(c3c[nH]c4ccc(C(=O)O)cc34)C(=O)NC2=O)c2ccccc12		CHEMBL271254	=	IC50	nM	380.0	CHEMBL2801	Homo sapiens	IC50	uM	0.38
	2121990	CHEMBL950209	Inhibition of CaMK2delta	B	CNCCc1cn(C2=C(c3c[nH]c4ccc(C(=O)OC)cc34)C(=O)NC2=O)c2ccccc12		CHEMBL271648	=	IC50	nM	21.0	CHEMBL2801	Homo sapiens	IC50	uM	0.021
	2121991	CHEMBL950209	Inhibition of CaMK2delta	B	COc1ccc2[nH]cc(C3=C(n4cc(CCN)c5ccccc54)C(=O)NC3=O)c2c1		CHEMBL271426	=	IC50	nM	170.0	CHEMBL2801	Homo sapiens	IC50	uM	0.17
	2121992	CHEMBL950209	Inhibition of CaMK2delta	B	CCc1ccc2[nH]cc(C3=C(n4cc(CCNC)c5ccccc54)C(=O)NC3=O)c2c1		CHEMBL411724	=	IC50	nM	110.0	CHEMBL2801	Homo sapiens	IC50	uM	0.11
	2121993	CHEMBL950209	Inhibition of CaMK2delta	B	N#Cc1ccc2[nH]cc(C3=C(n4cc(CCN)c5ccccc54)C(=O)NC3=O)c2c1		CHEMBL270032	=	IC50	nM	46.0	CHEMBL2801	Homo sapiens	IC50	uM	0.046
	2121994	CHEMBL950209	Inhibition of CaMK2delta	B	NCCc1cn(C2=C(c3c[nH]c4ccc(C(F)(F)F)cc34)C(=O)NC2=O)c2ccccc12		CHEMBL402533	=	IC50	nM	32.0	CHEMBL2801	Homo sapiens	IC50	uM	0.032
	2121995	CHEMBL950209	Inhibition of CaMK2delta	B	NCCc1cn(C2=C(c3c[nH]c4ccc(F)cc34)C(=O)NC2=O)c2ccccc12		CHEMBL403337	=	IC50	nM	38.0	CHEMBL2801	Homo sapiens	IC50	uM	0.038
	2121996	CHEMBL950209	Inhibition of CaMK2delta	B	CNCCc1cn(C2=C(c3c[nH]c4ccc(Cl)cc34)C(=O)NC2=O)c2ccccc12		CHEMBL402340	=	IC50	nM	13.0	CHEMBL2801	Homo sapiens	IC50	uM	0.013
	2121997	CHEMBL950209	Inhibition of CaMK2delta	B	NCCc1cn(C2=C(c3c[nH]c4ccc(Cl)cc34)C(=O)NC2=O)c2ccccc12		CHEMBL255607	=	IC50	nM	10.0	CHEMBL2801	Homo sapiens	IC50	uM	0.01
	2121998	CHEMBL950209	Inhibition of CaMK2delta	B	O=C1NC(=O)C(n2cc(C3CCNCC3)c3ccccc32)=C1c1c[nH]c2ccccc12		CHEMBL270846	=	IC50	nM	680.0	CHEMBL2801	Homo sapiens	IC50	uM	0.68
	2121999	CHEMBL950209	Inhibition of CaMK2delta	B	CN(C)Cc1cn(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc12		CHEMBL270648	=	IC50	nM	2410.0	CHEMBL2801	Homo sapiens	IC50	uM	2.41
	2122000	CHEMBL950209	Inhibition of CaMK2delta	B	CN(C)CCc1cn(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc12		CHEMBL256872	=	IC50	nM	560.0	CHEMBL2801	Homo sapiens	IC50	uM	0.56
	2122001	CHEMBL950209	Inhibition of CaMK2delta	B	CNCCc1cn(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc12		CHEMBL402152	=	IC50	nM	150.0	CHEMBL2801	Homo sapiens	IC50	uM	0.15
	2122002	CHEMBL950209	Inhibition of CaMK2delta	B	NCCc1cn(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc12		CHEMBL430412	=	IC50	nM	110.0	CHEMBL2801	Homo sapiens	IC50	uM	0.11
	2122003	CHEMBL950209	Inhibition of CaMK2delta	B	O=C1NC(=O)C(n2cc(CCCO)c3ccccc32)=C1c1c[nH]c2ccccc12		CHEMBL403611	=	IC50	nM	6000.0	CHEMBL2801	Homo sapiens	IC50	uM	6.0
	2122004	CHEMBL950209	Inhibition of CaMK2delta	B	CN(C)CCCc1cn(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc12		CHEMBL271695	=	IC50	nM	740.0	CHEMBL2801	Homo sapiens	IC50	uM	0.74
	2122005	CHEMBL950209	Inhibition of CaMK2delta	B	NCCCn1nc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL271902	=	IC50	nM	380.0	CHEMBL2801	Homo sapiens	IC50	uM	0.38
	2122006	CHEMBL950209	Inhibition of CaMK2delta	B	NCCCc1cn(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc12		CHEMBL270141	=	IC50	nM	190.0	CHEMBL2801	Homo sapiens	IC50	uM	0.19
	2122007	CHEMBL950209	Inhibition of CaMK2delta	B	Cc1c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc2n1CCCN		CHEMBL401681	=	IC50	nM	740.0	CHEMBL2801	Homo sapiens	IC50	uM	0.74
	2122008	CHEMBL950209	Inhibition of CaMK2delta	B	NCCCn1cc(C2=C(n3ccc4ccccc43)C(=O)NC2=O)c2ccccc21		CHEMBL446110	=	IC50	nM	4560.0	CHEMBL2801	Homo sapiens	IC50	uM	4.56
	2122009	CHEMBL950209	Inhibition of CaMK2delta	B	Cc1[nH]c2ccccc2c1C1=C(c2cn(CCCN)c3ccccc23)C(=O)NC1=O		CHEMBL256265	=	IC50	nM	750.0	CHEMBL2801	Homo sapiens	IC50	uM	0.75
	2147206	CHEMBL929085	Activity of human CaMK2delta kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	123.0	CHEMBL2801	Homo sapiens	Activity	%	123.0
	2470163	CHEMBL1034112	Inhibition of CAMK2D at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2801	Homo sapiens	INH	%	10.0
Not Evaluated	2476714	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL2801	Homo sapiens	Activity		
Not Evaluated	2478553	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL2801	Homo sapiens	Activity		
Not Evaluated	2478756	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL2801	Homo sapiens	Activity		
Not Evaluated	2479611	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL2801	Homo sapiens	Activity		
Not Evaluated	2479814	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL2801	Homo sapiens	Activity		
	2480611	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	2.0	CHEMBL2801	Homo sapiens	Activity	%	2.0
Not Evaluated	2480813	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL2801	Homo sapiens	Activity		
	2577232	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901	=	Activity	%	30.9	CHEMBL2801	Homo sapiens	Activity	%	30.9
Not Evaluated	2577435	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL2801	Homo sapiens	Activity		
Not Evaluated	2593640	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL2801	Homo sapiens	Activity		
Not Evaluated	2593906	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL2801	Homo sapiens	Activity		
Not Evaluated	2594109	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL2801	Homo sapiens	Activity		
Not Evaluated	2594849	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL2801	Homo sapiens	Activity		
Not Evaluated	2595052	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL2801	Homo sapiens	Activity		
Not Evaluated	2596249	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL2801	Homo sapiens	Activity		
Not Evaluated	2596452	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL2801	Homo sapiens	Activity		
Not Evaluated	2597721	CHEMBL982742	Binding affinity to human CAMK2D at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL2801	Homo sapiens	Activity		
	2901095	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901096	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901097	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901098	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901099	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901100	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901101	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901102	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901103	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901104	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901105	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901106	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901107	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901108	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901109	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901110	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901111	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901112	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901113	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901114	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901115	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901116	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	4600.0	CHEMBL2801	Homo sapiens	Kd	nM	4600.0
	2901117	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901118	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901119	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901120	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	36.0	CHEMBL2801	Homo sapiens	Kd	nM	36.0
	2901121	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901122	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901123	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901124	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901125	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901126	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901127	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.32	CHEMBL2801	Homo sapiens	Kd	nM	0.32
	2901128	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	760.0	CHEMBL2801	Homo sapiens	Kd	nM	760.0
	2901129	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	420.0	CHEMBL2801	Homo sapiens	Kd	nM	420.0
	2901130	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901131	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2901132	CHEMBL1063792	Binding constant for CAMK2D kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	2921416	CHEMBL1052876	Inhibition of CAMK2D assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	79.0	CHEMBL2801	Homo sapiens	Activity	%	79.0
	3052543	CHEMBL1050408	Residual activity of CAMK2D at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	97.0	CHEMBL2801	Homo sapiens	Residual activity	%	97.0
	3052795	CHEMBL1047821	Residual activity of CAMK2D at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	44.0	CHEMBL2801	Homo sapiens	Residual activity	%	44.0
	3054104	CHEMBL1066622	Residual activity of CAMK2D at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	92.0	CHEMBL2801	Homo sapiens	Residual activity	%	92.0
	3055391	CHEMBL1050408	Residual activity of CAMK2D at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	92.0	CHEMBL2801	Homo sapiens	Residual activity	%	92.0
	3055643	CHEMBL1047821	Residual activity of CAMK2D at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	28.0	CHEMBL2801	Homo sapiens	Residual activity	%	28.0
	3056948	CHEMBL1066622	Residual activity of CAMK2D at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	87.0	CHEMBL2801	Homo sapiens	Residual activity	%	87.0
	3058268	CHEMBL1050408	Residual activity of CAMK2D at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	96.0	CHEMBL2801	Homo sapiens	Residual activity	%	96.0
	3058520	CHEMBL1047821	Residual activity of CAMK2D at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	13.0	CHEMBL2801	Homo sapiens	Residual activity	%	13.0
	3072866	CHEMBL1066622	Residual activity of CAMK2D at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	105.0	CHEMBL2801	Homo sapiens	Residual activity	%	105.0
	3213887	CHEMBL1114035	Inhibition of CAMK2delta at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	1.0	CHEMBL2801	Homo sapiens	INH	%	1.0
	3224771	CHEMBL1102613	Inhibition of CAMK2delta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	3225021	CHEMBL1102613	Inhibition of CAMK2delta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	3331853	CHEMBL1168812	Inhibition of CAMK2D at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	3333268	CHEMBL1168812	Inhibition of CAMK2D at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	3334673	CHEMBL1168812	Inhibition of CAMK2D at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	3336093	CHEMBL1168812	Inhibition of CAMK2D at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	3337474	CHEMBL1168812	Inhibition of CAMK2D at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	3337722	CHEMBL1168812	Inhibition of CAMK2D at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	3339054	CHEMBL1168812	Inhibition of CAMK2D at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	3340356	CHEMBL1168812	Inhibition of CAMK2D at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	3340621	CHEMBL1168812	Inhibition of CAMK2D at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	3342037	CHEMBL1168812	Inhibition of CAMK2D at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	3358480	CHEMBL1174094	Inhibition of CAMK2D at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL2801	Homo sapiens	INH	%	100.0
	3358922	CHEMBL1174094	Inhibition of CAMK2D at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	100.0	CHEMBL2801	Homo sapiens	INH	%	100.0
	3409017	CHEMBL1219844	Inhibition of CaMK2delta ( assessed as residual activity at 1 uM )	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	Activity	%	45.0	CHEMBL2801	Homo sapiens	Activity	%	45.0
	3409030	CHEMBL1219844	Inhibition of CaMK2delta ( assessed as residual activity at 1 uM )	B	CC(C)NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214857	=	Activity	%	91.0	CHEMBL2801	Homo sapiens	Activity	%	91.0
	3409176	CHEMBL1219885	Inhibition of human CaMK2delta	B	NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1214999	=	Inhibition	%	26.0	CHEMBL2801	Homo sapiens	INH	%	26.0
	3409186	CHEMBL1219885	Inhibition of human CaMK2delta	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	Inhibition	%	80.0	CHEMBL2801	Homo sapiens	INH	%	80.0
	3443352	CHEMBL1244385	Inhibition of CaMK2delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	16.0	CHEMBL2801	Homo sapiens	INH	%	16.0
	3443569	CHEMBL1244385	Inhibition of CaMK2delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	5.0	CHEMBL2801	Homo sapiens	INH	%	5.0
	3444724	CHEMBL1244385	Inhibition of CaMK2delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	5.0	CHEMBL2801	Homo sapiens	INH	%	5.0
	3445052	CHEMBL1244750	Binding affinity to CAMK2D	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	8.8	CHEMBL2801	Homo sapiens	Kd	nM	8.8
	3445348	CHEMBL1244385	Inhibition of CaMK2delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	4.0	CHEMBL2801	Homo sapiens	INH	%	4.0
	3445565	CHEMBL1244385	Inhibition of CaMK2delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	22.0	CHEMBL2801	Homo sapiens	INH	%	22.0
	3445780	CHEMBL1244385	Inhibition of CaMK2delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	36.0	CHEMBL2801	Homo sapiens	INH	%	36.0
	3445970	CHEMBL1244385	Inhibition of CaMK2delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	17.0	CHEMBL2801	Homo sapiens	INH	%	17.0
	3449081	CHEMBL1244750	Binding affinity to CAMK2D	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	36.0	CHEMBL2801	Homo sapiens	Kd	nM	36.0
	3449120	CHEMBL1244750	Binding affinity to CAMK2D	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	420.0	CHEMBL2801	Homo sapiens	Kd	nM	420.0
	3449403	CHEMBL1244750	Binding affinity to CAMK2D	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	1000.0	CHEMBL2801	Homo sapiens	Kd	nM	1000.0
	3449586	CHEMBL1244750	Binding affinity to CAMK2D	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	3450010	CHEMBL1244750	Binding affinity to CAMK2D	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	3450014	CHEMBL1244750	Binding affinity to CAMK2D	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	uM	10.0
	3463185	CHEMBL1251724	Inhibition of CAMK2D at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	90.0	CHEMBL2801	Homo sapiens	INH	%	90.0
	3463404	CHEMBL1251724	Inhibition of CAMK2D at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	11.0	CHEMBL2801	Homo sapiens	INH	%	11.0
	3463948	CHEMBL1251724	Inhibition of CAMK2D at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	85.0	CHEMBL2801	Homo sapiens	INH	%	85.0
Not Active	3599523	CHEMBL1291139	Displacement of radiolabeled Autocamtide-2 from CAMK2D at 1 to 3 uM	B	Oc1ccc2c(c1)CCN(CCCCc1ccccc1)CC2O		CHEMBL1289626		Activity			CHEMBL2801	Homo sapiens	Activity		
	5120374	CHEMBL1648191	Inhibition of human CaMK2delta at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	106.0	CHEMBL2801	Homo sapiens	INH	%	106.0
	5235551	CHEMBL1686352	Inhibition of human CaMK2delta at 1 uM	B	C[C@H](C#N)NC(=O)c1cccc(-c2cc(-c3ccc(CNC4CCOCC4)cc3)on2)c1		CHEMBL1683440	=	Inhibition	%	37.0	CHEMBL2801	Homo sapiens	INH	%	37.0
	5236032	CHEMBL1686359	Inhibition of human CaMK2delta	B	C[C@H](C#N)NC(=O)c1cccc(-c2cc(-c3ccc(CNC4CCOCC4)cc3)on2)c1		CHEMBL1683440	>	IC50	nM	7900.0	CHEMBL2801	Homo sapiens	IC50	uM	7.9
	6340912	CHEMBL1826936	Activity of CAMK2D kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	90.0	CHEMBL2801	Homo sapiens	Activity	%	90.0
	7567164	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7567623	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	2700.0	CHEMBL2801	Homo sapiens	Kd	nM	2700.0
	7568094	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7568562	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	2900.0	CHEMBL2801	Homo sapiens	Kd	nM	2900.0
	7568994	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	420.0	CHEMBL2801	Homo sapiens	Kd	nM	420.0
	7569137	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7569597	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7570069	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	90.0	CHEMBL2801	Homo sapiens	Kd	nM	90.0
	7570532	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7571113	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	2400.0	CHEMBL2801	Homo sapiens	Kd	nM	2400.0
	7571570	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7572046	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7572483	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	570.0	CHEMBL2801	Homo sapiens	Kd	nM	570.0
	7573094	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7573551	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	6400.0	CHEMBL2801	Homo sapiens	Kd	nM	6400.0
	7574054	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	36.0	CHEMBL2801	Homo sapiens	Kd	nM	36.0
	7574462	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7575072	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7575562	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7576027	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7576435	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	590.0	CHEMBL2801	Homo sapiens	Kd	nM	590.0
	7577046	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7577063	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7577541	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7578011	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7578416	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7578612	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	270.0	CHEMBL2801	Homo sapiens	Kd	nM	270.0
	7579436	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1600.0	CHEMBL2801	Homo sapiens	Kd	nM	1600.0
	7579910	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7580379	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7580782	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7580970	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7581355	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7581800	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7582271	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	2800.0	CHEMBL2801	Homo sapiens	Kd	nM	2800.0
	7582735	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	3000.0	CHEMBL2801	Homo sapiens	Kd	nM	3000.0
	7583135	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7583316	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7583713	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7584158	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7584629	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	4600.0	CHEMBL2801	Homo sapiens	Kd	nM	4600.0
	7585091	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	1400.0	CHEMBL2801	Homo sapiens	Kd	nM	1400.0
	7585646	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7586054	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7586500	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7586971	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7587607	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7588026	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	8.8	CHEMBL2801	Homo sapiens	Kd	nM	8.8
	7588479	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7588959	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7589572	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7589996	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7590463	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	620.0	CHEMBL2801	Homo sapiens	Kd	nM	620.0
	7590495	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7590946	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7591545	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7591967	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7592470	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7592923	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7593512	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7593977	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7594450	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7594902	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7595482	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7595956	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7596427	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7596874	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.32	CHEMBL2801	Homo sapiens	Kd	nM	0.32
	7597010	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7597463	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7597936	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7598406	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2801	Homo sapiens	Kd	nM	10000.0
	7598848	CHEMBL1908467	Binding constant for CAMK2D kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	760.0	CHEMBL2801	Homo sapiens	Kd	nM	760.0
	7959695	CHEMBL1932822	Inhibition of CAMK2delta	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	=	IC50	nM	12000.0	CHEMBL2801	Homo sapiens	IC50	uM	12.0
	7959696	CHEMBL1932822	Inhibition of CAMK2delta	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL2801	Homo sapiens	IC50	uM	30.0
	7998187	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CN1CCCC1CCNc1nc(Nc2ccc(Cl)c(Cl)c2)nc2ccc(Cl)cc12.Cl.Cl.Cl.Cl.Cl		CHEMBL3216550	=	Inhibition	%	100.0	CHEMBL2801	Homo sapiens	INH	%	100.0
	7998188	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCN1CCCC(Nc2nc(Nc3cc(Cl)cc(Cl)c3)nc3ccc(Cl)cc23)C1.Cl.Cl.Cl.Cl.Cl		CHEMBL3215661	=	Inhibition	%	100.0	CHEMBL2801	Homo sapiens	INH	%	100.0
	7998189	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CN(C)C1CCC(Nc2nc(Nc3cc(Cl)cc(Cl)c3)nc3ccccc23)CC1.Cl		CHEMBL1939163	=	Inhibition	%	86.0	CHEMBL2801	Homo sapiens	INH	%	86.0
	7998190	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCN1CCC(CNc2cc(C)nc(NC(=N)Nc3ccc(Cl)c(Cl)c3)n2)C1		CHEMBL1939164	=	Inhibition	%	77.0	CHEMBL2801	Homo sapiens	INH	%	77.0
	7998191	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	Cc1cc(C)nc(NC(=N)Nc2ccc(S(=O)(=O)NC(=O)Nc3ccccc3)cc2)n1.Cl.Cl		CHEMBL3217206	=	Inhibition	%	66.0	CHEMBL2801	Homo sapiens	INH	%	66.0
	7998192	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCN1CCCC(Nc2cc(C)nc(Nc3nc4cc(Cl)c(Cl)cc4[nH]3)n2)C1		CHEMBL1939166	=	Inhibition	%	83.0	CHEMBL2801	Homo sapiens	INH	%	83.0
	7998193	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCNc1nc(Nc2ccccc2OC)nc(N2CCNCC2)n1.Cl		CHEMBL1939167	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	7998194	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCCCCNc1nc(Nc2cc(Cl)ccc2C)nc(N2CCNCC2)n1.Cl		CHEMBL1939168	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	7998195	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCNc1nc(Nc2ccccc2OC)nc(N2CCN(CCN(C)C)CC2)n1.Cl		CHEMBL1939169	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	7998196	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	COc1ccccc1Nc1nc(NC(C)C)nc(N2CCN(CCN(C)C)CC2)n1.Cl		CHEMBL1939170	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	7998197	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCNc1nc(Nc2cc(Cl)ccc2C)nc(N2CCN(CCN(C)C)CC2)n1.Cl		CHEMBL1939171	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	7998198	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCCCCNc1nc(Nc2cc(Cl)ccc2C)nc(N2CCN(CCN(C)C)CC2)n1.Cl		CHEMBL1939322	=	Inhibition	%	40.16	CHEMBL2801	Homo sapiens	INH	%	40.16
	7998199	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	Cc1ccc(Cl)cc1Nc1nc(NC(C)C)nc(N2CCN(CCN(C)C)CC2)n1.Cl		CHEMBL1939323	=	Inhibition	%	1.35	CHEMBL2801	Homo sapiens	INH	%	1.35
	7998200	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	COc1cc(C)ccc1Nc1nc(NC(C)C)nc(N2CCN(CCN(C)C)CC2)n1.Cl		CHEMBL1939324	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	7998201	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCCCCNc1nc(Nc2ccc(C)cc2OC)nc(N2CCN(CCN(C)C)CC2)n1.Cl		CHEMBL1939325	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	7998202	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCNc1nc(Nc2ccc(Cl)cc2)nc(N2CCN(CCN(C)C)CC2)n1.Cl		CHEMBL1939326	=	Inhibition	%	6.88	CHEMBL2801	Homo sapiens	INH	%	6.88
	7998203	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCCCCNc1nc(Nc2ccc(Cl)cc2)nc(N2CCN(CCN(C)C)CC2)n1.Cl		CHEMBL1939327	=	Inhibition	%	82.0	CHEMBL2801	Homo sapiens	INH	%	82.0
	7998204	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCCCCNc1nc(Nc2ccc([N+](=O)[O-])cc2)nc(N2CCN(CCN(C)C)CC2)n1.Cl		CHEMBL1939328	=	Inhibition	%	82.0	CHEMBL2801	Homo sapiens	INH	%	82.0
	7998205	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Inhibition	%	85.5	CHEMBL2801	Homo sapiens	INH	%	85.5
	7998206	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	N=C(Nc1cccc2ccccc12)SCCCSC(=N)Nc1cccc2ccccc12		CHEMBL1165454	=	Inhibition	%	24.5	CHEMBL2801	Homo sapiens	INH	%	24.5
	7998207	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CSc1nc(O)c(Nc2cccc(Cl)c2)c(O)n1		CHEMBL1547116	=	Inhibition	%	10.82	CHEMBL2801	Homo sapiens	INH	%	10.82
	7998208	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	C/N=C(\N)c1ccc(NC(=N)c2ccc(C(=N)Nc3ccc(/C(N)=N/C)cc3)cc2)cc1		CHEMBL1939329	=	Inhibition	%	8.42	CHEMBL2801	Homo sapiens	INH	%	8.42
	7998209	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CSc1nc(O)c(Nc2ccc(C)c(C)c2)c(O)n1		CHEMBL1939330	=	Inhibition	%	16.12	CHEMBL2801	Homo sapiens	INH	%	16.12
	7998210	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CNC(=N)c1ccc(NC(=N)c2cccc(C(=N)Nc3ccc(C(=N)NC)cc3)c2)cc1		CHEMBL1939331	=	Inhibition	%	5.15	CHEMBL2801	Homo sapiens	INH	%	5.15
	7998211	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	OC(CNc1ccccc1Cl)COc1ccc(Cl)cc1Cl		CHEMBL1939332	=	Inhibition	%	47.13	CHEMBL2801	Homo sapiens	INH	%	47.13
	7998212	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	Cc1cc(Nc2ccc(O)c(CN3CCCC3)c2)cc(Nc2ccc(O)c(CN3CCCC3)c2)n1		CHEMBL1939333	=	Inhibition	%	42.61	CHEMBL2801	Homo sapiens	INH	%	42.61
	7998213	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CN1CCN(CC(O)Cn2c(=O)c3c(nc(N4CCN(C)CC4)n3C)n(C)c2=O)CC1		CHEMBL1939334	=	Inhibition	%	12.48	CHEMBL2801	Homo sapiens	INH	%	12.48
	7998214	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	Cc1cc(N2CCC(N3CCCC3)CC2)nc(NC(=N)Nc2ccc(Cl)c(Cl)c2)n1		CHEMBL1939335	=	Inhibition	%	48.18	CHEMBL2801	Homo sapiens	INH	%	48.18
	7998215	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CC1(C)N=C(N)N=C(N)N1c1cccc(OCCOc2cccc(NC(=O)CBr)c2)c1		CHEMBL97143	=	Inhibition	%	46.12	CHEMBL2801	Homo sapiens	INH	%	46.12
	7998216	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	N=C(NC1CCC(C2CCC(N)CC2)CC1)C(=N)NC1CCC(C2CCC(N)CC2)CC1		CHEMBL1939336	=	Inhibition	%	12.71	CHEMBL2801	Homo sapiens	INH	%	12.71
	7998217	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCN1CCCC(Nc2cc(C)nc(NC(=N)Nc3ccc(Cl)c(Cl)c3)n2)C1		CHEMBL1939337	=	Inhibition	%	13.45	CHEMBL2801	Homo sapiens	INH	%	13.45
	7998218	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	N=C(Nc1cccc2ccccc12)SCCSC(=N)Nc1cccc2ccccc12		CHEMBL1939338	=	Inhibition	%	39.85	CHEMBL2801	Homo sapiens	INH	%	39.85
	7998219	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	N=C(Nc1ccccc1)SCCCSC(=N)Nc1ccccc1		CHEMBL1939339	=	Inhibition	%	26.25	CHEMBL2801	Homo sapiens	INH	%	26.25
	7998220	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCCCn1c(C)nc2c1/C(=N/NC(=N)N)c1ccccc1/C2=N/NC(=N)N		CHEMBL1939340	=	Inhibition	%	47.66	CHEMBL2801	Homo sapiens	INH	%	47.66
	7998221	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CC1=NN(c2ccccc2)/C(=N\NC(=N)N)C1CC1C(C)=NN(c2ccccc2)/C1=N/NC(=N)N		CHEMBL1939341	=	Inhibition	%	16.21	CHEMBL2801	Homo sapiens	INH	%	16.21
	7998222	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CNC(=N)c1ccc(NC(=N)c2ccc(NC(=N)c3ccc(C(=N)NC)cc3)cc2)cc1		CHEMBL1939342	=	Inhibition	%	30.98	CHEMBL2801	Homo sapiens	INH	%	30.98
	7998223	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	Cc1ccc(S(=O)(=O)Nc2cc(C)cc(CCN)c2C)cc1		CHEMBL1939343	=	Inhibition	%	45.94	CHEMBL2801	Homo sapiens	INH	%	45.94
	7998224	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCN1CCC(CNc2cc(C)nc(NC(=N)Nc3cc(Cl)cc(Cl)c3)n2)C1		CHEMBL1939344	=	Inhibition	%	49.1	CHEMBL2801	Homo sapiens	INH	%	49.1
	7998225	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	NCc1nnn(Cc2ccccc2)c1/N=C/Nc1c(CN)nnn1Cc1ccccc1		CHEMBL1939345	=	Inhibition	%	14.53	CHEMBL2801	Homo sapiens	INH	%	14.53
	7998226	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	COC(=O)C(CCCCN)NS(=O)(=O)c1ccccc1		CHEMBL1939346	=	Inhibition	%	39.09	CHEMBL2801	Homo sapiens	INH	%	39.09
	7998227	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CN1CCN(NCCN2CCCC(OC(=O)C(O)(c3ccccc3)c3ccccc3)C2)CC1		CHEMBL1939347	=	Inhibition	%	23.45	CHEMBL2801	Homo sapiens	INH	%	23.45
	7998228	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	CCCCN(C)CCNc1cc(C)nc(Nc2nc3ccc(Cl)cc3[nH]2)n1		CHEMBL1939348	=	Inhibition	%	35.49	CHEMBL2801	Homo sapiens	INH	%	35.49
	7999109	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	COc1cc(/C=N/n2c(-c3ccccc3)nc3ccccc3c2=O)cc(Br)c1O		CHEMBL1939349	=	Inhibition	%	32.07	CHEMBL2801	Homo sapiens	INH	%	32.07
	7999110	CHEMBL1941891	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate by spectrophotometry analysis	B	CN1CCCC1CCNc1nc(Nc2ccc(Cl)c(Cl)c2)nc2ccc(Cl)cc12.Cl.Cl.Cl.Cl.Cl		CHEMBL3216550	=	IC50	nM	2.0	CHEMBL2801	Homo sapiens	IC50	uM	0.002
	7999111	CHEMBL1941891	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate by spectrophotometry analysis	B	CCN1CCCC(Nc2nc(Nc3cc(Cl)cc(Cl)c3)nc3ccc(Cl)cc23)C1.Cl.Cl.Cl.Cl.Cl		CHEMBL3215661	=	IC50	nM	82.0	CHEMBL2801	Homo sapiens	IC50	uM	0.082
	7999112	CHEMBL1941891	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate by spectrophotometry analysis	B	CN(C)C1CCC(Nc2nc(Nc3cc(Cl)cc(Cl)c3)nc3ccccc23)CC1.Cl		CHEMBL1939163	=	IC50	nM	619.0	CHEMBL2801	Homo sapiens	IC50	uM	0.619
	7999113	CHEMBL1941891	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate by spectrophotometry analysis	B	CCN1CCC(CNc2cc(C)nc(NC(=N)Nc3ccc(Cl)c(Cl)c3)n2)C1		CHEMBL1939164	=	IC50	nM	2460.0	CHEMBL2801	Homo sapiens	IC50	uM	2.46
	7999114	CHEMBL1941891	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate by spectrophotometry analysis	B	Cc1cc(C)nc(NC(=N)Nc2ccc(S(=O)(=O)NC(=O)Nc3ccccc3)cc2)n1.Cl.Cl		CHEMBL3217206	=	IC50	nM	1660.0	CHEMBL2801	Homo sapiens	IC50	uM	1.66
	7999115	CHEMBL1941891	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate by spectrophotometry analysis	B	CCN1CCCC(Nc2cc(C)nc(Nc3nc4cc(Cl)c(Cl)cc4[nH]3)n2)C1		CHEMBL1939166	=	IC50	nM	1880.0	CHEMBL2801	Homo sapiens	IC50	uM	1.88
	7999116	CHEMBL1941891	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate by spectrophotometry analysis	B	CCCCCNc1nc(Nc2ccc(Cl)cc2)nc(N2CCN(CCN(C)C)CC2)n1.Cl		CHEMBL1939327	=	IC50	nM	401.0	CHEMBL2801	Homo sapiens	IC50	uM	0.401
	7999117	CHEMBL1941891	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate by spectrophotometry analysis	B	CCCCCNc1nc(Nc2ccc([N+](=O)[O-])cc2)nc(N2CCN(CCN(C)C)CC2)n1.Cl		CHEMBL1939328	=	IC50	nM	154.0	CHEMBL2801	Homo sapiens	IC50	uM	0.154
	7999118	CHEMBL1941891	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate by spectrophotometry analysis	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	IC50	nM	380.0	CHEMBL2801	Homo sapiens	IC50	uM	0.38
	7999119	CHEMBL1941890	Inhibition of human recombinant CAMK2delta using tetramethylbenzidine as substrate at 10 uM by spectrophotometry analysis	B	Cc1ncc2c(n1)NC(c1cc(Cl)cc(Cl)c1)NC2		CHEMBL1939350	=	Inhibition	%	6.9	CHEMBL2801	Homo sapiens	INH	%	6.9
	8042202	CHEMBL1954968	Inhibition of CAMK2D at 1 uM	B	CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cccc5[nH]ncc45)nc3s2)CC1		CHEMBL1949908	>	Inhibition	%	80.0	CHEMBL2801	Homo sapiens	INH	%	80.0
	8047091	CHEMBL1958826	Inhibition of CAMK2D at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	8061259	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.18	CHEMBL2801	Homo sapiens	Inhibition	%	-0.18
	8061436	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.47	CHEMBL2801	Homo sapiens	Inhibition	%	-0.47
	8061767	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.35	CHEMBL2801	Homo sapiens	Inhibition	%	2.35
	8061958	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.44	CHEMBL2801	Homo sapiens	Inhibition	%	2.44
	8062182	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	6.23	CHEMBL2801	Homo sapiens	Inhibition	%	6.23
	8062298	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.9	CHEMBL2801	Homo sapiens	Inhibition	%	2.9
	8062684	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.3	CHEMBL2801	Homo sapiens	Inhibition	%	2.3
	8062782	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	4.41	CHEMBL2801	Homo sapiens	Inhibition	%	4.41
	8063006	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.47	CHEMBL2801	Homo sapiens	Inhibition	%	1.47
	8063138	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.12	CHEMBL2801	Homo sapiens	Inhibition	%	2.12
	8063305	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.24	CHEMBL2801	Homo sapiens	Inhibition	%	0.24
	8063529	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.01	CHEMBL2801	Homo sapiens	Inhibition	%	-0.01
	8063637	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.17	CHEMBL2801	Homo sapiens	Inhibition	%	1.17
	8064043	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.59	CHEMBL2801	Homo sapiens	Inhibition	%	1.59
	8064158	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.76	CHEMBL2801	Homo sapiens	Inhibition	%	4.76
	8064382	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.23	CHEMBL2801	Homo sapiens	Inhibition	%	1.23
	8064592	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.72	CHEMBL2801	Homo sapiens	Inhibition	%	2.72
	8064730	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.93	CHEMBL2801	Homo sapiens	Inhibition	%	0.93
	8065120	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.17	CHEMBL2801	Homo sapiens	Inhibition	%	0.17
	8065236	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.87	CHEMBL2801	Homo sapiens	Inhibition	%	1.87
	8065460	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.97	CHEMBL2801	Homo sapiens	Inhibition	%	1.97
	8065635	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.33	CHEMBL2801	Homo sapiens	Inhibition	%	3.33
	8065974	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	17.34	CHEMBL2801	Homo sapiens	Inhibition	%	17.34
	8066184	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.0	CHEMBL2801	Homo sapiens	Inhibition	%	2.0
	8066320	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	8.26	CHEMBL2801	Homo sapiens	Inhibition	%	8.26
	8066544	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	6.12	CHEMBL2801	Homo sapiens	Inhibition	%	6.12
	8066710	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.7	CHEMBL2801	Homo sapiens	Inhibition	%	1.7
	8067058	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.53	CHEMBL2801	Homo sapiens	Inhibition	%	3.53
	8067233	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.61	CHEMBL2801	Homo sapiens	Inhibition	%	3.61
	8067578	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.43	CHEMBL2801	Homo sapiens	Inhibition	%	0.43
	8067788	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	3.76	CHEMBL2801	Homo sapiens	Inhibition	%	3.76
	8068147	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	36.37	CHEMBL2801	Homo sapiens	Inhibition	%	36.37
	8068311	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.08	CHEMBL2801	Homo sapiens	Inhibition	%	0.08
	8068660	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.08	CHEMBL2801	Homo sapiens	Inhibition	%	0.08
	8068834	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.6	CHEMBL2801	Homo sapiens	Inhibition	%	3.6
	8069058	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.81	CHEMBL2801	Homo sapiens	Inhibition	%	2.81
	8069183	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.99	CHEMBL2801	Homo sapiens	Inhibition	%	2.99
	8069478	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	11.5	CHEMBL2801	Homo sapiens	Inhibition	%	11.5
	8069639	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.56	CHEMBL2801	Homo sapiens	Inhibition	%	2.56
	8069863	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.57	CHEMBL2801	Homo sapiens	Inhibition	%	2.57
	8069989	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.72	CHEMBL2801	Homo sapiens	Inhibition	%	0.72
	8070385	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.06	CHEMBL2801	Homo sapiens	Inhibition	%	3.06
	8070510	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.8	CHEMBL2801	Homo sapiens	Inhibition	%	-0.8
	8070808	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	56.74	CHEMBL2801	Homo sapiens	Inhibition	%	56.74
	8071189	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.12	CHEMBL2801	Homo sapiens	Inhibition	%	-0.12
	8071315	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.08	CHEMBL2801	Homo sapiens	Inhibition	%	0.08
	8071539	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.08	CHEMBL2801	Homo sapiens	Inhibition	%	2.08
	8071712	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.12	CHEMBL2801	Homo sapiens	Inhibition	%	3.12
	8071837	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.63	CHEMBL2801	Homo sapiens	Inhibition	%	1.63
	8072061	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.25	CHEMBL2801	Homo sapiens	Inhibition	%	0.25
	8072151	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.53	CHEMBL2801	Homo sapiens	Inhibition	%	0.53
	8072375	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.94	CHEMBL2801	Homo sapiens	Inhibition	%	0.94
	8072532	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.6	CHEMBL2801	Homo sapiens	Inhibition	%	1.6
	8072881	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-1.72	CHEMBL2801	Homo sapiens	Inhibition	%	-1.72
	8073048	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.6	CHEMBL2801	Homo sapiens	Inhibition	%	4.6
	8073397	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.63	CHEMBL2801	Homo sapiens	Inhibition	%	1.63
	8073516	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.2	CHEMBL2801	Homo sapiens	Inhibition	%	1.2
	8073740	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	3.28	CHEMBL2801	Homo sapiens	Inhibition	%	3.28
	8073973	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.33	CHEMBL2801	Homo sapiens	Inhibition	%	-0.33
	8074125	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.54	CHEMBL2801	Homo sapiens	Inhibition	%	1.54
	8074479	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.17	CHEMBL2801	Homo sapiens	Inhibition	%	1.17
	8074636	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.62	CHEMBL2801	Homo sapiens	Inhibition	%	2.62
	8074987	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.04	CHEMBL2801	Homo sapiens	Inhibition	%	-0.04
	8075322	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.48	CHEMBL2801	Homo sapiens	Inhibition	%	1.48
	8075559	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.82	CHEMBL2801	Homo sapiens	Inhibition	%	1.82
	8075700	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.45	CHEMBL2801	Homo sapiens	Inhibition	%	1.45
	8075924	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.49	CHEMBL2801	Homo sapiens	Inhibition	%	4.49
	8076066	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.5	CHEMBL2801	Homo sapiens	Inhibition	%	-0.5
	8076214	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.58	CHEMBL2801	Homo sapiens	Inhibition	%	2.58
	8076438	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.83	CHEMBL2801	Homo sapiens	Inhibition	%	2.83
	8076572	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	9.94	CHEMBL2801	Homo sapiens	Inhibition	%	9.94
	8076898	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.85	CHEMBL2801	Homo sapiens	Inhibition	%	2.85
	8077145	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.76	CHEMBL2801	Homo sapiens	Inhibition	%	-0.76
	8077497	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.1	CHEMBL2801	Homo sapiens	Inhibition	%	1.1
	8077648	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	5.44	CHEMBL2801	Homo sapiens	Inhibition	%	5.44
	8078015	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.66	CHEMBL2801	Homo sapiens	Inhibition	%	3.66
	8078154	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-3.72	CHEMBL2801	Homo sapiens	Inhibition	%	-3.72
	8078378	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	1.69	CHEMBL2801	Homo sapiens	Inhibition	%	1.69
	8078480	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	16.07	CHEMBL2801	Homo sapiens	Inhibition	%	16.07
	8078730	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	14.33	CHEMBL2801	Homo sapiens	Inhibition	%	14.33
	8079070	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.51	CHEMBL2801	Homo sapiens	Inhibition	%	1.51
	8079228	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.89	CHEMBL2801	Homo sapiens	Inhibition	%	-0.89
	8079452	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	7.31	CHEMBL2801	Homo sapiens	Inhibition	%	7.31
	8079594	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.36	CHEMBL2801	Homo sapiens	Inhibition	%	2.36
	8079957	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	20.89	CHEMBL2801	Homo sapiens	Inhibition	%	20.89
	8080062	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.8	CHEMBL2801	Homo sapiens	Inhibition	%	2.8
	8080314	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	4.43	CHEMBL2801	Homo sapiens	Inhibition	%	4.43
	8080538	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	36.69	CHEMBL2801	Homo sapiens	Inhibition	%	36.69
	8080653	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.77	CHEMBL2801	Homo sapiens	Inhibition	%	0.77
	8081041	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.9	CHEMBL2801	Homo sapiens	Inhibition	%	-3.9
	8081176	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.19	CHEMBL2801	Homo sapiens	Inhibition	%	2.19
	8081544	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	70.99	CHEMBL2801	Homo sapiens	Inhibition	%	70.99
	8081647	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.12	CHEMBL2801	Homo sapiens	Inhibition	%	3.12
	8081871	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	12.0	CHEMBL2801	Homo sapiens	Inhibition	%	12.0
	8082123	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.42	CHEMBL2801	Homo sapiens	Inhibition	%	-1.42
	8082236	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.93	CHEMBL2801	Homo sapiens	Inhibition	%	1.93
	8082460	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-0.04	CHEMBL2801	Homo sapiens	Inhibition	%	-0.04
	8082633	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.49	CHEMBL2801	Homo sapiens	Inhibition	%	1.49
	8082756	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.89	CHEMBL2801	Homo sapiens	Inhibition	%	1.89
	8082980	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.44	CHEMBL2801	Homo sapiens	Inhibition	%	1.44
	8083136	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.56	CHEMBL2801	Homo sapiens	Inhibition	%	2.56
	8083459	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.31	CHEMBL2801	Homo sapiens	Inhibition	%	3.31
	8083713	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	4.05	CHEMBL2801	Homo sapiens	Inhibition	%	4.05
	8084047	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.76	CHEMBL2801	Homo sapiens	Inhibition	%	4.76
	8084232	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	4.26	CHEMBL2801	Homo sapiens	Inhibition	%	4.26
	8084574	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.28	CHEMBL2801	Homo sapiens	Inhibition	%	2.28
	8084735	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	8.04	CHEMBL2801	Homo sapiens	Inhibition	%	8.04
	8085057	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.0	CHEMBL2801	Homo sapiens	Inhibition	%	3.0
	8085313	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-4.62	CHEMBL2801	Homo sapiens	Inhibition	%	-4.62
	8085645	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.53	CHEMBL2801	Homo sapiens	Inhibition	%	0.53
	8085834	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	18.3	CHEMBL2801	Homo sapiens	Inhibition	%	18.3
	8086173	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.7	CHEMBL2801	Homo sapiens	Inhibition	%	2.7
	8086335	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	3.23	CHEMBL2801	Homo sapiens	Inhibition	%	3.23
	8086559	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	12.27	CHEMBL2801	Homo sapiens	Inhibition	%	12.27
	8086658	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.32	CHEMBL2801	Homo sapiens	Inhibition	%	2.32
	8086869	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.11	CHEMBL2801	Homo sapiens	Inhibition	%	3.11
	8087093	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	8.55	CHEMBL2801	Homo sapiens	Inhibition	%	8.55
	8087251	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.68	CHEMBL2801	Homo sapiens	Inhibition	%	2.68
	8087589	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.81	CHEMBL2801	Homo sapiens	Inhibition	%	3.81
	8087727	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.36	CHEMBL2801	Homo sapiens	Inhibition	%	3.36
	8087951	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.37	CHEMBL2801	Homo sapiens	Inhibition	%	1.37
	8088093	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.57	CHEMBL2801	Homo sapiens	Inhibition	%	6.57
	8088241	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.44	CHEMBL2801	Homo sapiens	Inhibition	%	0.44
	8088465	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.39	CHEMBL2801	Homo sapiens	Inhibition	%	1.39
	8088593	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	2.63	CHEMBL2801	Homo sapiens	Inhibition	%	2.63
	8088910	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.89	CHEMBL2801	Homo sapiens	Inhibition	%	4.89
	8089262	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	16.53	CHEMBL2801	Homo sapiens	Inhibition	%	16.53
	8089410	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.83	CHEMBL2801	Homo sapiens	Inhibition	%	2.83
	8089754	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.45	CHEMBL2801	Homo sapiens	Inhibition	%	1.45
	8089934	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.48	CHEMBL2801	Homo sapiens	Inhibition	%	-0.48
	8090323	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	7.41	CHEMBL2801	Homo sapiens	Inhibition	%	7.41
	8090490	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.22	CHEMBL2801	Homo sapiens	Inhibition	%	2.22
	8090853	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.07	CHEMBL2801	Homo sapiens	Inhibition	%	1.07
	8091058	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.72	CHEMBL2801	Homo sapiens	Inhibition	%	2.72
	8091419	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	5.36	CHEMBL2801	Homo sapiens	Inhibition	%	5.36
	8091574	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.75	CHEMBL2801	Homo sapiens	Inhibition	%	4.75
	8091914	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.92	CHEMBL2801	Homo sapiens	Inhibition	%	4.92
	8092275	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.5	CHEMBL2801	Homo sapiens	Inhibition	%	2.5
	8092426	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.55	CHEMBL2801	Homo sapiens	Inhibition	%	4.55
	8092798	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.89	CHEMBL2801	Homo sapiens	Inhibition	%	-0.89
	8092927	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.01	CHEMBL2801	Homo sapiens	Inhibition	%	5.01
	8093239	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.44	CHEMBL2801	Homo sapiens	Inhibition	%	2.44
	8093603	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.01	CHEMBL2801	Homo sapiens	Inhibition	%	-0.01
	8093742	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	11.32	CHEMBL2801	Homo sapiens	Inhibition	%	11.32
	8093966	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.92	CHEMBL2801	Homo sapiens	Inhibition	%	1.92
	8094086	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.43	CHEMBL2801	Homo sapiens	Inhibition	%	1.43
	8094266	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.09	CHEMBL2801	Homo sapiens	Inhibition	%	-0.09
	8094490	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.35	CHEMBL2801	Homo sapiens	Inhibition	%	0.35
	8094665	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	29.01	CHEMBL2801	Homo sapiens	Inhibition	%	29.01
	8094821	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.36	CHEMBL2801	Homo sapiens	Inhibition	%	3.36
	8095045	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.95	CHEMBL2801	Homo sapiens	Inhibition	%	2.95
	8095185	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.14	CHEMBL2801	Homo sapiens	Inhibition	%	0.14
	8095388	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.68	CHEMBL2801	Homo sapiens	Inhibition	%	1.68
	8095612	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.13	CHEMBL2801	Homo sapiens	Inhibition	%	0.13
	8095753	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	20.63	CHEMBL2801	Homo sapiens	Inhibition	%	20.63
	8095901	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.57	CHEMBL2801	Homo sapiens	Inhibition	%	1.57
	8096125	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.24	CHEMBL2801	Homo sapiens	Inhibition	%	4.24
	8096242	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.98	CHEMBL2801	Homo sapiens	Inhibition	%	3.98
	8096605	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.81	CHEMBL2801	Homo sapiens	Inhibition	%	0.81
	8096761	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.4	CHEMBL2801	Homo sapiens	Inhibition	%	7.4
	8096985	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.92	CHEMBL2801	Homo sapiens	Inhibition	%	3.92
	8097132	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.53	CHEMBL2801	Homo sapiens	Inhibition	%	1.53
	8097439	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	6.94	CHEMBL2801	Homo sapiens	Inhibition	%	6.94
	8097663	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.84	CHEMBL2801	Homo sapiens	Inhibition	%	3.84
	8097813	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.5	CHEMBL2801	Homo sapiens	Inhibition	%	1.5
	8098170	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.91	CHEMBL2801	Homo sapiens	Inhibition	%	1.91
	8098290	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.07	CHEMBL2801	Homo sapiens	Inhibition	%	0.07
	8098694	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.67	CHEMBL2801	Homo sapiens	Inhibition	%	0.67
	8098879	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	75.11	CHEMBL2801	Homo sapiens	Inhibition	%	75.11
	8099247	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.61	CHEMBL2801	Homo sapiens	Inhibition	%	3.61
	8099389	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.61	CHEMBL2801	Homo sapiens	Inhibition	%	0.61
	8099807	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-1.01	CHEMBL2801	Homo sapiens	Inhibition	%	-1.01
	8099954	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.56	CHEMBL2801	Homo sapiens	Inhibition	%	4.56
	8100324	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.48	CHEMBL2801	Homo sapiens	Inhibition	%	2.48
	8100440	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.24	CHEMBL2801	Homo sapiens	Inhibition	%	5.24
	8100664	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.46	CHEMBL2801	Homo sapiens	Inhibition	%	3.46
	8100804	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.03	CHEMBL2801	Homo sapiens	Inhibition	%	1.03
	8101188	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	8.26	CHEMBL2801	Homo sapiens	Inhibition	%	8.26
	8101330	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-2.56	CHEMBL2801	Homo sapiens	Inhibition	%	-2.56
	8101515	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.08	CHEMBL2801	Homo sapiens	Inhibition	%	2.08
	8101739	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	4.15	CHEMBL2801	Homo sapiens	Inhibition	%	4.15
	8101992	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	15.22	CHEMBL2801	Homo sapiens	Inhibition	%	15.22
	8102147	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.68	CHEMBL2801	Homo sapiens	Inhibition	%	-1.68
	8102502	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.08	CHEMBL2801	Homo sapiens	Inhibition	%	2.08
	8102622	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.84	CHEMBL2801	Homo sapiens	Inhibition	%	-0.84
	8102846	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.86	CHEMBL2801	Homo sapiens	Inhibition	%	1.86
	8103024	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.25	CHEMBL2801	Homo sapiens	Inhibition	%	0.25
	8103220	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.52	CHEMBL2801	Homo sapiens	Inhibition	%	4.52
	8103582	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.45	CHEMBL2801	Homo sapiens	Inhibition	%	0.45
	8103732	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.91	CHEMBL2801	Homo sapiens	Inhibition	%	1.91
	8103956	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.02	CHEMBL2801	Homo sapiens	Inhibition	%	3.02
	8104141	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.3	CHEMBL2801	Homo sapiens	Inhibition	%	1.3
	8104289	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	12.46	CHEMBL2801	Homo sapiens	Inhibition	%	12.46
	8104513	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	9.02	CHEMBL2801	Homo sapiens	Inhibition	%	9.02
	8104659	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	16.34	CHEMBL2801	Homo sapiens	Inhibition	%	16.34
	8104997	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.08	CHEMBL2801	Homo sapiens	Inhibition	%	5.08
	8105137	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.64	CHEMBL2801	Homo sapiens	Inhibition	%	-0.64
	8105527	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	10.17	CHEMBL2801	Homo sapiens	Inhibition	%	10.17
	8105665	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	5.55	CHEMBL2801	Homo sapiens	Inhibition	%	5.55
	8105889	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.94	CHEMBL2801	Homo sapiens	Inhibition	%	3.94
	8105945	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	4.28	CHEMBL2801	Homo sapiens	Inhibition	%	4.28
	8106169	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	3.37	CHEMBL2801	Homo sapiens	Inhibition	%	3.37
	8106334	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	3.65	CHEMBL2801	Homo sapiens	Inhibition	%	3.65
	8106490	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	3.58	CHEMBL2801	Homo sapiens	Inhibition	%	3.58
	8106714	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-4.81	CHEMBL2801	Homo sapiens	Inhibition	%	-4.81
	8106843	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	8.27	CHEMBL2801	Homo sapiens	Inhibition	%	8.27
	8107188	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.28	CHEMBL2801	Homo sapiens	Inhibition	%	-0.28
	8107360	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.18	CHEMBL2801	Homo sapiens	Inhibition	%	2.18
	8107561	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	8.64	CHEMBL2801	Homo sapiens	Inhibition	%	8.64
	8107785	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.42	CHEMBL2801	Homo sapiens	Inhibition	%	4.42
	8107920	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.08	CHEMBL2801	Homo sapiens	Inhibition	%	2.08
	8108302	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.51	CHEMBL2801	Homo sapiens	Inhibition	%	0.51
	8108477	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.37	CHEMBL2801	Homo sapiens	Inhibition	%	0.37
	8108848	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	38.1	CHEMBL2801	Homo sapiens	Inhibition	%	38.1
	8108990	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.42	CHEMBL2801	Homo sapiens	Inhibition	%	0.42
	8109328	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.82	CHEMBL2801	Homo sapiens	Inhibition	%	2.82
	8109458	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.18	CHEMBL2801	Homo sapiens	Inhibition	%	1.18
	8109682	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-2.69	CHEMBL2801	Homo sapiens	Inhibition	%	-2.69
	8109853	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	44.3	CHEMBL2801	Homo sapiens	Inhibition	%	44.3
	8110209	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	7.34	CHEMBL2801	Homo sapiens	Inhibition	%	7.34
	8110488	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.88	CHEMBL2801	Homo sapiens	Inhibition	%	4.88
	8110654	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	4.37	CHEMBL2801	Homo sapiens	Inhibition	%	4.37
	8111036	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-4.58	CHEMBL2801	Homo sapiens	Inhibition	%	-4.58
	8111159	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.51	CHEMBL2801	Homo sapiens	Inhibition	%	1.51
	8111510	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.64	CHEMBL2801	Homo sapiens	Inhibition	%	0.64
	8111676	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.35	CHEMBL2801	Homo sapiens	Inhibition	%	1.35
	8111900	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.61	CHEMBL2801	Homo sapiens	Inhibition	%	0.61
	8112105	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	6.85	CHEMBL2801	Homo sapiens	Inhibition	%	6.85
	8112242	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.75	CHEMBL2801	Homo sapiens	Inhibition	%	0.75
	8112466	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.55	CHEMBL2801	Homo sapiens	Inhibition	%	1.55
	8112634	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.74	CHEMBL2801	Homo sapiens	Inhibition	%	3.74
	8112806	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.18	CHEMBL2801	Homo sapiens	Inhibition	%	0.18
	8113182	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.94	CHEMBL2801	Homo sapiens	Inhibition	%	3.94
	8113318	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.29	CHEMBL2801	Homo sapiens	Inhibition	%	1.29
	8113542	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-1.29	CHEMBL2801	Homo sapiens	Inhibition	%	-1.29
	8113666	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.42	CHEMBL2801	Homo sapiens	Inhibition	%	3.42
	8114006	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.02	CHEMBL2801	Homo sapiens	Inhibition	%	0.02
	8114182	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.02	CHEMBL2801	Homo sapiens	Inhibition	%	3.02
	8114538	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.02	CHEMBL2801	Homo sapiens	Inhibition	%	3.02
	8114814	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.35	CHEMBL2801	Homo sapiens	Inhibition	%	2.35
	8114980	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	3.01	CHEMBL2801	Homo sapiens	Inhibition	%	3.01
	8115369	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.74	CHEMBL2801	Homo sapiens	Inhibition	%	-0.74
	8115489	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.63	CHEMBL2801	Homo sapiens	Inhibition	%	2.63
	8115713	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.76	CHEMBL2801	Homo sapiens	Inhibition	%	1.76
	8115846	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.35	CHEMBL2801	Homo sapiens	Inhibition	%	0.35
	8116229	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	12.19	CHEMBL2801	Homo sapiens	Inhibition	%	12.19
	8116432	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.43	CHEMBL2801	Homo sapiens	Inhibition	%	4.43
	8116790	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.56	CHEMBL2801	Homo sapiens	Inhibition	%	-0.56
	8116962	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.95	CHEMBL2801	Homo sapiens	Inhibition	%	2.95
	8117133	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.44	CHEMBL2801	Homo sapiens	Inhibition	%	-0.44
	8117357	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.63	CHEMBL2801	Homo sapiens	Inhibition	%	-0.63
	8117515	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	7.7	CHEMBL2801	Homo sapiens	Inhibition	%	7.7
	8117869	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.59	CHEMBL2801	Homo sapiens	Inhibition	%	1.59
	8118007	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.91	CHEMBL2801	Homo sapiens	Inhibition	%	1.91
	8118347	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.78	CHEMBL2801	Homo sapiens	Inhibition	%	4.78
	8118519	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	7.55	CHEMBL2801	Homo sapiens	Inhibition	%	7.55
	8118743	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.18	CHEMBL2801	Homo sapiens	Inhibition	%	3.18
	8118879	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.67	CHEMBL2801	Homo sapiens	Inhibition	%	1.67
	8119150	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	4.57	CHEMBL2801	Homo sapiens	Inhibition	%	4.57
	8119309	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	4.94	CHEMBL2801	Homo sapiens	Inhibition	%	4.94
	8119533	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.65	CHEMBL2801	Homo sapiens	Inhibition	%	3.65
	8119700	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-2.74	CHEMBL2801	Homo sapiens	Inhibition	%	-2.74
	8120043	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.83	CHEMBL2801	Homo sapiens	Inhibition	%	3.83
	8120182	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.22	CHEMBL2801	Homo sapiens	Inhibition	%	0.22
	8120406	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.06	CHEMBL2801	Homo sapiens	Inhibition	%	-0.06
	8120566	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.73	CHEMBL2801	Homo sapiens	Inhibition	%	0.73
	8120767	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	8.15	CHEMBL2801	Homo sapiens	Inhibition	%	8.15
	8121119	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.81	CHEMBL2801	Homo sapiens	Inhibition	%	0.81
	8121291	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.04	CHEMBL2801	Homo sapiens	Inhibition	%	1.04
	8121682	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	4.29	CHEMBL2801	Homo sapiens	Inhibition	%	4.29
	8121845	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.32	CHEMBL2801	Homo sapiens	Inhibition	%	3.32
	8122190	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-3.72	CHEMBL2801	Homo sapiens	Inhibition	%	-3.72
	8122328	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	4.38	CHEMBL2801	Homo sapiens	Inhibition	%	4.38
	8122552	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	4.43	CHEMBL2801	Homo sapiens	Inhibition	%	4.43
	8122672	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	8.49	CHEMBL2801	Homo sapiens	Inhibition	%	8.49
	8123063	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	7.05	CHEMBL2801	Homo sapiens	Inhibition	%	7.05
	8123205	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.23	CHEMBL2801	Homo sapiens	Inhibition	%	3.23
	8123483	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	14.17	CHEMBL2801	Homo sapiens	Inhibition	%	14.17
	8123857	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	12.38	CHEMBL2801	Homo sapiens	Inhibition	%	12.38
	8124024	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-1.07	CHEMBL2801	Homo sapiens	Inhibition	%	-1.07
	8124367	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	6.9	CHEMBL2801	Homo sapiens	Inhibition	%	6.9
	8124730	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.31	CHEMBL2801	Homo sapiens	Inhibition	%	2.31
	8124895	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.8	CHEMBL2801	Homo sapiens	Inhibition	%	0.8
	8125096	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.44	CHEMBL2801	Homo sapiens	Inhibition	%	4.44
	8125320	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	7.05	CHEMBL2801	Homo sapiens	Inhibition	%	7.05
	8125450	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.25	CHEMBL2801	Homo sapiens	Inhibition	%	-1.25
	8125618	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.85	CHEMBL2801	Homo sapiens	Inhibition	%	-0.85
	8125842	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.87	CHEMBL2801	Homo sapiens	Inhibition	%	2.87
	8126006	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.8	CHEMBL2801	Homo sapiens	Inhibition	%	-0.8
	8126170	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	7.99	CHEMBL2801	Homo sapiens	Inhibition	%	7.99
	8126394	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.84	CHEMBL2801	Homo sapiens	Inhibition	%	3.84
	8126509	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.29	CHEMBL2801	Homo sapiens	Inhibition	%	0.29
	8126869	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	16.32	CHEMBL2801	Homo sapiens	Inhibition	%	16.32
	8126991	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.93	CHEMBL2801	Homo sapiens	Inhibition	%	3.93
	8127215	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	10.27	CHEMBL2801	Homo sapiens	Inhibition	%	10.27
	8127382	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.73	CHEMBL2801	Homo sapiens	Inhibition	%	4.73
	8127524	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	7.03	CHEMBL2801	Homo sapiens	Inhibition	%	7.03
	8127748	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.02	CHEMBL2801	Homo sapiens	Inhibition	%	3.02
	8127812	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.36	CHEMBL2801	Homo sapiens	Inhibition	%	3.36
	8128036	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.83	CHEMBL2801	Homo sapiens	Inhibition	%	3.83
	8128188	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.56	CHEMBL2801	Homo sapiens	Inhibition	%	3.56
	8128355	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-1.61	CHEMBL2801	Homo sapiens	Inhibition	%	-1.61
	8128579	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.13	CHEMBL2801	Homo sapiens	Inhibition	%	-0.13
	8128698	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	35.39	CHEMBL2801	Homo sapiens	Inhibition	%	35.39
	8129059	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.23	CHEMBL2801	Homo sapiens	Inhibition	%	1.23
	8129230	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.38	CHEMBL2801	Homo sapiens	Inhibition	%	-0.38
	8129643	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.38	CHEMBL2801	Homo sapiens	Inhibition	%	1.38
	8129782	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.45	CHEMBL2801	Homo sapiens	Inhibition	%	1.45
	8130167	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.95	CHEMBL2801	Homo sapiens	Inhibition	%	1.95
	8130339	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.61	CHEMBL2801	Homo sapiens	Inhibition	%	-0.61
	8130723	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	14.34	CHEMBL2801	Homo sapiens	Inhibition	%	14.34
	8130839	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.72	CHEMBL2801	Homo sapiens	Inhibition	%	2.72
	8131063	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.76	CHEMBL2801	Homo sapiens	Inhibition	%	3.76
	8131202	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	2.24	CHEMBL2801	Homo sapiens	Inhibition	%	2.24
	8131546	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.82	CHEMBL2801	Homo sapiens	Inhibition	%	2.82
	8131713	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	10.58	CHEMBL2801	Homo sapiens	Inhibition	%	10.58
	8132078	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	2.75	CHEMBL2801	Homo sapiens	Inhibition	%	2.75
	8132364	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.09	CHEMBL2801	Homo sapiens	Inhibition	%	3.09
	8132511	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.04	CHEMBL2801	Homo sapiens	Inhibition	%	4.04
	8132903	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.98	CHEMBL2801	Homo sapiens	Inhibition	%	-0.98
	8133024	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.06	CHEMBL2801	Homo sapiens	Inhibition	%	2.06
	8133248	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.21	CHEMBL2801	Homo sapiens	Inhibition	%	3.21
	8133386	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.44	CHEMBL2801	Homo sapiens	Inhibition	%	2.44
	8133558	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.18	CHEMBL2801	Homo sapiens	Inhibition	%	2.18
	8133782	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.56	CHEMBL2801	Homo sapiens	Inhibition	%	-2.56
	8133962	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	3.39	CHEMBL2801	Homo sapiens	Inhibition	%	3.39
	8134110	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.8	CHEMBL2801	Homo sapiens	Inhibition	%	-0.8
	8134334	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.85	CHEMBL2801	Homo sapiens	Inhibition	%	-0.85
	8134494	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.18	CHEMBL2801	Homo sapiens	Inhibition	%	1.18
	8134678	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.44	CHEMBL2801	Homo sapiens	Inhibition	%	-2.44
	8134902	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	4.73	CHEMBL2801	Homo sapiens	Inhibition	%	4.73
	8135062	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.75	CHEMBL2801	Homo sapiens	Inhibition	%	2.75
	8135401	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.83	CHEMBL2801	Homo sapiens	Inhibition	%	1.83
	8135542	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.36	CHEMBL2801	Homo sapiens	Inhibition	%	4.36
	8135887	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	6.35	CHEMBL2801	Homo sapiens	Inhibition	%	6.35
	8136055	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.36	CHEMBL2801	Homo sapiens	Inhibition	%	3.36
	8136279	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	6.18	CHEMBL2801	Homo sapiens	Inhibition	%	6.18
	8136423	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.69	CHEMBL2801	Homo sapiens	Inhibition	%	2.69
	8136713	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.38	CHEMBL2801	Homo sapiens	Inhibition	%	3.38
	8136848	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.72	CHEMBL2801	Homo sapiens	Inhibition	%	2.72
	8137072	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.98	CHEMBL2801	Homo sapiens	Inhibition	%	3.98
	8137235	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.11	CHEMBL2801	Homo sapiens	Inhibition	%	1.11
	8137579	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.04	CHEMBL2801	Homo sapiens	Inhibition	%	1.04
	8137727	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.77	CHEMBL2801	Homo sapiens	Inhibition	%	0.77
	8138117	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.91	CHEMBL2801	Homo sapiens	Inhibition	%	1.91
	8138296	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.93	CHEMBL2801	Homo sapiens	Inhibition	%	2.93
	8138668	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.04	CHEMBL2801	Homo sapiens	Inhibition	%	-3.04
	8138826	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.48	CHEMBL2801	Homo sapiens	Inhibition	%	-0.48
	8139235	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.27	CHEMBL2801	Homo sapiens	Inhibition	%	3.27
	8139394	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.0	CHEMBL2801	Homo sapiens	Inhibition	%	5.0
	8139732	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.77	CHEMBL2801	Homo sapiens	Inhibition	%	1.77
	8139873	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.62	CHEMBL2801	Homo sapiens	Inhibition	%	2.62
	8140097	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.95	CHEMBL2801	Homo sapiens	Inhibition	%	3.95
	8140220	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.68	CHEMBL2801	Homo sapiens	Inhibition	%	4.68
	8140603	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.1	CHEMBL2801	Homo sapiens	Inhibition	%	3.1
	8140746	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.08	CHEMBL2801	Homo sapiens	Inhibition	%	3.08
	8141048	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.43	CHEMBL2801	Homo sapiens	Inhibition	%	3.43
	8141402	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.25	CHEMBL2801	Homo sapiens	Inhibition	%	2.25
	8141562	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.17	CHEMBL2801	Homo sapiens	Inhibition	%	1.17
	8141905	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.43	CHEMBL2801	Homo sapiens	Inhibition	%	1.43
	8142066	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.97	CHEMBL2801	Homo sapiens	Inhibition	%	0.97
	8142290	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.2	CHEMBL2801	Homo sapiens	Inhibition	%	0.2
	8142458	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	6.59	CHEMBL2801	Homo sapiens	Inhibition	%	6.59
	8142634	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.53	CHEMBL2801	Homo sapiens	Inhibition	%	3.53
	8143007	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.11	CHEMBL2801	Homo sapiens	Inhibition	%	-1.11
	8143162	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.73	CHEMBL2801	Homo sapiens	Inhibition	%	0.73
	8143386	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.72	CHEMBL2801	Homo sapiens	Inhibition	%	0.72
	8143573	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	9.08	CHEMBL2801	Homo sapiens	Inhibition	%	9.08
	8143732	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.93	CHEMBL2801	Homo sapiens	Inhibition	%	2.93
	8144070	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.65	CHEMBL2801	Homo sapiens	Inhibition	%	2.65
	8144433	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.29	CHEMBL2801	Homo sapiens	Inhibition	%	3.29
	8144563	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	5.47	CHEMBL2801	Homo sapiens	Inhibition	%	5.47
	8144940	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.89	CHEMBL2801	Homo sapiens	Inhibition	%	3.89
	8145077	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.72	CHEMBL2801	Homo sapiens	Inhibition	%	3.72
	8145301	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.42	CHEMBL2801	Homo sapiens	Inhibition	%	4.42
	8145390	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.99	CHEMBL2801	Homo sapiens	Inhibition	%	2.99
	8145738	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.34	CHEMBL2801	Homo sapiens	Inhibition	%	2.34
	8145899	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.22	CHEMBL2801	Homo sapiens	Inhibition	%	1.22
	8146123	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	-0.38	CHEMBL2801	Homo sapiens	Inhibition	%	-0.38
	8146243	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.39	CHEMBL2801	Homo sapiens	Inhibition	%	1.39
	8146627	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	3.02	CHEMBL2801	Homo sapiens	Inhibition	%	3.02
	8146794	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	49.9	CHEMBL2801	Homo sapiens	Inhibition	%	49.9
	8146963	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.76	CHEMBL2801	Homo sapiens	Inhibition	%	2.76
	8147187	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	11.08	CHEMBL2801	Homo sapiens	Inhibition	%	11.08
	8147329	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.96	CHEMBL2801	Homo sapiens	Inhibition	%	0.96
	8147706	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.66	CHEMBL2801	Homo sapiens	Inhibition	%	1.66
	8147893	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.29	CHEMBL2801	Homo sapiens	Inhibition	%	3.29
	8148051	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	5.15	CHEMBL2801	Homo sapiens	Inhibition	%	5.15
	8148275	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.06	CHEMBL2801	Homo sapiens	Inhibition	%	3.06
	8148389	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	3.02	CHEMBL2801	Homo sapiens	Inhibition	%	3.02
	8148752	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	8.0	CHEMBL2801	Homo sapiens	Inhibition	%	8.0
	8148890	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.24	CHEMBL2801	Homo sapiens	Inhibition	%	4.24
	8149114	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	6.79	CHEMBL2801	Homo sapiens	Inhibition	%	6.79
	8149273	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.25	CHEMBL2801	Homo sapiens	Inhibition	%	1.25
	8149631	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.51	CHEMBL2801	Homo sapiens	Inhibition	%	3.51
	8149729	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.03	CHEMBL2801	Homo sapiens	Inhibition	%	4.03
	8149953	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	5.12	CHEMBL2801	Homo sapiens	Inhibition	%	5.12
	8150078	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	1.58	CHEMBL2801	Homo sapiens	Inhibition	%	1.58
	8150462	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.91	CHEMBL2801	Homo sapiens	Inhibition	%	0.91
	8150582	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	2.79	CHEMBL2801	Homo sapiens	Inhibition	%	2.79
	8150806	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.08	CHEMBL2801	Homo sapiens	Inhibition	%	1.08
	8150971	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	13.0	CHEMBL2801	Homo sapiens	Inhibition	%	13.0
	8151134	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.96	CHEMBL2801	Homo sapiens	Inhibition	%	-2.96
	8151535	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.51	CHEMBL2801	Homo sapiens	Inhibition	%	2.51
	8151673	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-1.12	CHEMBL2801	Homo sapiens	Inhibition	%	-1.12
	8152051	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.95	CHEMBL2801	Homo sapiens	Inhibition	%	0.95
	8152239	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	9.61	CHEMBL2801	Homo sapiens	Inhibition	%	9.61
	8152621	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	6.25	CHEMBL2801	Homo sapiens	Inhibition	%	6.25
	8152735	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.29	CHEMBL2801	Homo sapiens	Inhibition	%	3.29
	8152959	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	6.46	CHEMBL2801	Homo sapiens	Inhibition	%	6.46
	8153098	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.16	CHEMBL2801	Homo sapiens	Inhibition	%	1.16
	8153459	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.29	CHEMBL2801	Homo sapiens	Inhibition	%	4.29
	8153616	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.48	CHEMBL2801	Homo sapiens	Inhibition	%	2.48
	8153973	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	6.88	CHEMBL2801	Homo sapiens	Inhibition	%	6.88
	8154294	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.24	CHEMBL2801	Homo sapiens	Inhibition	%	4.24
	8154420	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	4.15	CHEMBL2801	Homo sapiens	Inhibition	%	4.15
	8154644	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	3.15	CHEMBL2801	Homo sapiens	Inhibition	%	3.15
	8154803	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.19	CHEMBL2801	Homo sapiens	Inhibition	%	1.19
	8155147	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.93	CHEMBL2801	Homo sapiens	Inhibition	%	0.93
	8155323	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.49	CHEMBL2801	Homo sapiens	Inhibition	%	0.49
	8155484	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.9	CHEMBL2801	Homo sapiens	Inhibition	%	1.9
	8155708	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.82	CHEMBL2801	Homo sapiens	Inhibition	%	2.82
	8155886	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.18	CHEMBL2801	Homo sapiens	Inhibition	%	4.18
	8156024	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.41	CHEMBL2801	Homo sapiens	Inhibition	%	2.41
	8156248	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.44	CHEMBL2801	Homo sapiens	Inhibition	%	0.44
	8156460	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.37	CHEMBL2801	Homo sapiens	Inhibition	%	3.37
	8156610	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.23	CHEMBL2801	Homo sapiens	Inhibition	%	3.23
	8156834	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.06	CHEMBL2801	Homo sapiens	Inhibition	%	1.06
	8156977	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	7.79	CHEMBL2801	Homo sapiens	Inhibition	%	7.79
	8157321	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	4.44	CHEMBL2801	Homo sapiens	Inhibition	%	4.44
	8157462	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.19	CHEMBL2801	Homo sapiens	Inhibition	%	3.19
	8157816	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	4.14	CHEMBL2801	Homo sapiens	Inhibition	%	4.14
	8157977	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.5	CHEMBL2801	Homo sapiens	Inhibition	%	2.5
	8158201	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	3.68	CHEMBL2801	Homo sapiens	Inhibition	%	3.68
	8158451	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.1	CHEMBL2801	Homo sapiens	Inhibition	%	4.1
	8158609	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	7.16	CHEMBL2801	Homo sapiens	Inhibition	%	7.16
	8158778	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.1	CHEMBL2801	Homo sapiens	Inhibition	%	3.1
	8159002	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	25.34	CHEMBL2801	Homo sapiens	Inhibition	%	25.34
	8159137	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.54	CHEMBL2801	Homo sapiens	Inhibition	%	3.54
	8159481	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.78	CHEMBL2801	Homo sapiens	Inhibition	%	1.78
	8159612	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.02	CHEMBL2801	Homo sapiens	Inhibition	%	6.02
	8159836	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	26.85	CHEMBL2801	Homo sapiens	Inhibition	%	26.85
	8159977	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.93	CHEMBL2801	Homo sapiens	Inhibition	%	0.93
	8160338	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.65	CHEMBL2801	Homo sapiens	Inhibition	%	5.65
	8160488	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.92	CHEMBL2801	Homo sapiens	Inhibition	%	-1.92
	8160782	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.7	CHEMBL2801	Homo sapiens	Inhibition	%	3.7
	8161156	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.97	CHEMBL2801	Homo sapiens	Inhibition	%	3.97
	8161299	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	7.61	CHEMBL2801	Homo sapiens	Inhibition	%	7.61
	8161648	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.96	CHEMBL2801	Homo sapiens	Inhibition	%	3.96
	8161786	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	5.08	CHEMBL2801	Homo sapiens	Inhibition	%	5.08
	8162010	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.57	CHEMBL2801	Homo sapiens	Inhibition	%	2.57
	8162140	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	14.93	CHEMBL2801	Homo sapiens	Inhibition	%	14.93
	8162524	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	6.84	CHEMBL2801	Homo sapiens	Inhibition	%	6.84
	8162777	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.33	CHEMBL2801	Homo sapiens	Inhibition	%	4.33
	8162925	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	7.83	CHEMBL2801	Homo sapiens	Inhibition	%	7.83
	8163318	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.34	CHEMBL2801	Homo sapiens	Inhibition	%	2.34
	8163452	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.65	CHEMBL2801	Homo sapiens	Inhibition	%	2.65
	8163676	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.98	CHEMBL2801	Homo sapiens	Inhibition	%	3.98
	8163799	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.01	CHEMBL2801	Homo sapiens	Inhibition	%	2.01
	8164157	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	72.84	CHEMBL2801	Homo sapiens	Inhibition	%	72.84
	8164297	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.69	CHEMBL2801	Homo sapiens	Inhibition	%	0.69
	8164676	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	17.8	CHEMBL2801	Homo sapiens	Inhibition	%	17.8
	8164820	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.53	CHEMBL2801	Homo sapiens	Inhibition	%	1.53
	8165044	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.65	CHEMBL2801	Homo sapiens	Inhibition	%	3.65
	8165114	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.46	CHEMBL2801	Homo sapiens	Inhibition	%	4.46
	8165479	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.53	CHEMBL2801	Homo sapiens	Inhibition	%	0.53
	8165622	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	35.69	CHEMBL2801	Homo sapiens	Inhibition	%	35.69
	8165846	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.95	CHEMBL2801	Homo sapiens	Inhibition	%	2.95
	8165972	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	11.69	CHEMBL2801	Homo sapiens	Inhibition	%	11.69
	8166334	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	7.84	CHEMBL2801	Homo sapiens	Inhibition	%	7.84
	8166464	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.67	CHEMBL2801	Homo sapiens	Inhibition	%	3.67
	8166688	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.45	CHEMBL2801	Homo sapiens	Inhibition	%	3.45
	8166789	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	3.54	CHEMBL2801	Homo sapiens	Inhibition	%	3.54
	8167101	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.77	CHEMBL2801	Homo sapiens	Inhibition	%	1.77
	8167242	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	30.57	CHEMBL2801	Homo sapiens	Inhibition	%	30.57
	8167466	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	7.45	CHEMBL2801	Homo sapiens	Inhibition	%	7.45
	8167630	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.57	CHEMBL2801	Homo sapiens	Inhibition	%	4.57
	8167987	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.55	CHEMBL2801	Homo sapiens	Inhibition	%	3.55
	8168111	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.48	CHEMBL2801	Homo sapiens	Inhibition	%	1.48
	8168476	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.46	CHEMBL2801	Homo sapiens	Inhibition	%	4.46
	8168612	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.31	CHEMBL2801	Homo sapiens	Inhibition	%	-0.31
	8168836	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.03	CHEMBL2801	Homo sapiens	Inhibition	%	-2.03
	8169000	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	63.35	CHEMBL2801	Homo sapiens	Inhibition	%	63.35
	8169366	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.38	CHEMBL2801	Homo sapiens	Inhibition	%	3.38
	8169446	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	8.21	CHEMBL2801	Homo sapiens	Inhibition	%	8.21
	8169670	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	8.76	CHEMBL2801	Homo sapiens	Inhibition	%	8.76
	8169804	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.74	CHEMBL2801	Homo sapiens	Inhibition	%	3.74
	8170173	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.63	CHEMBL2801	Homo sapiens	Inhibition	%	1.63
	8170298	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.36	CHEMBL2801	Homo sapiens	Inhibition	%	3.36
	8170522	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.56	CHEMBL2801	Homo sapiens	Inhibition	%	3.56
	8170662	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	2.49	CHEMBL2801	Homo sapiens	Inhibition	%	2.49
	8171021	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.72	CHEMBL2801	Homo sapiens	Inhibition	%	2.72
	8171218	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	3.41	CHEMBL2801	Homo sapiens	Inhibition	%	3.41
	8171435	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	4.0	CHEMBL2801	Homo sapiens	Inhibition	%	4.0
	8171800	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	25.68	CHEMBL2801	Homo sapiens	Inhibition	%	25.68
	8171953	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.52	CHEMBL2801	Homo sapiens	Inhibition	%	2.52
	8172309	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	4.2	CHEMBL2801	Homo sapiens	Inhibition	%	4.2
	8172437	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.35	CHEMBL2801	Homo sapiens	Inhibition	%	1.35
	8172661	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.35	CHEMBL2801	Homo sapiens	Inhibition	%	-0.35
	8172803	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.95	CHEMBL2801	Homo sapiens	Inhibition	%	3.95
	8173163	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.61	CHEMBL2801	Homo sapiens	Inhibition	%	-1.61
	8173328	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.21	CHEMBL2801	Homo sapiens	Inhibition	%	4.21
	8173693	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.26	CHEMBL2801	Homo sapiens	Inhibition	%	3.26
	8174004	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	32.5	CHEMBL2801	Homo sapiens	Inhibition	%	32.5
	8174136	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.37	CHEMBL2801	Homo sapiens	Inhibition	%	1.37
	8174360	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.0	CHEMBL2801	Homo sapiens	Inhibition	%	3.0
	8174508	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.24	CHEMBL2801	Homo sapiens	Inhibition	%	2.24
	8174854	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.6	CHEMBL2801	Homo sapiens	Inhibition	%	3.6
	8174997	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.75	CHEMBL2801	Homo sapiens	Inhibition	%	4.75
	8175357	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	8.29	CHEMBL2801	Homo sapiens	Inhibition	%	8.29
	8175613	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	6.83	CHEMBL2801	Homo sapiens	Inhibition	%	6.83
	8175776	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.35	CHEMBL2801	Homo sapiens	Inhibition	%	2.35
	8176000	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.73	CHEMBL2801	Homo sapiens	Inhibition	%	3.73
	8176153	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.42	CHEMBL2801	Homo sapiens	Inhibition	%	6.42
	8176302	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	16.14	CHEMBL2801	Homo sapiens	Inhibition	%	16.14
	8176526	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.54	CHEMBL2801	Homo sapiens	Inhibition	%	2.54
	8176658	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	14.14	CHEMBL2801	Homo sapiens	Inhibition	%	14.14
	8177012	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.74	CHEMBL2801	Homo sapiens	Inhibition	%	0.74
	8177154	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	4.52	CHEMBL2801	Homo sapiens	Inhibition	%	4.52
	8177378	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	4.7	CHEMBL2801	Homo sapiens	Inhibition	%	4.7
	8177516	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	17.45	CHEMBL2801	Homo sapiens	Inhibition	%	17.45
	8177680	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	12.82	CHEMBL2801	Homo sapiens	Inhibition	%	12.82
	8177904	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.16	CHEMBL2801	Homo sapiens	Inhibition	%	4.16
	8178044	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	7.6	CHEMBL2801	Homo sapiens	Inhibition	%	7.6
	8178356	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.42	CHEMBL2801	Homo sapiens	Inhibition	%	2.42
	8178707	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.08	CHEMBL2801	Homo sapiens	Inhibition	%	3.08
	8178856	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.64	CHEMBL2801	Homo sapiens	Inhibition	%	3.64
	8179203	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.34	CHEMBL2801	Homo sapiens	Inhibition	%	4.34
	8179347	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.39	CHEMBL2801	Homo sapiens	Inhibition	%	3.39
	8179571	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	11.76	CHEMBL2801	Homo sapiens	Inhibition	%	11.76
	8179708	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.58	CHEMBL2801	Homo sapiens	Inhibition	%	1.58
	8179965	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.23	CHEMBL2801	Homo sapiens	Inhibition	%	3.23
	8180343	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.12	CHEMBL2801	Homo sapiens	Inhibition	%	1.12
	8180499	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	15.24	CHEMBL2801	Homo sapiens	Inhibition	%	15.24
	8180871	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	14.98	CHEMBL2801	Homo sapiens	Inhibition	%	14.98
	8181004	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	3.19	CHEMBL2801	Homo sapiens	Inhibition	%	3.19
	8181228	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	3.36	CHEMBL2801	Homo sapiens	Inhibition	%	3.36
	8181359	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-2.27	CHEMBL2801	Homo sapiens	Inhibition	%	-2.27
	8181723	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.79	CHEMBL2801	Homo sapiens	Inhibition	%	3.79
	8181862	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	57.56	CHEMBL2801	Homo sapiens	Inhibition	%	57.56
	8182249	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.81	CHEMBL2801	Homo sapiens	Inhibition	%	4.81
	8182389	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.73	CHEMBL2801	Homo sapiens	Inhibition	%	1.73
	8182705	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.41	CHEMBL2801	Homo sapiens	Inhibition	%	2.41
	8183051	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.49	CHEMBL2801	Homo sapiens	Inhibition	%	3.49
	8183200	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.91	CHEMBL2801	Homo sapiens	Inhibition	%	1.91
	8183424	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	9.35	CHEMBL2801	Homo sapiens	Inhibition	%	9.35
	8183553	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-3.32	CHEMBL2801	Homo sapiens	Inhibition	%	-3.32
	8183919	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.98	CHEMBL2801	Homo sapiens	Inhibition	%	2.98
	8184055	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.84	CHEMBL2801	Homo sapiens	Inhibition	%	1.84
	8184321	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.34	CHEMBL2801	Homo sapiens	Inhibition	%	3.34
	8184692	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.72	CHEMBL2801	Homo sapiens	Inhibition	%	2.72
	8184849	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	3.8	CHEMBL2801	Homo sapiens	Inhibition	%	3.8
	8185073	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	5.51	CHEMBL2801	Homo sapiens	Inhibition	%	5.51
	8185222	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.37	CHEMBL2801	Homo sapiens	Inhibition	%	0.37
	8185577	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.0	CHEMBL2801	Homo sapiens	Inhibition	%	3.0
	8185708	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	3.2	CHEMBL2801	Homo sapiens	Inhibition	%	3.2
	8186071	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.53	CHEMBL2801	Homo sapiens	Inhibition	%	3.53
	8186212	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.14	CHEMBL2801	Homo sapiens	Inhibition	%	3.14
	8186436	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.4	CHEMBL2801	Homo sapiens	Inhibition	%	7.4
	8186600	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.35	CHEMBL2801	Homo sapiens	Inhibition	%	4.35
	8186739	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.42	CHEMBL2801	Homo sapiens	Inhibition	%	4.42
	8186963	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.54	CHEMBL2801	Homo sapiens	Inhibition	%	4.54
	8187061	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.47	CHEMBL2801	Homo sapiens	Inhibition	%	2.47
	8187285	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	6.44	CHEMBL2801	Homo sapiens	Inhibition	%	6.44
	8187409	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.75	CHEMBL2801	Homo sapiens	Inhibition	%	2.75
	8187781	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.92	CHEMBL2801	Homo sapiens	Inhibition	%	2.92
	8187910	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-2.99	CHEMBL2801	Homo sapiens	Inhibition	%	-2.99
	8188277	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.81	CHEMBL2801	Homo sapiens	Inhibition	%	4.81
	8188412	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.8	CHEMBL2801	Homo sapiens	Inhibition	%	1.8
	8188636	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	4.11	CHEMBL2801	Homo sapiens	Inhibition	%	4.11
	8188686	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.96	CHEMBL2801	Homo sapiens	Inhibition	%	3.96
	8188910	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.38	CHEMBL2801	Homo sapiens	Inhibition	%	5.38
	8189058	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.75	CHEMBL2801	Homo sapiens	Inhibition	%	0.75
	8189438	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.11	CHEMBL2801	Homo sapiens	Inhibition	%	5.11
	8189587	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.1	CHEMBL2801	Homo sapiens	Inhibition	%	1.1
	8189943	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.51	CHEMBL2801	Homo sapiens	Inhibition	%	5.51
	8190075	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.86	CHEMBL2801	Homo sapiens	Inhibition	%	4.86
	8190299	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	7.42	CHEMBL2801	Homo sapiens	Inhibition	%	7.42
	8190439	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.41	CHEMBL2801	Homo sapiens	Inhibition	%	4.41
	8190800	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.32	CHEMBL2801	Homo sapiens	Inhibition	%	1.32
	8190964	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	7.01	CHEMBL2801	Homo sapiens	Inhibition	%	7.01
	8191326	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.02	CHEMBL2801	Homo sapiens	Inhibition	%	5.02
	8191646	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.67	CHEMBL2801	Homo sapiens	Inhibition	%	0.67
	8191768	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.82	CHEMBL2801	Homo sapiens	Inhibition	%	5.82
	8192141	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.2	CHEMBL2801	Homo sapiens	Inhibition	%	2.2
	8192270	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.75	CHEMBL2801	Homo sapiens	Inhibition	%	0.75
	8192494	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-0.53	CHEMBL2801	Homo sapiens	Inhibition	%	-0.53
	8192638	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.3	CHEMBL2801	Homo sapiens	Inhibition	%	2.3
	8192998	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.7	CHEMBL2801	Homo sapiens	Inhibition	%	0.7
	8193270	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.36	CHEMBL2801	Homo sapiens	Inhibition	%	1.36
	8193415	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.93	CHEMBL2801	Homo sapiens	Inhibition	%	3.93
	8193796	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	16.34	CHEMBL2801	Homo sapiens	Inhibition	%	16.34
	8193945	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.38	CHEMBL2801	Homo sapiens	Inhibition	%	-2.38
	8194169	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.97	CHEMBL2801	Homo sapiens	Inhibition	%	-0.97
	8194300	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.6	CHEMBL2801	Homo sapiens	Inhibition	%	2.6
	8194655	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.21	CHEMBL2801	Homo sapiens	Inhibition	%	4.21
	8194798	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.63	CHEMBL2801	Homo sapiens	Inhibition	%	4.63
	8195155	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.99	CHEMBL2801	Homo sapiens	Inhibition	%	3.99
	8195319	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.46	CHEMBL2801	Homo sapiens	Inhibition	%	3.46
	8195543	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	11.42	CHEMBL2801	Homo sapiens	Inhibition	%	11.42
	8195682	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.96	CHEMBL2801	Homo sapiens	Inhibition	%	4.96
	8196004	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.6	CHEMBL2801	Homo sapiens	Inhibition	%	3.6
	8196121	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.68	CHEMBL2801	Homo sapiens	Inhibition	%	1.68
	8196345	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.41	CHEMBL2801	Homo sapiens	Inhibition	%	2.41
	8196495	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	3.9	CHEMBL2801	Homo sapiens	Inhibition	%	3.9
	8196847	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	0.52	CHEMBL2801	Homo sapiens	Inhibition	%	0.52
	8196988	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.14	CHEMBL2801	Homo sapiens	Inhibition	%	3.14
	8197349	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.42	CHEMBL2801	Homo sapiens	Inhibition	%	1.42
	8197624	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.98	CHEMBL2801	Homo sapiens	Inhibition	%	3.98
	8197764	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.36	CHEMBL2801	Homo sapiens	Inhibition	%	0.36
	8197988	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.88	CHEMBL2801	Homo sapiens	Inhibition	%	2.88
	8198145	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.18	CHEMBL2801	Homo sapiens	Inhibition	%	4.18
	8198507	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.86	CHEMBL2801	Homo sapiens	Inhibition	%	2.86
	8198637	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.68	CHEMBL2801	Homo sapiens	Inhibition	%	3.68
	8198992	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.17	CHEMBL2801	Homo sapiens	Inhibition	%	5.17
	8199140	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.46	CHEMBL2801	Homo sapiens	Inhibition	%	4.46
	8199364	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.05	CHEMBL2801	Homo sapiens	Inhibition	%	4.05
	8199498	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.79	CHEMBL2801	Homo sapiens	Inhibition	%	2.79
	8199885	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.39	CHEMBL2801	Homo sapiens	Inhibition	%	2.39
	8200023	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.65	CHEMBL2801	Homo sapiens	Inhibition	%	4.65
	8200351	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.7	CHEMBL2801	Homo sapiens	Inhibition	%	1.7
	8200690	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.57	CHEMBL2801	Homo sapiens	Inhibition	%	2.57
	8200840	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	4.15	CHEMBL2801	Homo sapiens	Inhibition	%	4.15
	8201194	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.97	CHEMBL2801	Homo sapiens	Inhibition	%	2.97
	8201329	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.4	CHEMBL2801	Homo sapiens	Inhibition	%	2.4
	8201553	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.59	CHEMBL2801	Homo sapiens	Inhibition	%	4.59
	8201686	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.62	CHEMBL2801	Homo sapiens	Inhibition	%	-0.62
	8201965	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.17	CHEMBL2801	Homo sapiens	Inhibition	%	3.17
	8202329	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-2.31	CHEMBL2801	Homo sapiens	Inhibition	%	-2.31
	8202496	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.28	CHEMBL2801	Homo sapiens	Inhibition	%	4.28
	8202845	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.06	CHEMBL2801	Homo sapiens	Inhibition	%	4.06
	8202975	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.71	CHEMBL2801	Homo sapiens	Inhibition	%	3.71
	8203199	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	7.42	CHEMBL2801	Homo sapiens	Inhibition	%	7.42
	8203330	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	4.36	CHEMBL2801	Homo sapiens	Inhibition	%	4.36
	8203700	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.65	CHEMBL2801	Homo sapiens	Inhibition	%	3.65
	8203834	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.05	CHEMBL2801	Homo sapiens	Inhibition	%	2.05
	8204058	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.82	CHEMBL2801	Homo sapiens	Inhibition	%	3.82
	8204224	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	5.41	CHEMBL2801	Homo sapiens	Inhibition	%	5.41
	8204361	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.51	CHEMBL2801	Homo sapiens	Inhibition	%	4.51
	8204585	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	6.51	CHEMBL2801	Homo sapiens	Inhibition	%	6.51
	8204690	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.08	CHEMBL2801	Homo sapiens	Inhibition	%	1.08
	8205029	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	11.42	CHEMBL2801	Homo sapiens	Inhibition	%	11.42
	8205178	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.77	CHEMBL2801	Homo sapiens	Inhibition	%	3.77
	8205402	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	9.6	CHEMBL2801	Homo sapiens	Inhibition	%	9.6
	8205538	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.48	CHEMBL2801	Homo sapiens	Inhibition	%	1.48
	8205901	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.84	CHEMBL2801	Homo sapiens	Inhibition	%	2.84
	8206033	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.45	CHEMBL2801	Homo sapiens	Inhibition	%	0.45
	8206257	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.29	CHEMBL2801	Homo sapiens	Inhibition	%	-1.29
	8206309	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.68	CHEMBL2801	Homo sapiens	Inhibition	%	2.68
	8206533	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.75	CHEMBL2801	Homo sapiens	Inhibition	%	2.75
	8206676	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.31	CHEMBL2801	Homo sapiens	Inhibition	%	-1.31
	8206856	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.33	CHEMBL2801	Homo sapiens	Inhibition	%	3.33
	8207080	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.12	CHEMBL2801	Homo sapiens	Inhibition	%	4.12
	8207206	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.83	CHEMBL2801	Homo sapiens	Inhibition	%	2.83
	8207560	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	6.47	CHEMBL2801	Homo sapiens	Inhibition	%	6.47
	8207692	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	5.37	CHEMBL2801	Homo sapiens	Inhibition	%	5.37
	8207916	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.83	CHEMBL2801	Homo sapiens	Inhibition	%	4.83
	8208061	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.72	CHEMBL2801	Homo sapiens	Inhibition	%	3.72
	8208417	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.97	CHEMBL2801	Homo sapiens	Inhibition	%	3.97
	8208583	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.33	CHEMBL2801	Homo sapiens	Inhibition	%	0.33
	8208940	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.94	CHEMBL2801	Homo sapiens	Inhibition	%	3.94
	8209045	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.21	CHEMBL2801	Homo sapiens	Inhibition	%	1.21
	8209269	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	11.57	CHEMBL2801	Homo sapiens	Inhibition	%	11.57
	8209385	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.62	CHEMBL2801	Homo sapiens	Inhibition	%	0.62
	8209759	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.57	CHEMBL2801	Homo sapiens	Inhibition	%	2.57
	8209895	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.36	CHEMBL2801	Homo sapiens	Inhibition	%	3.36
	8210119	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	5.14	CHEMBL2801	Homo sapiens	Inhibition	%	5.14
	8210260	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.34	CHEMBL2801	Homo sapiens	Inhibition	%	3.34
	8210620	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	7.67	CHEMBL2801	Homo sapiens	Inhibition	%	7.67
	8210879	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.68	CHEMBL2801	Homo sapiens	Inhibition	%	2.68
	8211023	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.25	CHEMBL2801	Homo sapiens	Inhibition	%	4.25
	8211417	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.06	CHEMBL2801	Homo sapiens	Inhibition	%	4.06
	8211540	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.46	CHEMBL2801	Homo sapiens	Inhibition	%	3.46
	8211893	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	20.15	CHEMBL2801	Homo sapiens	Inhibition	%	20.15
	8212249	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.07	CHEMBL2801	Homo sapiens	Inhibition	%	5.07
	8212390	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.59	CHEMBL2801	Homo sapiens	Inhibition	%	2.59
	8212747	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.26	CHEMBL2801	Homo sapiens	Inhibition	%	3.26
	8212917	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.19	CHEMBL2801	Homo sapiens	Inhibition	%	3.19
	8213270	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	7.79	CHEMBL2801	Homo sapiens	Inhibition	%	7.79
	8213598	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-2.31	CHEMBL2801	Homo sapiens	Inhibition	%	-2.31
	8213711	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.75	CHEMBL2801	Homo sapiens	Inhibition	%	2.75
	8213935	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.28	CHEMBL2801	Homo sapiens	Inhibition	%	1.28
	8214082	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.65	CHEMBL2801	Homo sapiens	Inhibition	%	3.65
	8214443	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	19.06	CHEMBL2801	Homo sapiens	Inhibition	%	19.06
	8214577	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.94	CHEMBL2801	Homo sapiens	Inhibition	%	2.94
	8214953	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-1.29	CHEMBL2801	Homo sapiens	Inhibition	%	-1.29
	8215204	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.96	CHEMBL2801	Homo sapiens	Inhibition	%	1.96
	8215357	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	11.27	CHEMBL2801	Homo sapiens	Inhibition	%	11.27
	8215581	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.92	CHEMBL2801	Homo sapiens	Inhibition	%	3.92
	8215745	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.62	CHEMBL2801	Homo sapiens	Inhibition	%	3.62
	8215864	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.45	CHEMBL2801	Homo sapiens	Inhibition	%	3.45
	8216088	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	7.22	CHEMBL2801	Homo sapiens	Inhibition	%	7.22
	8216207	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.57	CHEMBL2801	Homo sapiens	Inhibition	%	2.57
	8216567	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	6.22	CHEMBL2801	Homo sapiens	Inhibition	%	6.22
	8216705	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.77	CHEMBL2801	Homo sapiens	Inhibition	%	3.77
	8216929	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.63	CHEMBL2801	Homo sapiens	Inhibition	%	2.63
	8217063	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.04	CHEMBL2801	Homo sapiens	Inhibition	%	6.04
	8217237	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.76	CHEMBL2801	Homo sapiens	Inhibition	%	0.76
	8217461	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.58	CHEMBL2801	Homo sapiens	Inhibition	%	0.58
	8217592	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	18.29	CHEMBL2801	Homo sapiens	Inhibition	%	18.29
	8217917	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	1.44	CHEMBL2801	Homo sapiens	Inhibition	%	1.44
	8218256	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.23	CHEMBL2801	Homo sapiens	Inhibition	%	1.23
	8218383	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	8.19	CHEMBL2801	Homo sapiens	Inhibition	%	8.19
	8218750	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	6.01	CHEMBL2801	Homo sapiens	Inhibition	%	6.01
	8218881	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	5.54	CHEMBL2801	Homo sapiens	Inhibition	%	5.54
	8219105	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.01	CHEMBL2801	Homo sapiens	Inhibition	%	2.01
	8219265	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.13	CHEMBL2801	Homo sapiens	Inhibition	%	-0.13
	8219515	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.44	CHEMBL2801	Homo sapiens	Inhibition	%	2.44
	8219900	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.31	CHEMBL2801	Homo sapiens	Inhibition	%	5.31
	8220069	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.6	CHEMBL2801	Homo sapiens	Inhibition	%	3.6
	8220422	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.29	CHEMBL2801	Homo sapiens	Inhibition	%	3.29
	8220536	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	7.23	CHEMBL2801	Homo sapiens	Inhibition	%	7.23
	8220760	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.82	CHEMBL2801	Homo sapiens	Inhibition	%	1.82
	8220898	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	12.96	CHEMBL2801	Homo sapiens	Inhibition	%	12.96
	8221258	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.0	CHEMBL2801	Homo sapiens	Inhibition	%	4.0
	8221391	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.26	CHEMBL2801	Homo sapiens	Inhibition	%	3.26
	8221780	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.18	CHEMBL2801	Homo sapiens	Inhibition	%	-0.18
	8221911	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	62.77	CHEMBL2801	Homo sapiens	Inhibition	%	62.77
	8222135	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	8.4	CHEMBL2801	Homo sapiens	Inhibition	%	8.4
	8222233	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.73	CHEMBL2801	Homo sapiens	Inhibition	%	1.73
	8222591	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.92	CHEMBL2801	Homo sapiens	Inhibition	%	2.92
	8222709	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	36.06	CHEMBL2801	Homo sapiens	Inhibition	%	36.06
	8222933	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.76	CHEMBL2801	Homo sapiens	Inhibition	%	1.76
	8223077	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	21.47	CHEMBL2801	Homo sapiens	Inhibition	%	21.47
	8223430	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.57	CHEMBL2801	Homo sapiens	Inhibition	%	4.57
	8223591	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.39	CHEMBL2801	Homo sapiens	Inhibition	%	2.39
	8223841	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.49	CHEMBL2801	Homo sapiens	Inhibition	%	3.49
	8224065	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.21	CHEMBL2801	Homo sapiens	Inhibition	%	3.21
	8224227	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	4.6	CHEMBL2801	Homo sapiens	Inhibition	%	4.6
	8224397	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.39	CHEMBL2801	Homo sapiens	Inhibition	%	3.39
	8224756	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.98	CHEMBL2801	Homo sapiens	Inhibition	%	2.98
	8225094	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.42	CHEMBL2801	Homo sapiens	Inhibition	%	4.42
	8225228	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.13	CHEMBL2801	Homo sapiens	Inhibition	%	5.13
	8225590	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.63	CHEMBL2801	Homo sapiens	Inhibition	%	1.63
	8225725	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	6.33	CHEMBL2801	Homo sapiens	Inhibition	%	6.33
	8225949	CHEMBL1961956	GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.07	CHEMBL2801	Homo sapiens	Inhibition	%	3.07
	8226107	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.43	CHEMBL2801	Homo sapiens	Inhibition	%	0.43
	8226456	CHEMBL1961957	GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	8.79	CHEMBL2801	Homo sapiens	Inhibition	%	8.79
inactive	9624344	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624345	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624346	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624347	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	125.89	CHEMBL2801	Homo sapiens	pKi		6.9
inactive	9624348	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624349	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1980435	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
inactive	9624350	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624351	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	1000.0	CHEMBL2801	Homo sapiens	pKi		6.0
active	9624352	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
active	9624353	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9624354	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624355	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
active	9624356	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9624357	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624358	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	39.81	CHEMBL2801	Homo sapiens	pKi		7.4
inactive	9624359	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624360	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	251.19	CHEMBL2801	Homo sapiens	pKi		6.6
active	9624361	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9624362	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624363	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624364	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9624365	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	63.1	CHEMBL2801	Homo sapiens	pKi		7.2
active	9624366	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	1000.0	CHEMBL2801	Homo sapiens	pKi		6.0
active	9624367	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9624368	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	501.19	CHEMBL2801	Homo sapiens	pKi		6.3
active	9624369	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9624370	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624371	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)CNS(C)(=O)=O		CHEMBL1971172	=	Ki	nM	794.33	CHEMBL2801	Homo sapiens	pKi		6.1
inactive	9624372	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624373	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	=	Ki	nM	158.49	CHEMBL2801	Homo sapiens	pKi		6.8
inactive	9624374	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624375	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624376	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
inactive	9624377	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624378	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624379	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
active	9624380	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	199.53	CHEMBL2801	Homo sapiens	pKi		6.7
active	9624381	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
inactive	9624382	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624383	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624384	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624385	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624386	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624387	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
inactive	9624388	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1983589	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9624389	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CS(=O)(=O)NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2005718	=	Ki	nM	794.33	CHEMBL2801	Homo sapiens	pKi		6.1
inactive	9624390	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624391	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624392	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624393	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624394	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624395	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624396	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624397	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624398	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624399	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624400	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624401	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624402	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9624403	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624404	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624405	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624406	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9624407	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624408	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624409	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624410	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(F)n1		CHEMBL1987261	=	Ki	nM	398.11	CHEMBL2801	Homo sapiens	pKi		6.4
active	9624411	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
inactive	9624412	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624413	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624414	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624415	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	794.33	CHEMBL2801	Homo sapiens	pKi		6.1
inactive	9624416	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624417	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
inactive	9624418	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624419	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624420	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624421	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1985723	=	Ki	nM	501.19	CHEMBL2801	Homo sapiens	pKi		6.3
active	9624422	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624423	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	5.012	CHEMBL2801	Homo sapiens	pKi		8.3
inactive	9624424	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624425	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
active	9624426	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
active	9624427	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9624428	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	N#Cc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1977128	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9624429	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624430	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624431	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
inactive	9624432	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624433	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)C1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1965702	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
inactive	9624434	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9624435	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624436	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624437	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624438	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624439	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
active	9624440	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
active	9624441	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
active	9624442	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9624443	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624444	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC1CCCN1CCc1cc2cc(-c3ccc(OC(F)(F)F)cc3)ccc2[nH]1		CHEMBL1990635	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624445	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
active	9624446	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
inactive	9624447	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624448	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624449	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)CNC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2006456	=	Ki	nM	1000.0	CHEMBL2801	Homo sapiens	pKi		6.0
active	9624450	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9624451	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624452	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624453	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9624454	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624455	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624456	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
active	9624457	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9624458	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	501.19	CHEMBL2801	Homo sapiens	pKi		6.3
active	9624459	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
inactive	9624460	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624461	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624462	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624463	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9624464	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624465	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624466	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9624467	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
active	9624468	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	501.19	CHEMBL2801	Homo sapiens	pKi		6.3
inactive	9624469	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624470	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624471	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624472	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624473	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624474	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9624475	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624476	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	199.53	CHEMBL2801	Homo sapiens	pKi		6.7
inactive	9624477	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624478	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624479	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624480	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCC(=O)c1ccc(NCc2c[nH]nc2-c2ccc(C(F)(F)F)cc2)cc1		CHEMBL2003405	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9624481	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624482	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624483	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624484	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1980178	=	Ki	nM	630.96	CHEMBL2801	Homo sapiens	pKi		6.2
active	9624485	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
inactive	9624486	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624487	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9624488	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624489	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624490	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624491	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	630.96	CHEMBL2801	Homo sapiens	pKi		6.2
inactive	9624492	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624493	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624494	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9624495	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624496	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624497	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624498	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624499	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624500	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9624501	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624502	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624503	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9624504	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9624505	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9624506	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628056	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628057	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628058	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	1000.0	CHEMBL2801	Homo sapiens	pKi		6.0
inactive	9628059	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628060	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628061	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628062	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628063	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628064	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1972290	=	Ki	nM	1000.0	CHEMBL2801	Homo sapiens	pKi		6.0
inactive	9628065	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628066	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628067	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628068	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9628069	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628070	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9628071	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628072	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628073	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628074	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628075	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cn1cc(Nc2ncc(Cl)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1984548	=	Ki	nM	100.0	CHEMBL2801	Homo sapiens	pKi		7.0
active	9628076	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	1000.0	CHEMBL2801	Homo sapiens	pKi		6.0
active	9628077	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	=	Ki	nM	125.89	CHEMBL2801	Homo sapiens	pKi		6.9
inactive	9628078	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628079	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
inactive	9628080	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628081	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628082	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628083	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628084	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	=	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
inactive	9628085	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628086	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9628087	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628088	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	79.43	CHEMBL2801	Homo sapiens	pKi		7.1
inactive	9628089	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628090	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628091	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	199.53	CHEMBL2801	Homo sapiens	pKi		6.7
inactive	9628092	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628093	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628094	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628095	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628096	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628097	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628098	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9628099	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628100	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628101	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1972339	=	Ki	nM	251.19	CHEMBL2801	Homo sapiens	pKi		6.6
inactive	9628102	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628103	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628104	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628105	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628106	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628107	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628108	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628109	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628110	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9628111	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628112	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628113	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9628114	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(Cl)c1		CHEMBL1983595	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9628115	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	501.19	CHEMBL2801	Homo sapiens	pKi		6.3
active	9628116	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
active	9628117	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	=	Ki	nM	794.33	CHEMBL2801	Homo sapiens	pKi		6.1
active	9628118	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
active	9628119	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCOCC2)n1		CHEMBL1980253	=	Ki	nM	398.11	CHEMBL2801	Homo sapiens	pKi		6.4
active	9628120	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
active	9628121	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
active	9628122	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628123	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
inactive	9628124	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628125	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	316.23	CHEMBL2801	Homo sapiens	pKi		6.5
active	9628126	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
inactive	9628127	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628128	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	=	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
inactive	9628129	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628130	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628131	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628132	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628133	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9628134	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNCC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1996980	=	Ki	nM	398.11	CHEMBL2801	Homo sapiens	pKi		6.4
inactive	9628135	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628136	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628137	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cn1cc(Nc2ncc(Br)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1994669	=	Ki	nM	31.62	CHEMBL2801	Homo sapiens	pKi		7.5
inactive	9628138	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628139	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628140	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	1000.0	CHEMBL2801	Homo sapiens	pKi		6.0
inactive	9628141	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628142	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628143	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628144	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	316.23	CHEMBL2801	Homo sapiens	pKi		6.5
inactive	9628145	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628146	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	25.12	CHEMBL2801	Homo sapiens	pKi		7.6
active	9628147	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
active	9628148	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628149	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628150	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628151	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	63.1	CHEMBL2801	Homo sapiens	pKi		7.2
active	9628152	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	1000.0	CHEMBL2801	Homo sapiens	pKi		6.0
active	9628153	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
inactive	9628154	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628155	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628156	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628157	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628158	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9628159	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628160	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628161	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628162	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc(F)cc2)n1		CHEMBL1992231	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9628163	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	199.53	CHEMBL2801	Homo sapiens	pKi		6.7
active	9628164	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628165	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628166	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628167	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	=	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
inactive	9628168	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628169	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628170	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
active	9628171	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	794.33	CHEMBL2801	Homo sapiens	pKi		6.1
inactive	9628172	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628173	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	31.62	CHEMBL2801	Homo sapiens	pKi		7.5
inactive	9628174	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC1CCCCC1Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1994438	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628175	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628176	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9628177	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9628178	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628179	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628180	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628181	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
active	9628182	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9628183	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628184	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628185	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628186	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628187	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9628188	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
inactive	9628189	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9628190	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
active	9628191	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
inactive	9628192	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628193	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9628194	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628195	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
active	9628196	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	=	Ki	nM	199.53	CHEMBL2801	Homo sapiens	pKi		6.7
inactive	9628197	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628198	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	158.49	CHEMBL2801	Homo sapiens	pKi		6.8
active	9628199	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	158.49	CHEMBL2801	Homo sapiens	pKi		6.8
inactive	9628200	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628201	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(OC)cc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL2002613	=	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
inactive	9628202	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628203	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628204	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628205	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
active	9628206	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9628207	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628208	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628209	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628210	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
active	9628211	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
active	9628212	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1998432	=	Ki	nM	251.19	CHEMBL2801	Homo sapiens	pKi		6.6
active	9628213	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9628214	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628215	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628216	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628217	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
inactive	9628218	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628219	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9628220	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628221	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628222	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628223	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	1000.0	CHEMBL2801	Homo sapiens	pKi		6.0
inactive	9628224	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628225	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628226	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
active	9628227	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	158.49	CHEMBL2801	Homo sapiens	pKi		6.8
inactive	9628228	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628229	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	794.33	CHEMBL2801	Homo sapiens	pKi		6.1
inactive	9628230	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628231	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9628232	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628233	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	398.11	CHEMBL2801	Homo sapiens	pKi		6.4
active	9628234	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	3.981	CHEMBL2801	Homo sapiens	pKi		8.4
inactive	9628235	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(F)c2)n1		CHEMBL243298	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628236	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628237	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628238	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	794.33	CHEMBL2801	Homo sapiens	pKi		6.1
active	9628239	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628240	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628241	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628242	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	630.96	CHEMBL2801	Homo sapiens	pKi		6.2
inactive	9628243	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628244	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	794.33	CHEMBL2801	Homo sapiens	pKi		6.1
inactive	9628245	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccc(F)cc1		CHEMBL1966204	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9628246	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628247	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
active	9628248	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
active	9628249	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9628250	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628251	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
active	9628252	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	=	Ki	nM	251.19	CHEMBL2801	Homo sapiens	pKi		6.6
inactive	9628253	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628254	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9628255	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628256	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9628257	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628258	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628259	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628260	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9628261	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628262	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628263	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9628264	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628265	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9628266	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628267	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628268	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628269	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628270	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628271	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628272	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628273	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9628274	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
active	9628275	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9628276	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9628277	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	630.96	CHEMBL2801	Homo sapiens	pKi		6.2
active	9628278	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628279	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628280	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccc(Cl)cc1		CHEMBL1987073	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9628281	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	79.43	CHEMBL2801	Homo sapiens	pKi		7.1
inactive	9628282	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1995712	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9628283	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9628284	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628285	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628286	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628287	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
active	9628288	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9628289	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628290	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628291	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9628292	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
active	9628293	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	79.43	CHEMBL2801	Homo sapiens	pKi		7.1
active	9628294	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
active	9631857	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
active	9631858	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
active	9631859	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
active	9631860	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
active	9631861	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CS(=O)(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1980562	=	Ki	nM	398.11	CHEMBL2801	Homo sapiens	pKi		6.4
inactive	9631862	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631863	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631864	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631865	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccccc3)ccc2c1=O		CHEMBL1997839	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9631866	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(O)c1ccccc1Nc1ncnc(Nc2cccc(F)c2)n1		CHEMBL1979933	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9631867	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631868	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631869	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	OC1CCCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1976936	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9631870	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631871	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631872	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631873	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9631874	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Clc1cc(-c2c[nH]c3ncccc23)ncn1		CHEMBL1972988	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9631875	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCNc1nc(C)c(C=CC(C)(C)c2ccc(C(F)(F)F)cc2)c(NCC)n1		CHEMBL1994214	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
inactive	9631876	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631877	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631878	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631879	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631880	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9631881	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631882	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1987448	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9631883	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631884	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9631885	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631886	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631887	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631888	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9631889	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631890	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631891	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631892	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631893	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631894	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CS(=O)(=O)NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005216	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9631895	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9631896	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631897	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631898	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631899	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631900	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631901	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	630.96	CHEMBL2801	Homo sapiens	pKi		6.2
active	9631902	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	15.85	CHEMBL2801	Homo sapiens	pKi		7.8
active	9631903	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	251.19	CHEMBL2801	Homo sapiens	pKi		6.6
inactive	9631904	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631905	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631906	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631907	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631908	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9631909	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631910	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9631911	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631912	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631913	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631914	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
active	9631915	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631916	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	15.85	CHEMBL2801	Homo sapiens	pKi		7.8
inactive	9631917	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631918	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631919	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631920	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631921	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631922	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631923	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	251.19	CHEMBL2801	Homo sapiens	pKi		6.6
inactive	9631924	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631925	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631926	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631927	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631928	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
active	9631929	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	79.43	CHEMBL2801	Homo sapiens	pKi		7.1
active	9631930	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	125.89	CHEMBL2801	Homo sapiens	pKi		6.9
inactive	9631931	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631932	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9631933	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631934	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCCOc1ccccc1CCc1cccc2nc(N)nc(N)c12		CHEMBL1983255	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9631935	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631936	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631937	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
inactive	9631938	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631939	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	398.11	CHEMBL2801	Homo sapiens	pKi		6.4
inactive	9631940	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631941	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	316.23	CHEMBL2801	Homo sapiens	pKi		6.5
inactive	9631942	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631943	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631944	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631945	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631946	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631947	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
active	9631948	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
inactive	9631949	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631950	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)c1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1		CHEMBL1992363	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9631951	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631952	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9631953	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631954	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631955	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631956	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631957	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631958	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)CC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1982271	=	Ki	nM	630.96	CHEMBL2801	Homo sapiens	pKi		6.2
inactive	9631959	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631960	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	630.96	CHEMBL2801	Homo sapiens	pKi		6.2
inactive	9631961	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631962	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631963	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631964	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631965	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631966	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9631967	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631968	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631969	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9631970	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631971	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9631972	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631973	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631974	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631975	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	398.11	CHEMBL2801	Homo sapiens	pKi		6.4
inactive	9631976	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631977	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9631978	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL1986666	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9631979	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9631980	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631981	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
active	9631982	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	1995.26	CHEMBL2801	Homo sapiens	pKi		5.7
active	9631983	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
inactive	9631984	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631985	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631986	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631987	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	39.81	CHEMBL2801	Homo sapiens	pKi		7.4
inactive	9631988	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631989	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631990	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631991	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9631992	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	25.12	CHEMBL2801	Homo sapiens	pKi		7.6
inactive	9631993	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631994	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631995	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631996	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631997	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631998	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9631999	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632000	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	=	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
inactive	9632001	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	N#Cc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1		CHEMBL1990162	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
active	9632002	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1992220	=	Ki	nM	158.49	CHEMBL2801	Homo sapiens	pKi		6.8
active	9632003	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	63.1	CHEMBL2801	Homo sapiens	pKi		7.2
active	9632004	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
inactive	9632005	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632006	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632007	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
active	9632008	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	501.19	CHEMBL2801	Homo sapiens	pKi		6.3
inactive	9632009	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632010	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
active	9632011	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	1584.89	CHEMBL2801	Homo sapiens	pKi		5.8
active	9632012	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	12.59	CHEMBL2801	Homo sapiens	pKi		7.9
inactive	9632013	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632014	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CS(=O)(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1987948	=	Ki	nM	630.96	CHEMBL2801	Homo sapiens	pKi		6.2
inactive	9632015	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632016	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632017	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632018	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	10.0	CHEMBL2801	Homo sapiens	pKi		8.0
inactive	9632019	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632020	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632021	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	Ki	nM	794.33	CHEMBL2801	Homo sapiens	pKi		6.1
inactive	9632022	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632023	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632024	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632025	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632026	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9632027	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632028	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9632029	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632030	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632031	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
active	9632032	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(CN)CNc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1968930	=	Ki	nM	316.23	CHEMBL2801	Homo sapiens	pKi		6.5
inactive	9632033	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632034	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632035	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632036	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
inactive	9632037	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632038	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632039	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9632040	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632041	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632042	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632043	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632044	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
inactive	9632045	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632046	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632047	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632048	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632049	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632050	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	501.19	CHEMBL2801	Homo sapiens	pKi		6.3
inactive	9632051	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632052	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632053	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632054	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632055	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632056	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632057	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	5011.87	CHEMBL2801	Homo sapiens	pKi		5.3
active	9632058	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005509	=	Ki	nM	125.89	CHEMBL2801	Homo sapiens	pKi		6.9
inactive	9632059	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632060	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632061	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632062	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632063	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632064	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632065	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632066	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632067	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	=	Ki	nM	794.33	CHEMBL2801	Homo sapiens	pKi		6.1
inactive	9632068	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632069	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632070	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632071	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632072	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc(CNc2cc(-c3c[nH]c4ncccc34)cc(F)n2)cc1		CHEMBL1986855	=	Ki	nM	316.23	CHEMBL2801	Homo sapiens	pKi		6.5
active	9632073	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
active	9632074	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	3981.07	CHEMBL2801	Homo sapiens	pKi		5.4
inactive	9632075	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632076	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	2511.89	CHEMBL2801	Homo sapiens	pKi		5.6
inactive	9632077	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632078	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632079	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632080	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632081	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632082	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	3162.28	CHEMBL2801	Homo sapiens	pKi		5.5
inactive	9632083	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632084	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632085	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632086	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CCCCOc1ccc(C(C)(C)CC)cc1S(=O)(=O)Nc1ccc(-c2csc3ncnc(N)c23)cc1		CHEMBL1985690	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632087	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
inactive	9632088	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
active	9632089	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	19.95	CHEMBL2801	Homo sapiens	pKi		7.7
active	9632090	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
active	9632091	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	=	Ki	nM	1258.93	CHEMBL2801	Homo sapiens	pKi		5.9
active	9632092	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	=	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632093	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
inactive	9632094	CHEMBL1963738	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	6309.57	CHEMBL2801	Homo sapiens	pKi		5.2
	10838662	CHEMBL2014540	Inhibition of CaMK2d at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	91.0	CHEMBL2801	Homo sapiens	INH	%	91.0
	10850049	CHEMBL2019771	Inhibition of human CaMK2delta at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	10984737	CHEMBL2072033	Inhibition of human CaMK2delta at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	12046255	CHEMBL2156492	Inhibition of CaMK2 delta at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	4.8	CHEMBL2801	Homo sapiens	INH	%	4.8
	12081734	CHEMBL2166441	Inhibition of CAMK2D assessed as residual enzyme activity at 10 uM by radiometric protein kinase assay	B	Cc1c2c(cc[n+]1Cc1ccc(F)cc1)c1ccc(OCc3cccc(F)c3)cc1n2Cc1cccc(F)c1.[Br-]		CHEMBL2164692	=	Activity	%	2.0	CHEMBL2801	Homo sapiens	Activity	%	2.0
	12135278	CHEMBL2184766	Inhibition of CAMK2D at 10 uM	B	O=C(Nc1cc(Nc2ccc3c(c2)CCCCC3=O)ccc1F)c1ccccc1		CHEMBL2177219	>	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	12145277	CHEMBL2186663	Inhibition of CAMK2delta using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL2801	Homo sapiens	INH	%	25.0
	12145278	CHEMBL2186663	Inhibition of CAMK2delta using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL2801	Homo sapiens	INH	%	25.0
	12173711	CHEMBL2209755	Inhibition of CAMK2D assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	64.0	CHEMBL2801	Homo sapiens	Activity	%	64.0
	12183918	CHEMBL2216384	Inhibition of CAMK2D	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL2801	Homo sapiens	pIC50		5.0
	12241751	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	104.0	CHEMBL2801	Homo sapiens	Residual Activity	%	104.0
	12241752	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	28.0	CHEMBL2801	Homo sapiens	Residual Activity	%	28.0
	12241753	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	97.0	CHEMBL2801	Homo sapiens	Residual Activity	%	97.0
	12241754	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	108.0	CHEMBL2801	Homo sapiens	Residual Activity	%	108.0
	12241755	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	85.0	CHEMBL2801	Homo sapiens	Residual Activity	%	85.0
	12241756	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	98.0	CHEMBL2801	Homo sapiens	Residual Activity	%	98.0
	12241757	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	23.0	CHEMBL2801	Homo sapiens	Residual Activity	%	23.0
	12241758	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	60.0	CHEMBL2801	Homo sapiens	Residual Activity	%	60.0
	12241759	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	106.0	CHEMBL2801	Homo sapiens	Residual Activity	%	106.0
	12241760	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	97.0	CHEMBL2801	Homo sapiens	Residual Activity	%	97.0
	12241761	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	107.0	CHEMBL2801	Homo sapiens	Residual Activity	%	107.0
	12241762	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	103.0	CHEMBL2801	Homo sapiens	Residual Activity	%	103.0
	12241763	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	109.0	CHEMBL2801	Homo sapiens	Residual Activity	%	109.0
	12241764	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	106.0	CHEMBL2801	Homo sapiens	Residual Activity	%	106.0
	12241765	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	51.0	CHEMBL2801	Homo sapiens	Residual Activity	%	51.0
	12241766	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	79.0	CHEMBL2801	Homo sapiens	Residual Activity	%	79.0
	12241767	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	109.0	CHEMBL2801	Homo sapiens	Residual Activity	%	109.0
	12241768	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	108.0	CHEMBL2801	Homo sapiens	Residual Activity	%	108.0
	12241769	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	86.0	CHEMBL2801	Homo sapiens	Residual Activity	%	86.0
	12241770	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	24.0	CHEMBL2801	Homo sapiens	Residual Activity	%	24.0
	12241771	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	115.0	CHEMBL2801	Homo sapiens	Residual Activity	%	115.0
	12241772	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	110.0	CHEMBL2801	Homo sapiens	Residual Activity	%	110.0
	12241773	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	109.0	CHEMBL2801	Homo sapiens	Residual Activity	%	109.0
	12241774	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	109.0	CHEMBL2801	Homo sapiens	Residual Activity	%	109.0
	12241775	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	98.0	CHEMBL2801	Homo sapiens	Residual Activity	%	98.0
	12241776	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	85.0	CHEMBL2801	Homo sapiens	Residual Activity	%	85.0
	12241777	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	23.0	CHEMBL2801	Homo sapiens	Residual Activity	%	23.0
	12241778	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	79.0	CHEMBL2801	Homo sapiens	Residual Activity	%	79.0
	12241779	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	104.0	CHEMBL2801	Homo sapiens	Residual Activity	%	104.0
	12241780	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	77.0	CHEMBL2801	Homo sapiens	Residual Activity	%	77.0
	12241781	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	96.0	CHEMBL2801	Homo sapiens	Residual Activity	%	96.0
	12241782	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	102.0	CHEMBL2801	Homo sapiens	Residual Activity	%	102.0
	12241783	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	102.0	CHEMBL2801	Homo sapiens	Residual Activity	%	102.0
	12241784	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	99.0	CHEMBL2801	Homo sapiens	Residual Activity	%	99.0
	12241785	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	101.0	CHEMBL2801	Homo sapiens	Residual Activity	%	101.0
	12241786	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	104.0	CHEMBL2801	Homo sapiens	Residual Activity	%	104.0
	12241787	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	95.0	CHEMBL2801	Homo sapiens	Residual Activity	%	95.0
	12241788	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	109.0	CHEMBL2801	Homo sapiens	Residual Activity	%	109.0
	12241789	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	105.0	CHEMBL2801	Homo sapiens	Residual Activity	%	105.0
	12241790	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	18.0	CHEMBL2801	Homo sapiens	Residual Activity	%	18.0
	12241791	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	112.0	CHEMBL2801	Homo sapiens	Residual Activity	%	112.0
	12241792	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	102.0	CHEMBL2801	Homo sapiens	Residual Activity	%	102.0
	12241793	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	1.0	CHEMBL2801	Homo sapiens	Residual Activity	%	1.0
	12241794	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	8.0	CHEMBL2801	Homo sapiens	Residual Activity	%	8.0
	12241795	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	101.0	CHEMBL2801	Homo sapiens	Residual Activity	%	101.0
	12241796	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	87.0	CHEMBL2801	Homo sapiens	Residual Activity	%	87.0
	12241797	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	106.0	CHEMBL2801	Homo sapiens	Residual Activity	%	106.0
	12241798	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	38.0	CHEMBL2801	Homo sapiens	Residual Activity	%	38.0
	12241799	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	104.0	CHEMBL2801	Homo sapiens	Residual Activity	%	104.0
	12241800	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	104.0	CHEMBL2801	Homo sapiens	Residual Activity	%	104.0
	12241801	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	42.0	CHEMBL2801	Homo sapiens	Residual Activity	%	42.0
	12241802	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	98.0	CHEMBL2801	Homo sapiens	Residual Activity	%	98.0
	12241803	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	18.0	CHEMBL2801	Homo sapiens	Residual Activity	%	18.0
	12241804	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	98.0	CHEMBL2801	Homo sapiens	Residual Activity	%	98.0
	12241805	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	110.0	CHEMBL2801	Homo sapiens	Residual Activity	%	110.0
	12241806	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	80.0	CHEMBL2801	Homo sapiens	Residual Activity	%	80.0
	12241807	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	108.0	CHEMBL2801	Homo sapiens	Residual Activity	%	108.0
	12241808	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	105.0	CHEMBL2801	Homo sapiens	Residual Activity	%	105.0
	12241809	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	79.0	CHEMBL2801	Homo sapiens	Residual Activity	%	79.0
	12241810	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	102.0	CHEMBL2801	Homo sapiens	Residual Activity	%	102.0
	12241811	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	69.0	CHEMBL2801	Homo sapiens	Residual Activity	%	69.0
	12241812	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	5.0	CHEMBL2801	Homo sapiens	Residual Activity	%	5.0
	12241813	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	108.0	CHEMBL2801	Homo sapiens	Residual Activity	%	108.0
	12241814	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	100.0	CHEMBL2801	Homo sapiens	Residual Activity	%	100.0
	12241815	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	105.0	CHEMBL2801	Homo sapiens	Residual Activity	%	105.0
	12241816	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	89.0	CHEMBL2801	Homo sapiens	Residual Activity	%	89.0
	12241817	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	102.0	CHEMBL2801	Homo sapiens	Residual Activity	%	102.0
	12241818	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	101.0	CHEMBL2801	Homo sapiens	Residual Activity	%	101.0
	12241819	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	76.0	CHEMBL2801	Homo sapiens	Residual Activity	%	76.0
	12241820	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	105.0	CHEMBL2801	Homo sapiens	Residual Activity	%	105.0
	12241821	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	112.0	CHEMBL2801	Homo sapiens	Residual Activity	%	112.0
	12241822	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	66.0	CHEMBL2801	Homo sapiens	Residual Activity	%	66.0
	12241823	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	16.0	CHEMBL2801	Homo sapiens	Residual Activity	%	16.0
	12241824	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	100.0	CHEMBL2801	Homo sapiens	Residual Activity	%	100.0
	12241825	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	22.0	CHEMBL2801	Homo sapiens	Residual Activity	%	22.0
	12241826	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	44.0	CHEMBL2801	Homo sapiens	Residual Activity	%	44.0
	12241827	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	106.0	CHEMBL2801	Homo sapiens	Residual Activity	%	106.0
	12241828	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	3.0	CHEMBL2801	Homo sapiens	Residual Activity	%	3.0
	12241829	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	101.0	CHEMBL2801	Homo sapiens	Residual Activity	%	101.0
	12241830	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	2.0	CHEMBL2801	Homo sapiens	Residual Activity	%	2.0
	12241831	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	99.0	CHEMBL2801	Homo sapiens	Residual Activity	%	99.0
	12241832	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	75.0	CHEMBL2801	Homo sapiens	Residual Activity	%	75.0
	12241833	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	15.0	CHEMBL2801	Homo sapiens	Residual Activity	%	15.0
	12241834	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	107.0	CHEMBL2801	Homo sapiens	Residual Activity	%	107.0
	12241835	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	18.0	CHEMBL2801	Homo sapiens	Residual Activity	%	18.0
	12241836	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	109.0	CHEMBL2801	Homo sapiens	Residual Activity	%	109.0
	12241837	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	102.0	CHEMBL2801	Homo sapiens	Residual Activity	%	102.0
	12241838	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	108.0	CHEMBL2801	Homo sapiens	Residual Activity	%	108.0
	12241839	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	96.0	CHEMBL2801	Homo sapiens	Residual Activity	%	96.0
	12241840	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	10.0	CHEMBL2801	Homo sapiens	Residual Activity	%	10.0
	12241841	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	95.0	CHEMBL2801	Homo sapiens	Residual Activity	%	95.0
	12241842	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	94.0	CHEMBL2801	Homo sapiens	Residual Activity	%	94.0
	12241843	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	63.0	CHEMBL2801	Homo sapiens	Residual Activity	%	63.0
	12241844	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	107.0	CHEMBL2801	Homo sapiens	Residual Activity	%	107.0
	12241845	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	114.0	CHEMBL2801	Homo sapiens	Residual Activity	%	114.0
	12241846	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	103.0	CHEMBL2801	Homo sapiens	Residual Activity	%	103.0
	12241847	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	99.0	CHEMBL2801	Homo sapiens	Residual Activity	%	99.0
	12241848	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	104.0	CHEMBL2801	Homo sapiens	Residual Activity	%	104.0
	12241849	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	95.0	CHEMBL2801	Homo sapiens	Residual Activity	%	95.0
	12241850	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	87.0	CHEMBL2801	Homo sapiens	Residual Activity	%	87.0
	12241851	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	12.0	CHEMBL2801	Homo sapiens	Residual Activity	%	12.0
	12241852	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL2801	Homo sapiens	Residual Activity	%	0.0
	12241853	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	101.0	CHEMBL2801	Homo sapiens	Residual Activity	%	101.0
	12241854	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	-1.0	CHEMBL2801	Homo sapiens	Residual Activity	%	-1.0
	12241855	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	32.0	CHEMBL2801	Homo sapiens	Residual Activity	%	32.0
	12241856	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	86.0	CHEMBL2801	Homo sapiens	Residual Activity	%	86.0
	12241857	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	89.0	CHEMBL2801	Homo sapiens	Residual Activity	%	89.0
	12241858	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	95.0	CHEMBL2801	Homo sapiens	Residual Activity	%	95.0
	12241859	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	107.0	CHEMBL2801	Homo sapiens	Residual Activity	%	107.0
	12241860	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	58.0	CHEMBL2801	Homo sapiens	Residual Activity	%	58.0
	12241861	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	113.0	CHEMBL2801	Homo sapiens	Residual Activity	%	113.0
	12241862	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	104.0	CHEMBL2801	Homo sapiens	Residual Activity	%	104.0
	12241863	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	10.0	CHEMBL2801	Homo sapiens	Residual Activity	%	10.0
	12241864	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	87.0	CHEMBL2801	Homo sapiens	Residual Activity	%	87.0
	12241865	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	91.0	CHEMBL2801	Homo sapiens	Residual Activity	%	91.0
	12241866	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	98.0	CHEMBL2801	Homo sapiens	Residual Activity	%	98.0
	12241867	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	83.0	CHEMBL2801	Homo sapiens	Residual Activity	%	83.0
	12241868	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	101.0	CHEMBL2801	Homo sapiens	Residual Activity	%	101.0
	12241869	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	100.0	CHEMBL2801	Homo sapiens	Residual Activity	%	100.0
	12241870	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	108.0	CHEMBL2801	Homo sapiens	Residual Activity	%	108.0
	12241871	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	62.0	CHEMBL2801	Homo sapiens	Residual Activity	%	62.0
	12241872	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	44.0	CHEMBL2801	Homo sapiens	Residual Activity	%	44.0
	12241873	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	19.0	CHEMBL2801	Homo sapiens	Residual Activity	%	19.0
	12241874	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	73.0	CHEMBL2801	Homo sapiens	Residual Activity	%	73.0
	12241875	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	6.0	CHEMBL2801	Homo sapiens	Residual Activity	%	6.0
	12241876	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	102.0	CHEMBL2801	Homo sapiens	Residual Activity	%	102.0
	12241877	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	99.0	CHEMBL2801	Homo sapiens	Residual Activity	%	99.0
	12241878	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	102.0	CHEMBL2801	Homo sapiens	Residual Activity	%	102.0
	12241879	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	73.0	CHEMBL2801	Homo sapiens	Residual Activity	%	73.0
	12241880	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL2801	Homo sapiens	Residual Activity	%	0.0
	12241881	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	92.0	CHEMBL2801	Homo sapiens	Residual Activity	%	92.0
	12241882	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	94.0	CHEMBL2801	Homo sapiens	Residual Activity	%	94.0
	12241883	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	43.0	CHEMBL2801	Homo sapiens	Residual Activity	%	43.0
	12241884	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	97.0	CHEMBL2801	Homo sapiens	Residual Activity	%	97.0
	12241885	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	42.0	CHEMBL2801	Homo sapiens	Residual Activity	%	42.0
	12241886	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	80.0	CHEMBL2801	Homo sapiens	Residual Activity	%	80.0
	12244487	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	86.0	CHEMBL2801	Homo sapiens	Residual Activity	%	86.0
	12244488	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	83.0	CHEMBL2801	Homo sapiens	Residual Activity	%	83.0
	12244489	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	1.0	CHEMBL2801	Homo sapiens	Residual Activity	%	1.0
	12244490	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	85.0	CHEMBL2801	Homo sapiens	Residual Activity	%	85.0
	12244491	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	62.0	CHEMBL2801	Homo sapiens	Residual Activity	%	62.0
	12244492	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	91.0	CHEMBL2801	Homo sapiens	Residual Activity	%	91.0
	12244493	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	80.0	CHEMBL2801	Homo sapiens	Residual Activity	%	80.0
	12244494	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	40.0	CHEMBL2801	Homo sapiens	Residual Activity	%	40.0
	12244495	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	100.0	CHEMBL2801	Homo sapiens	Residual Activity	%	100.0
	12244496	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	94.0	CHEMBL2801	Homo sapiens	Residual Activity	%	94.0
	12244497	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	17.0	CHEMBL2801	Homo sapiens	Residual Activity	%	17.0
	12244498	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	83.0	CHEMBL2801	Homo sapiens	Residual Activity	%	83.0
	12244499	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	77.0	CHEMBL2801	Homo sapiens	Residual Activity	%	77.0
	12244500	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	110.0	CHEMBL2801	Homo sapiens	Residual Activity	%	110.0
	12244501	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	42.0	CHEMBL2801	Homo sapiens	Residual Activity	%	42.0
	12244502	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	83.0	CHEMBL2801	Homo sapiens	Residual Activity	%	83.0
	12244503	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	101.0	CHEMBL2801	Homo sapiens	Residual Activity	%	101.0
	12244504	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	80.0	CHEMBL2801	Homo sapiens	Residual Activity	%	80.0
	12244505	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	106.0	CHEMBL2801	Homo sapiens	Residual Activity	%	106.0
	12244506	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	31.0	CHEMBL2801	Homo sapiens	Residual Activity	%	31.0
	12244507	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	98.0	CHEMBL2801	Homo sapiens	Residual Activity	%	98.0
	12244508	CHEMBL2219014	Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	-1.0	CHEMBL2801	Homo sapiens	Residual Activity	%	-1.0
	12244509	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	46.0	CHEMBL2801	Homo sapiens	Residual Activity	%	46.0
	12244510	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	4.0	CHEMBL2801	Homo sapiens	Residual Activity	%	4.0
	12244511	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	67.0	CHEMBL2801	Homo sapiens	Residual Activity	%	67.0
	12244512	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	96.0	CHEMBL2801	Homo sapiens	Residual Activity	%	96.0
	12244513	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	42.0	CHEMBL2801	Homo sapiens	Residual Activity	%	42.0
	12244514	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	63.0	CHEMBL2801	Homo sapiens	Residual Activity	%	63.0
	12244515	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	7.0	CHEMBL2801	Homo sapiens	Residual Activity	%	7.0
	12244516	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	18.0	CHEMBL2801	Homo sapiens	Residual Activity	%	18.0
	12244517	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	85.0	CHEMBL2801	Homo sapiens	Residual Activity	%	85.0
	12244518	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	52.0	CHEMBL2801	Homo sapiens	Residual Activity	%	52.0
	12244519	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	97.0	CHEMBL2801	Homo sapiens	Residual Activity	%	97.0
	12244520	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	85.0	CHEMBL2801	Homo sapiens	Residual Activity	%	85.0
	12244521	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	79.0	CHEMBL2801	Homo sapiens	Residual Activity	%	79.0
	12244522	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	78.0	CHEMBL2801	Homo sapiens	Residual Activity	%	78.0
	12244523	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	9.0	CHEMBL2801	Homo sapiens	Residual Activity	%	9.0
	12244524	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	59.0	CHEMBL2801	Homo sapiens	Residual Activity	%	59.0
	12244525	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	78.0	CHEMBL2801	Homo sapiens	Residual Activity	%	78.0
	12244526	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	85.0	CHEMBL2801	Homo sapiens	Residual Activity	%	85.0
	12244527	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	66.0	CHEMBL2801	Homo sapiens	Residual Activity	%	66.0
	12244528	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	11.0	CHEMBL2801	Homo sapiens	Residual Activity	%	11.0
	12244529	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	83.0	CHEMBL2801	Homo sapiens	Residual Activity	%	83.0
	12244530	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	88.0	CHEMBL2801	Homo sapiens	Residual Activity	%	88.0
	12244531	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	97.0	CHEMBL2801	Homo sapiens	Residual Activity	%	97.0
	12244532	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	90.0	CHEMBL2801	Homo sapiens	Residual Activity	%	90.0
	12244533	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	91.0	CHEMBL2801	Homo sapiens	Residual Activity	%	91.0
	12244534	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	38.0	CHEMBL2801	Homo sapiens	Residual Activity	%	38.0
	12244535	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	4.0	CHEMBL2801	Homo sapiens	Residual Activity	%	4.0
	12244536	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	28.0	CHEMBL2801	Homo sapiens	Residual Activity	%	28.0
	12244537	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	93.0	CHEMBL2801	Homo sapiens	Residual Activity	%	93.0
	12244538	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	23.0	CHEMBL2801	Homo sapiens	Residual Activity	%	23.0
	12244539	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	80.0	CHEMBL2801	Homo sapiens	Residual Activity	%	80.0
	12244540	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	90.0	CHEMBL2801	Homo sapiens	Residual Activity	%	90.0
	12244541	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	2.0	CHEMBL2801	Homo sapiens	Residual Activity	%	2.0
	12244542	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	75.0	CHEMBL2801	Homo sapiens	Residual Activity	%	75.0
	12244543	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	99.0	CHEMBL2801	Homo sapiens	Residual Activity	%	99.0
	12244544	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	92.0	CHEMBL2801	Homo sapiens	Residual Activity	%	92.0
	12244545	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	54.0	CHEMBL2801	Homo sapiens	Residual Activity	%	54.0
	12244546	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	99.0	CHEMBL2801	Homo sapiens	Residual Activity	%	99.0
	12244547	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	99.0	CHEMBL2801	Homo sapiens	Residual Activity	%	99.0
	12244548	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	20.0	CHEMBL2801	Homo sapiens	Residual Activity	%	20.0
	12244549	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	112.0	CHEMBL2801	Homo sapiens	Residual Activity	%	112.0
	12244550	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	86.0	CHEMBL2801	Homo sapiens	Residual Activity	%	86.0
	12244551	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	1.0	CHEMBL2801	Homo sapiens	Residual Activity	%	1.0
	12244552	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	1.0	CHEMBL2801	Homo sapiens	Residual Activity	%	1.0
	12244553	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	85.0	CHEMBL2801	Homo sapiens	Residual Activity	%	85.0
	12244554	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	30.0	CHEMBL2801	Homo sapiens	Residual Activity	%	30.0
	12244555	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	100.0	CHEMBL2801	Homo sapiens	Residual Activity	%	100.0
	12244556	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	9.0	CHEMBL2801	Homo sapiens	Residual Activity	%	9.0
	12244557	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	103.0	CHEMBL2801	Homo sapiens	Residual Activity	%	103.0
	12244558	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	61.0	CHEMBL2801	Homo sapiens	Residual Activity	%	61.0
	12244559	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	8.0	CHEMBL2801	Homo sapiens	Residual Activity	%	8.0
	12244560	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	68.0	CHEMBL2801	Homo sapiens	Residual Activity	%	68.0
	12244561	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	4.0	CHEMBL2801	Homo sapiens	Residual Activity	%	4.0
	12244562	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	60.0	CHEMBL2801	Homo sapiens	Residual Activity	%	60.0
	12244563	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	96.0	CHEMBL2801	Homo sapiens	Residual Activity	%	96.0
	12244564	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	87.0	CHEMBL2801	Homo sapiens	Residual Activity	%	87.0
	12244565	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	91.0	CHEMBL2801	Homo sapiens	Residual Activity	%	91.0
	12244566	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	91.0	CHEMBL2801	Homo sapiens	Residual Activity	%	91.0
	12244567	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	22.0	CHEMBL2801	Homo sapiens	Residual Activity	%	22.0
	12244568	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	83.0	CHEMBL2801	Homo sapiens	Residual Activity	%	83.0
	12244569	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	10.0	CHEMBL2801	Homo sapiens	Residual Activity	%	10.0
	12244570	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	1.0	CHEMBL2801	Homo sapiens	Residual Activity	%	1.0
	12244571	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	94.0	CHEMBL2801	Homo sapiens	Residual Activity	%	94.0
	12244572	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	76.0	CHEMBL2801	Homo sapiens	Residual Activity	%	76.0
	12244573	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	98.0	CHEMBL2801	Homo sapiens	Residual Activity	%	98.0
	12244574	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	35.0	CHEMBL2801	Homo sapiens	Residual Activity	%	35.0
	12244575	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	110.0	CHEMBL2801	Homo sapiens	Residual Activity	%	110.0
	12244576	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	77.0	CHEMBL2801	Homo sapiens	Residual Activity	%	77.0
	12244577	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	28.0	CHEMBL2801	Homo sapiens	Residual Activity	%	28.0
	12244578	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	111.0	CHEMBL2801	Homo sapiens	Residual Activity	%	111.0
	12244579	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	81.0	CHEMBL2801	Homo sapiens	Residual Activity	%	81.0
	12244580	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	19.0	CHEMBL2801	Homo sapiens	Residual Activity	%	19.0
	12244581	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	5.0	CHEMBL2801	Homo sapiens	Residual Activity	%	5.0
	12244582	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	83.0	CHEMBL2801	Homo sapiens	Residual Activity	%	83.0
	12244583	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	4.0	CHEMBL2801	Homo sapiens	Residual Activity	%	4.0
	12244584	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	12.0	CHEMBL2801	Homo sapiens	Residual Activity	%	12.0
	12244585	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	82.0	CHEMBL2801	Homo sapiens	Residual Activity	%	82.0
	12244586	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	1.0	CHEMBL2801	Homo sapiens	Residual Activity	%	1.0
	12244587	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	80.0	CHEMBL2801	Homo sapiens	Residual Activity	%	80.0
	12244588	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL2801	Homo sapiens	Residual Activity	%	-1.0
	12244589	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	91.0	CHEMBL2801	Homo sapiens	Residual Activity	%	91.0
	12244590	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	31.0	CHEMBL2801	Homo sapiens	Residual Activity	%	31.0
	12244591	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	18.0	CHEMBL2801	Homo sapiens	Residual Activity	%	18.0
	12244592	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	92.0	CHEMBL2801	Homo sapiens	Residual Activity	%	92.0
	12244593	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	13.0	CHEMBL2801	Homo sapiens	Residual Activity	%	13.0
	12244594	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	78.0	CHEMBL2801	Homo sapiens	Residual Activity	%	78.0
	12244595	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	83.0	CHEMBL2801	Homo sapiens	Residual Activity	%	83.0
	12244596	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	89.0	CHEMBL2801	Homo sapiens	Residual Activity	%	89.0
	12244597	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	84.0	CHEMBL2801	Homo sapiens	Residual Activity	%	84.0
	12244598	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	2.0	CHEMBL2801	Homo sapiens	Residual Activity	%	2.0
	12244599	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	62.0	CHEMBL2801	Homo sapiens	Residual Activity	%	62.0
	12244600	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	93.0	CHEMBL2801	Homo sapiens	Residual Activity	%	93.0
	12244601	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	20.0	CHEMBL2801	Homo sapiens	Residual Activity	%	20.0
	12244602	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	97.0	CHEMBL2801	Homo sapiens	Residual Activity	%	97.0
	12244603	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	102.0	CHEMBL2801	Homo sapiens	Residual Activity	%	102.0
	12244604	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	64.0	CHEMBL2801	Homo sapiens	Residual Activity	%	64.0
	12244605	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	82.0	CHEMBL2801	Homo sapiens	Residual Activity	%	82.0
	12244606	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	107.0	CHEMBL2801	Homo sapiens	Residual Activity	%	107.0
	12244607	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	98.0	CHEMBL2801	Homo sapiens	Residual Activity	%	98.0
	12244608	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	82.0	CHEMBL2801	Homo sapiens	Residual Activity	%	82.0
	12244609	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	6.0	CHEMBL2801	Homo sapiens	Residual Activity	%	6.0
	12244610	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL2801	Homo sapiens	Residual Activity	%	1.0
	12244611	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	99.0	CHEMBL2801	Homo sapiens	Residual Activity	%	99.0
	12244612	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	5.0	CHEMBL2801	Homo sapiens	Residual Activity	%	5.0
	12244613	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	20.0	CHEMBL2801	Homo sapiens	Residual Activity	%	20.0
	12244614	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	58.0	CHEMBL2801	Homo sapiens	Residual Activity	%	58.0
	12244615	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	69.0	CHEMBL2801	Homo sapiens	Residual Activity	%	69.0
	12244616	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	81.0	CHEMBL2801	Homo sapiens	Residual Activity	%	81.0
	12244617	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	89.0	CHEMBL2801	Homo sapiens	Residual Activity	%	89.0
	12244618	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	16.0	CHEMBL2801	Homo sapiens	Residual Activity	%	16.0
	12244619	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	99.0	CHEMBL2801	Homo sapiens	Residual Activity	%	99.0
	12244620	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	81.0	CHEMBL2801	Homo sapiens	Residual Activity	%	81.0
	12244621	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	3.0	CHEMBL2801	Homo sapiens	Residual Activity	%	3.0
	12244622	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	34.0	CHEMBL2801	Homo sapiens	Residual Activity	%	34.0
	12244623	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	61.0	CHEMBL2801	Homo sapiens	Residual Activity	%	61.0
	12244624	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	90.0	CHEMBL2801	Homo sapiens	Residual Activity	%	90.0
	12244625	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	31.0	CHEMBL2801	Homo sapiens	Residual Activity	%	31.0
	12244626	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	47.0	CHEMBL2801	Homo sapiens	Residual Activity	%	47.0
	12244627	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	56.0	CHEMBL2801	Homo sapiens	Residual Activity	%	56.0
	12244628	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	95.0	CHEMBL2801	Homo sapiens	Residual Activity	%	95.0
	12244629	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	22.0	CHEMBL2801	Homo sapiens	Residual Activity	%	22.0
	12244630	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	10.0	CHEMBL2801	Homo sapiens	Residual Activity	%	10.0
	12244631	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	11.0	CHEMBL2801	Homo sapiens	Residual Activity	%	11.0
	12244632	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	65.0	CHEMBL2801	Homo sapiens	Residual Activity	%	65.0
	12244633	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	1.0	CHEMBL2801	Homo sapiens	Residual Activity	%	1.0
	12244634	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	94.0	CHEMBL2801	Homo sapiens	Residual Activity	%	94.0
	12244635	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	46.0	CHEMBL2801	Homo sapiens	Residual Activity	%	46.0
	12244636	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	98.0	CHEMBL2801	Homo sapiens	Residual Activity	%	98.0
	12244637	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	42.0	CHEMBL2801	Homo sapiens	Residual Activity	%	42.0
	12244638	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL2801	Homo sapiens	Residual Activity	%	0.0
	12244639	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	54.0	CHEMBL2801	Homo sapiens	Residual Activity	%	54.0
	12244640	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	93.0	CHEMBL2801	Homo sapiens	Residual Activity	%	93.0
	12244641	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	8.0	CHEMBL2801	Homo sapiens	Residual Activity	%	8.0
	12244642	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	99.0	CHEMBL2801	Homo sapiens	Residual Activity	%	99.0
	12244643	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	10.0	CHEMBL2801	Homo sapiens	Residual Activity	%	10.0
	12244644	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	24.0	CHEMBL2801	Homo sapiens	Residual Activity	%	24.0
	12244645	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	36.0	CHEMBL2801	Homo sapiens	Residual Activity	%	36.0
	12244646	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	49.0	CHEMBL2801	Homo sapiens	Residual Activity	%	49.0
	12244647	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	2.0	CHEMBL2801	Homo sapiens	Residual Activity	%	2.0
	12244648	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	36.0	CHEMBL2801	Homo sapiens	Residual Activity	%	36.0
	12244649	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	47.0	CHEMBL2801	Homo sapiens	Residual Activity	%	47.0
	12244650	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	35.0	CHEMBL2801	Homo sapiens	Residual Activity	%	35.0
	12244651	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	31.0	CHEMBL2801	Homo sapiens	Residual Activity	%	31.0
	12244652	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	6.0	CHEMBL2801	Homo sapiens	Residual Activity	%	6.0
	12244653	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	98.0	CHEMBL2801	Homo sapiens	Residual Activity	%	98.0
	12244654	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	67.0	CHEMBL2801	Homo sapiens	Residual Activity	%	67.0
	12244655	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	4.0	CHEMBL2801	Homo sapiens	Residual Activity	%	4.0
	12244656	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	24.0	CHEMBL2801	Homo sapiens	Residual Activity	%	24.0
	12244657	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	26.0	CHEMBL2801	Homo sapiens	Residual Activity	%	26.0
	12244658	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	80.0	CHEMBL2801	Homo sapiens	Residual Activity	%	80.0
	12244659	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	8.0	CHEMBL2801	Homo sapiens	Residual Activity	%	8.0
	12244660	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	26.0	CHEMBL2801	Homo sapiens	Residual Activity	%	26.0
	12244661	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	77.0	CHEMBL2801	Homo sapiens	Residual Activity	%	77.0
	12244662	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	64.0	CHEMBL2801	Homo sapiens	Residual Activity	%	64.0
	12244663	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	88.0	CHEMBL2801	Homo sapiens	Residual Activity	%	88.0
	12244664	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	14.0	CHEMBL2801	Homo sapiens	Residual Activity	%	14.0
	12244665	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	76.0	CHEMBL2801	Homo sapiens	Residual Activity	%	76.0
	12244666	CHEMBL2219015	Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	0.0	CHEMBL2801	Homo sapiens	Residual Activity	%	0.0
	12728862	CHEMBL2353145	Inhibition of CAMK2delta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	96.0	CHEMBL2801	Homo sapiens	Activity	%	96.0
	12730003	CHEMBL2353648	Inhibition of CAMK2delta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	109.0	CHEMBL2801	Homo sapiens	Activity	%	109.0
	12730251	CHEMBL2353145	Inhibition of CAMK2delta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL2801	Homo sapiens	Activity	%	98.0
	12730917	CHEMBL2349845	Inhibition of CAMK2d (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	95.0	CHEMBL2801	Homo sapiens	Activity	%	95.0
	13375929	CHEMBL2405939	Inhibition of CAMK2D (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	2.0	CHEMBL2801	Homo sapiens	INH	%	2.0
	13419703	CHEMBL2422267	Inhibition of CAMK2gamma (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	17.0	CHEMBL2801	Homo sapiens	INH	%	17.0
	13419704	CHEMBL2422267	Inhibition of CAMK2gamma (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	17.0	CHEMBL2801	Homo sapiens	INH	%	17.0
	13419705	CHEMBL2422267	Inhibition of CAMK2gamma (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	18.0	CHEMBL2801	Homo sapiens	INH	%	18.0
	13442391	CHEMBL2428013	Competitive binding affinity to CAMK2D (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	85.0	CHEMBL2801	Homo sapiens	INH	%	85.0
	13445526	CHEMBL2428013	Competitive binding affinity to CAMK2D (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	91.0	CHEMBL2801	Homo sapiens	INH	%	91.0
	13448581	CHEMBL2428013	Competitive binding affinity to CAMK2D (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	93.0	CHEMBL2801	Homo sapiens	INH	%	93.0
	13448717	CHEMBL2428013	Competitive binding affinity to CAMK2D (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	13451512	CHEMBL2428013	Competitive binding affinity to CAMK2D (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	83.0	CHEMBL2801	Homo sapiens	INH	%	83.0
	13454697	CHEMBL2428013	Competitive binding affinity to CAMK2D (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	74.0	CHEMBL2801	Homo sapiens	INH	%	74.0
	13476421	CHEMBL2438990	Inhibition of human wild type CAMK2D at 1 uM by qPCR analysis relative to control	B	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O		CHEMBL290352	=	Inhibition	%	87.0	CHEMBL2801	Homo sapiens	INH	%	87.0
	13827727	CHEMBL3090384	Inhibition of CAMK2D (unknown origin) at 10 uM	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)OCc1ccc(OC[C@H](O)CO)cc1C2=O		CHEMBL3087471	>	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
Not Active	13863526	CHEMBL3101996	Inhibition of CAMK2D (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1		CHEMBL3099716		Inhibition	%		CHEMBL2801	Homo sapiens	INH		
Not Active	13863527	CHEMBL3101996	Inhibition of CAMK2D (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1		CHEMBL3099720		Inhibition	%		CHEMBL2801	Homo sapiens	INH		
	13872193	CHEMBL3102380	Inhibition of human CaMK2delta assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	110.0	CHEMBL2801	Homo sapiens	Activity	%	110.0
	13966044	CHEMBL3136660	Inhibition of human full length CAMK2D expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	37.5	CHEMBL2801	Homo sapiens	INH	%	37.5
	13973319	CHEMBL3135057	Inhibition of human full length CAMK2D expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	13974037	CHEMBL3136629	Inhibition of human full length CAMK2D expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	13974128	CHEMBL3135774	Inhibition of human full length CAMK2D expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	42.5	CHEMBL2801	Homo sapiens	INH	%	42.5
	13974219	CHEMBL3135444	Inhibition of human full length CAMK2D expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	4.0	CHEMBL2801	Homo sapiens	INH	%	4.0
	13974957	CHEMBL3136979	Inhibition of human full length CAMK2D expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	63.5	CHEMBL2801	Homo sapiens	INH	%	63.5
	13975048	CHEMBL3136126	Inhibition of human full length CAMK2D expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	7.5	CHEMBL2801	Homo sapiens	INH	%	7.5
	13975139	CHEMBL3134744	Inhibition of human full length CAMK2D expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	13975230	CHEMBL3136388	Inhibition of human full length CAMK2D expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	8.0	CHEMBL2801	Homo sapiens	INH	%	8.0
	13975873	CHEMBL3135488	Inhibition of human full length CAMK2D expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	25.0	CHEMBL2801	Homo sapiens	INH	%	25.0
	13975966	CHEMBL3137020	Inhibition of human full length CAMK2D expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	16.0	CHEMBL2801	Homo sapiens	INH	%	16.0
	13976057	CHEMBL3136041	Inhibition of human full length CAMK2D expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	45.5	CHEMBL2801	Homo sapiens	INH	%	45.5
	13976148	CHEMBL3135085	Inhibition of human full length CAMK2D expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	17.5	CHEMBL2801	Homo sapiens	INH	%	17.5
	14582449	CHEMBL3240233	Inhibition of human CAMK2d assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	94.5	CHEMBL2801	Homo sapiens	Activity	%	94.5
	14663223	CHEMBL3268850	Inhibition of CAMK2D (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	79.0	CHEMBL2801	Homo sapiens	INH	%	79.0
	14663224	CHEMBL3268850	Inhibition of CAMK2D (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	90.0	CHEMBL2801	Homo sapiens	INH	%	90.0
	14663225	CHEMBL3268850	Inhibition of CAMK2D (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	93.0	CHEMBL2801	Homo sapiens	INH	%	93.0
	14979204	CHEMBL3379061	Inhibition of CAMK2delta (unknown origin) by Millipore kinase analysis	B	COc1cc(-c2cn[nH]c2)ccc1C(=O)Nc1ccc2c(c1)CCNCC2	Outside typical range	CHEMBL3355059	=	IC50	nM	810000.0	CHEMBL2801	Homo sapiens	IC50	uM	810.0
	14979205	CHEMBL3379060	Inhibition of CAMK2delta (unknown origin) at 1 uM by Millipore kinase analysis	B	COc1cc(-c2cn[nH]c2)ccc1C(=O)Nc1ccc2c(c1)CCNCC2		CHEMBL3355059	=	Inhibition	%	60.0	CHEMBL2801	Homo sapiens	INH	%	60.0
	15014115	CHEMBL3361870	Inhibition of CamK2-delta (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	6.8	CHEMBL2801	Homo sapiens	INH	%	6.8
	15258395	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	-0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.3
	15258455	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	-0.6	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.6
	15258515	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	0.7	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.7
	15258575	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15258635	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	1.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	1.5
	15258695	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15258755	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	0.9	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.9
	15258815	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.2
	15258875	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	1.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	1.0
	15258935	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.3
	15258995	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	2.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	2.1
	15259055	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	-0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.3
	15259115	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	2.8	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	2.8
	15259175	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	0.7	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.7
	15259235	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	2.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	2.5
	15259295	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	-0.7	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.7
	15259355	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	0.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.0
	15259415	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15259475	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	0.9	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.9
	15259535	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.2
	15259595	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	0.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.4
	15259655	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	-0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.1
	15259715	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	2.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	2.3
	15259775	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.3
	15259835	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	0.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.4
	15259895	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	-0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.2
	15259955	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	-0.6	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.6
	15260015	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	0.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.5
	15260075	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	-0.6	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.6
	15260135	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	1.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	1.2
	15260195	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	-1.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-1.1
	15260255	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	-2.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-2.0
	15260315	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	2.7	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	2.7
	15260375	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	0.6	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.6
	15260435	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15260495	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	-0.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.4
	15260555	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	0.6	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.6
	15260615	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15260675	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.3
	15260735	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	0.9	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.9
	15260795	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	-0.8	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.8
	15260855	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	-0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.1
	15260915	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	0.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.0
	15260975	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	-0.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.4
	15261035	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	0.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.5
	15261095	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15261178	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15261238	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	-0.7	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.7
	15261298	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	-1.6	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-1.6
	15261358	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	0.6	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.6
	15261413	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15261473	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.2
	15261533	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	2.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	2.0
	15261593	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-0.8	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.8
	15261666	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	-0.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.5
	15261726	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	0.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.0
	15261786	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	0.7	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.7
	15261846	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	1.9	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	1.9
	15261902	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.4
	15261962	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	1.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	1.0
	15262022	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	0.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.4
	15262082	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	0.7	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.7
	15262142	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	2.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	2.3
	15262155	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	-0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262215	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	-0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262275	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	-0.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.4
	15262335	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	-0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.2
	15262395	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	-0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.2
	15262455	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.3
	15262515	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	0.9	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.9
	15262575	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	-0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262635	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	-0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.2
	15262695	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	0.8	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.8
	15262755	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	-0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262815	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	0.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.5
	15262875	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	1.8	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	1.8
	15262935	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	-0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.2
	15262995	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.2
	15263055	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	0.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.0
	15263115	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.4
	15263175	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.3
	15263235	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	1.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	1.0
	15263295	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	-0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.2
	15263355	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	0.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.5
	15263391	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	0.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.0
	15263451	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	0.7	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.7
	15263506	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	-0.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.5
	15263566	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	0.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.0
	15263626	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	-0.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.4
	15263686	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	-0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.3
	15263760	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	-0.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.4
	15263820	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	0.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.4
	15263880	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	0.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.5
	15263940	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	-0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.3
	15263994	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	-0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264054	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-2.9	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-2.9
	15264114	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	-0.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.5
	15264174	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	-0.8	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.8
	15264247	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	-0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.3
	15264307	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	0.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.5
	15264367	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15264427	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	0.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.0
	15264483	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	2.8	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	2.8
	15264543	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	3.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	3.5
	15264603	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	-1.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-1.2
	15264663	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	-0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264735	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	1.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	1.1
	15264795	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	2.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	2.1
	15264855	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	1.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	1.2
	15264915	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.2
	15264971	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15265031	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	-0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.3
	15265091	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	-0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.2
	15265151	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	-0.8	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.8
	15265211	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	-0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.2
	15265224	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	-0.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.4
	15265284	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	-0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.2
	15265344	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	-0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265404	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	-0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.3
	15265520	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.0
	15265580	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	-0.6	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.6
	15265640	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	-0.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.4
	15265700	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	3.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	3.2
	15265712	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	-0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.2
	15265772	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15265832	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.0
	15265892	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.3
	15265952	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	3.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	3.3
	15266009	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15266069	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15266129	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	3.6	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	3.6
	15266189	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	1.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	1.2
	15266261	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-1.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-1.5
	15266321	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	-0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.2
	15266381	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	-0.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.5
	15266441	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	2.7	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	2.7
	15266496	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	-0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.3
	15266556	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	1.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	1.1
	15266616	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	-0.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.5
	15266676	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	1.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	1.0
	15266749	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	-0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.3
	15266809	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	-0.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.5
	15266869	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	-5.4	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-5.4
	15266929	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	-0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.1
	15266984	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	1.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	1.1
	15267044	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	-0.5	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.5
	15267104	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	0.0	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.0
	15267164	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	17.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	17.1
	15267237	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	-0.2	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.2
	15267297	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	-0.6	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.6
	15267357	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	-0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.1
	15267417	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	-0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	-0.3
	15267472	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	0.6	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.6
	15267532	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	0.7	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.7
	15267592	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	0.1	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.1
	15267652	CHEMBL3430794	Delta TM value showing the stabilisation of CAMK2D produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	0.3	CHEMBL2801	Homo sapiens	Thermal melting change	degrees C	0.3
	15756084	CHEMBL3632287	Inhibition of CAMK2delta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	7.04	CHEMBL2801	Homo sapiens	INH	%	7.04
	15757064	CHEMBL3632287	Inhibition of CAMK2delta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	3.15	CHEMBL2801	Homo sapiens	INH	%	3.15
	15758638	CHEMBL3632287	Inhibition of CAMK2delta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	-0.09	CHEMBL2801	Homo sapiens	INH	%	-0.09
	16413414	CHEMBL3743730	Inhibition of CaMK2delta (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2801	Homo sapiens	IC50	uM	10.0
	16431755	CHEMBL3748647	Inhibition of human CAMK2delta using [KKLNRTLSFAEPG] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2801	Homo sapiens	IC50	uM	10.0
	16450805	CHEMBL3762323	Inhibition of CamKIIdelta (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-4.2	CHEMBL2801	Homo sapiens	INH	%	-4.2
	16495349	CHEMBL3776896	Inhibition of N-terminal His6-tagged recombinant human CAMK2delta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-12.0	CHEMBL2801	Homo sapiens	Activity	%	-12.0
	16508118	CHEMBL3776896	Inhibition of N-terminal His6-tagged recombinant human CAMK2delta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	0.0	CHEMBL2801	Homo sapiens	Activity	%	0.0
	16509095	CHEMBL3776896	Inhibition of N-terminal His6-tagged recombinant human CAMK2delta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	3.0	CHEMBL2801	Homo sapiens	Activity	%	3.0
	16566184	CHEMBL3803174	Inhibition of CAMK2D (unknown origin)	B	C[C@H]1CN(c2cccc3nc(-c4nc(-c5cc(C(=O)N(C)C)ccn5)cnc4N)n(C)c23)CCN1		CHEMBL3800585	=	IC50	nM	690.0	CHEMBL2801	Homo sapiens	IC50	uM	0.69
	16578338	CHEMBL3804392	Inhibition of partial length wild type human CAMK2delta expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	83.0	CHEMBL2801	Homo sapiens	Activity	%	83.0
	16593476	CHEMBL3812161	Inhibition of full length His-tagged human recombinant CaMK2 delta expressed in baculovirus using Fluorescein-CREBtide as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL2801	Homo sapiens	INH	%	40.0
	16614405	CHEMBL3817225	Inhibition of human CAMK2delta at 1 uM using [KKLNRTLSFAEPG] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-2.0	CHEMBL2801	Homo sapiens	INH	%	-2.0
	16618246	CHEMBL3816208	Inhibition of full length recombinant human His-tagged CAMK2D expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
287894	17670258	CHEMBL3706051	In Vitro Inhibition Assay: The kinase activity of CaMKII beta is evaluated by means of a radioactive test on the recombinant CaMKII beta enzyme. The amount of ATP-gamma 33P incorporated into the specific substrate Autocamtide-2 during its phosphorylation by CaMKII beta is measured. The effect of the products is quantified by the concentration of product that inhibits the total activity of CaMKII beta by 50% (50% inhibitory concentration=IC50). For the determination of the IC50 values, the product is diluted in 100% of DMSO to obtain a 10 mM stock solution. The concentration range tested during the radioactive test ranges from 3 to 10 000 nM with a final concentration in the test of 1% DMSO. This concentration range may, for the most powerful compounds, be extended to 0.1 nM. On the day of the operation, 5 ul of the compounds are deposited in each well of a 96-well plate at 10 times the concentration of that to be tested. Each concentration is tested in duplicate on the same plate.	B	CCn1c(N)c(C(N)=O)c(=O)c2cnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)nc21		CHEMBL3699625	=	IC50	nM	2.0	CHEMBL2801	Homo sapiens	IC50	nM	2.0
287895	17670259	CHEMBL3706051	In Vitro Inhibition Assay: The kinase activity of CaMKII beta is evaluated by means of a radioactive test on the recombinant CaMKII beta enzyme. The amount of ATP-gamma 33P incorporated into the specific substrate Autocamtide-2 during its phosphorylation by CaMKII beta is measured. The effect of the products is quantified by the concentration of product that inhibits the total activity of CaMKII beta by 50% (50% inhibitory concentration=IC50). For the determination of the IC50 values, the product is diluted in 100% of DMSO to obtain a 10 mM stock solution. The concentration range tested during the radioactive test ranges from 3 to 10 000 nM with a final concentration in the test of 1% DMSO. This concentration range may, for the most powerful compounds, be extended to 0.1 nM. On the day of the operation, 5 ul of the compounds are deposited in each well of a 96-well plate at 10 times the concentration of that to be tested. Each concentration is tested in duplicate on the same plate.	B	CCn1c(N)c(C(N)=O)c(=O)c2cnc(Nc3ccc(N4CCC(N5CCCC5)CC4)c(Cl)c3)nc21		CHEMBL3699629	=	IC50	nM	8.0	CHEMBL2801	Homo sapiens	IC50	nM	8.0
287896	17670260	CHEMBL3706051	In Vitro Inhibition Assay: The kinase activity of CaMKII beta is evaluated by means of a radioactive test on the recombinant CaMKII beta enzyme. The amount of ATP-gamma 33P incorporated into the specific substrate Autocamtide-2 during its phosphorylation by CaMKII beta is measured. The effect of the products is quantified by the concentration of product that inhibits the total activity of CaMKII beta by 50% (50% inhibitory concentration=IC50). For the determination of the IC50 values, the product is diluted in 100% of DMSO to obtain a 10 mM stock solution. The concentration range tested during the radioactive test ranges from 3 to 10 000 nM with a final concentration in the test of 1% DMSO. This concentration range may, for the most powerful compounds, be extended to 0.1 nM. On the day of the operation, 5 ul of the compounds are deposited in each well of a 96-well plate at 10 times the concentration of that to be tested. Each concentration is tested in duplicate on the same plate.	B	CCn1c(N)c(C(N)=O)c(=O)c2cnc(Nc3ccc(C4CCN(C5CC5)CC4)cc3OC)nc21		CHEMBL3699624	=	IC50	nM	17.0	CHEMBL2801	Homo sapiens	IC50	nM	17.0
287897	17670261	CHEMBL3706051	In Vitro Inhibition Assay: The kinase activity of CaMKII beta is evaluated by means of a radioactive test on the recombinant CaMKII beta enzyme. The amount of ATP-gamma 33P incorporated into the specific substrate Autocamtide-2 during its phosphorylation by CaMKII beta is measured. The effect of the products is quantified by the concentration of product that inhibits the total activity of CaMKII beta by 50% (50% inhibitory concentration=IC50). For the determination of the IC50 values, the product is diluted in 100% of DMSO to obtain a 10 mM stock solution. The concentration range tested during the radioactive test ranges from 3 to 10 000 nM with a final concentration in the test of 1% DMSO. This concentration range may, for the most powerful compounds, be extended to 0.1 nM. On the day of the operation, 5 ul of the compounds are deposited in each well of a 96-well plate at 10 times the concentration of that to be tested. Each concentration is tested in duplicate on the same plate.	B	CCn1c(N)c(C(N)=O)c(=O)c2cnc(Nc3ccc(C4CCN(CCC(F)(F)F)CC4)cc3OC)nc21		CHEMBL3699626	=	IC50	nM	22.0	CHEMBL2801	Homo sapiens	IC50	nM	22.0
287898	17670262	CHEMBL3706051	In Vitro Inhibition Assay: The kinase activity of CaMKII beta is evaluated by means of a radioactive test on the recombinant CaMKII beta enzyme. The amount of ATP-gamma 33P incorporated into the specific substrate Autocamtide-2 during its phosphorylation by CaMKII beta is measured. The effect of the products is quantified by the concentration of product that inhibits the total activity of CaMKII beta by 50% (50% inhibitory concentration=IC50). For the determination of the IC50 values, the product is diluted in 100% of DMSO to obtain a 10 mM stock solution. The concentration range tested during the radioactive test ranges from 3 to 10 000 nM with a final concentration in the test of 1% DMSO. This concentration range may, for the most powerful compounds, be extended to 0.1 nM. On the day of the operation, 5 ul of the compounds are deposited in each well of a 96-well plate at 10 times the concentration of that to be tested. Each concentration is tested in duplicate on the same plate.	B	CCn1c(N)c(C(N)=O)c(=O)c2cnc(Nc3ccc4c(c3)CCNC4)nc21		CHEMBL3699630	=	IC50	nM	37.0	CHEMBL2801	Homo sapiens	IC50	nM	37.0
287899	17670263	CHEMBL3706051	In Vitro Inhibition Assay: The kinase activity of CaMKII beta is evaluated by means of a radioactive test on the recombinant CaMKII beta enzyme. The amount of ATP-gamma 33P incorporated into the specific substrate Autocamtide-2 during its phosphorylation by CaMKII beta is measured. The effect of the products is quantified by the concentration of product that inhibits the total activity of CaMKII beta by 50% (50% inhibitory concentration=IC50). For the determination of the IC50 values, the product is diluted in 100% of DMSO to obtain a 10 mM stock solution. The concentration range tested during the radioactive test ranges from 3 to 10 000 nM with a final concentration in the test of 1% DMSO. This concentration range may, for the most powerful compounds, be extended to 0.1 nM. On the day of the operation, 5 ul of the compounds are deposited in each well of a 96-well plate at 10 times the concentration of that to be tested. Each concentration is tested in duplicate on the same plate.	B	COc1cc(C2CCNCC2)ccc1Nc1ncc2c(=O)c(C(N)=O)c(N)n(-c3ccccc3)c2n1		CHEMBL3699634	=	IC50	nM	39.0	CHEMBL2801	Homo sapiens	IC50	nM	39.0
287900	17670264	CHEMBL3706051	In Vitro Inhibition Assay: The kinase activity of CaMKII beta is evaluated by means of a radioactive test on the recombinant CaMKII beta enzyme. The amount of ATP-gamma 33P incorporated into the specific substrate Autocamtide-2 during its phosphorylation by CaMKII beta is measured. The effect of the products is quantified by the concentration of product that inhibits the total activity of CaMKII beta by 50% (50% inhibitory concentration=IC50). For the determination of the IC50 values, the product is diluted in 100% of DMSO to obtain a 10 mM stock solution. The concentration range tested during the radioactive test ranges from 3 to 10 000 nM with a final concentration in the test of 1% DMSO. This concentration range may, for the most powerful compounds, be extended to 0.1 nM. On the day of the operation, 5 ul of the compounds are deposited in each well of a 96-well plate at 10 times the concentration of that to be tested. Each concentration is tested in duplicate on the same plate.	B	COc1cc(C2CCNCC2)ccc1Nc1ncc2c(=O)c(C(N)=O)c(N)n(CCO)c2n1		CHEMBL3699635	=	IC50	nM	57.0	CHEMBL2801	Homo sapiens	IC50	nM	57.0
287901	17670265	CHEMBL3706051	In Vitro Inhibition Assay: The kinase activity of CaMKII beta is evaluated by means of a radioactive test on the recombinant CaMKII beta enzyme. The amount of ATP-gamma 33P incorporated into the specific substrate Autocamtide-2 during its phosphorylation by CaMKII beta is measured. The effect of the products is quantified by the concentration of product that inhibits the total activity of CaMKII beta by 50% (50% inhibitory concentration=IC50). For the determination of the IC50 values, the product is diluted in 100% of DMSO to obtain a 10 mM stock solution. The concentration range tested during the radioactive test ranges from 3 to 10 000 nM with a final concentration in the test of 1% DMSO. This concentration range may, for the most powerful compounds, be extended to 0.1 nM. On the day of the operation, 5 ul of the compounds are deposited in each well of a 96-well plate at 10 times the concentration of that to be tested. Each concentration is tested in duplicate on the same plate.	B	CCn1c(N)c(C(N)=O)c(=O)c2cnc(Nc3ccc(OC4CCN(C)CC4)cc3)nc21		CHEMBL3699631	=	IC50	nM	118.0	CHEMBL2801	Homo sapiens	IC50	nM	118.0
287902	17670266	CHEMBL3706051	In Vitro Inhibition Assay: The kinase activity of CaMKII beta is evaluated by means of a radioactive test on the recombinant CaMKII beta enzyme. The amount of ATP-gamma 33P incorporated into the specific substrate Autocamtide-2 during its phosphorylation by CaMKII beta is measured. The effect of the products is quantified by the concentration of product that inhibits the total activity of CaMKII beta by 50% (50% inhibitory concentration=IC50). For the determination of the IC50 values, the product is diluted in 100% of DMSO to obtain a 10 mM stock solution. The concentration range tested during the radioactive test ranges from 3 to 10 000 nM with a final concentration in the test of 1% DMSO. This concentration range may, for the most powerful compounds, be extended to 0.1 nM. On the day of the operation, 5 ul of the compounds are deposited in each well of a 96-well plate at 10 times the concentration of that to be tested. Each concentration is tested in duplicate on the same plate.	B	CC(C)Cn1c(N)c(C(N)=O)c(=O)c2cnc(Nc3ccc(CCN4CCOCC4)cc3)nc21		CHEMBL3699627	=	IC50	nM	139.0	CHEMBL2801	Homo sapiens	IC50	nM	139.0
287903	17670267	CHEMBL3706051	In Vitro Inhibition Assay: The kinase activity of CaMKII beta is evaluated by means of a radioactive test on the recombinant CaMKII beta enzyme. The amount of ATP-gamma 33P incorporated into the specific substrate Autocamtide-2 during its phosphorylation by CaMKII beta is measured. The effect of the products is quantified by the concentration of product that inhibits the total activity of CaMKII beta by 50% (50% inhibitory concentration=IC50). For the determination of the IC50 values, the product is diluted in 100% of DMSO to obtain a 10 mM stock solution. The concentration range tested during the radioactive test ranges from 3 to 10 000 nM with a final concentration in the test of 1% DMSO. This concentration range may, for the most powerful compounds, be extended to 0.1 nM. On the day of the operation, 5 ul of the compounds are deposited in each well of a 96-well plate at 10 times the concentration of that to be tested. Each concentration is tested in duplicate on the same plate.	B	CCn1c(N)c(C(N)=O)c(=O)c2cnc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nc21		CHEMBL3699623	=	IC50	nM	260.0	CHEMBL2801	Homo sapiens	IC50	nM	260.0
287904	17670268	CHEMBL3706051	In Vitro Inhibition Assay: The kinase activity of CaMKII beta is evaluated by means of a radioactive test on the recombinant CaMKII beta enzyme. The amount of ATP-gamma 33P incorporated into the specific substrate Autocamtide-2 during its phosphorylation by CaMKII beta is measured. The effect of the products is quantified by the concentration of product that inhibits the total activity of CaMKII beta by 50% (50% inhibitory concentration=IC50). For the determination of the IC50 values, the product is diluted in 100% of DMSO to obtain a 10 mM stock solution. The concentration range tested during the radioactive test ranges from 3 to 10 000 nM with a final concentration in the test of 1% DMSO. This concentration range may, for the most powerful compounds, be extended to 0.1 nM. On the day of the operation, 5 ul of the compounds are deposited in each well of a 96-well plate at 10 times the concentration of that to be tested. Each concentration is tested in duplicate on the same plate.	B	CCn1c(N)c(C(N)=O)c(=O)c2cnc(Nc3cccc(CN(C)C)c3)nc21		CHEMBL3699632	=	IC50	nM	268.0	CHEMBL2801	Homo sapiens	IC50	nM	268.0
287905	17670269	CHEMBL3706051	In Vitro Inhibition Assay: The kinase activity of CaMKII beta is evaluated by means of a radioactive test on the recombinant CaMKII beta enzyme. The amount of ATP-gamma 33P incorporated into the specific substrate Autocamtide-2 during its phosphorylation by CaMKII beta is measured. The effect of the products is quantified by the concentration of product that inhibits the total activity of CaMKII beta by 50% (50% inhibitory concentration=IC50). For the determination of the IC50 values, the product is diluted in 100% of DMSO to obtain a 10 mM stock solution. The concentration range tested during the radioactive test ranges from 3 to 10 000 nM with a final concentration in the test of 1% DMSO. This concentration range may, for the most powerful compounds, be extended to 0.1 nM. On the day of the operation, 5 ul of the compounds are deposited in each well of a 96-well plate at 10 times the concentration of that to be tested. Each concentration is tested in duplicate on the same plate.	B	CCc1cc(N2CCN(C3CC3)CC2)ccc1Nc1ncc2c(=O)c(C(N)=O)c(N)n(CC)c2n1		CHEMBL3699633	=	IC50	nM	396.0	CHEMBL2801	Homo sapiens	IC50	nM	396.0
287906	17670270	CHEMBL3706051	In Vitro Inhibition Assay: The kinase activity of CaMKII beta is evaluated by means of a radioactive test on the recombinant CaMKII beta enzyme. The amount of ATP-gamma 33P incorporated into the specific substrate Autocamtide-2 during its phosphorylation by CaMKII beta is measured. The effect of the products is quantified by the concentration of product that inhibits the total activity of CaMKII beta by 50% (50% inhibitory concentration=IC50). For the determination of the IC50 values, the product is diluted in 100% of DMSO to obtain a 10 mM stock solution. The concentration range tested during the radioactive test ranges from 3 to 10 000 nM with a final concentration in the test of 1% DMSO. This concentration range may, for the most powerful compounds, be extended to 0.1 nM. On the day of the operation, 5 ul of the compounds are deposited in each well of a 96-well plate at 10 times the concentration of that to be tested. Each concentration is tested in duplicate on the same plate.	B	CN(C)Cc1ccc(Nc2ncc3c(=O)c(C(N)=O)c(N)n(CC(F)(F)F)c3n2)cc1		CHEMBL3699628	=	IC50	nM	663.0	CHEMBL2801	Homo sapiens	IC50	nM	663.0
Inactive	17886450	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886451	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886452	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886453	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886454	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886455	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886456	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886457	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886458	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886459	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886460	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886461	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886462	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886463	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886464	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886465	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886466	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886467	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886468	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886469	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886470	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886471	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886472	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	207.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	207.0
Inactive	17886473	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886474	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886475	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886476	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886477	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886478	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	332.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	332.0
Inactive	17886479	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886480	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886481	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886482	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	588.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	588.0
Inactive	17886483	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886484	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886485	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886486	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886487	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886488	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886489	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886490	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886491	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886492	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886493	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886494	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886495	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886496	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886497	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886498	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Kd	nM	19.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	19.0
Inactive	17886499	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886500	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886501	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886502	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886503	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886504	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886505	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886506	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886507	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886508	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886509	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886510	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886511	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886512	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886513	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886514	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886515	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886516	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886517	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886518	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886519	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886520	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886521	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886522	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886523	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886524	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886525	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	704.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	704.0
Inactive	17886526	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886527	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886528	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886529	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886530	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886531	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886532	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886533	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886534	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886535	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886536	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	666.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	666.0
Inactive	17886537	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886538	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886539	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886540	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886541	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886542	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886543	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886544	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886545	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	821.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	821.0
Inactive	17886546	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886547	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886548	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886549	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886550	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886551	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886552	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886553	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886554	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886555	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886556	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886557	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886558	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886559	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886560	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886561	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886562	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886563	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886564	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886565	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886566	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886567	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886568	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886569	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886570	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886571	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886572	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886573	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886574	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886575	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886576	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886577	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886578	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886579	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886580	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886581	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886582	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886583	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886584	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886585	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886586	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886587	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	=	Kd	nM	293.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	293.0
Inactive	17886588	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886589	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886590	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886591	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886592	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886593	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886594	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886595	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886596	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886597	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886598	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886599	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886600	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886601	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	703.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	703.0
Active	17886602	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	190.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	190.0
Inactive	17886603	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886604	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886605	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886606	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886607	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	Kd	nM	20301.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	20301.0
Inactive	17886608	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886609	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886610	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	520.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	520.0
Inactive	17886611	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886612	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886613	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886614	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886615	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886616	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886617	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886618	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886619	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886620	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886621	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886622	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	312.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	312.0
Inactive	17886623	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886624	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886625	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886626	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886627	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886628	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886629	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886630	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886631	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886632	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	343.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	343.0
Inactive	17886633	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886634	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886635	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886636	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886637	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886638	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886639	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886640	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886641	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886642	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886643	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886644	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886645	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886646	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886647	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886648	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886649	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886650	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886651	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886652	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Active	17886653	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	310.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	310.0
Inactive	17886654	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886655	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886656	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886657	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886658	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886659	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886660	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886661	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886662	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886663	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886664	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886665	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886666	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886667	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886668	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886669	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886670	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886671	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886672	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886673	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886674	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886675	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886676	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886677	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886678	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886679	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886680	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886681	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886682	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886683	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886684	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886685	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886686	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886687	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886688	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886689	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886690	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886691	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17886692	CHEMBL3991641	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL2801	Homo sapiens	Kd apparent	nM	30000.0
	18114453	CHEMBL4025041	Inhibition of wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL2801	Homo sapiens	Activity	%	100.0
	18153127	CHEMBL4034276	Inhibition of CaMK2d Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-5.3	CHEMBL2801	Homo sapiens	INH	%	-5.3
	18156553	CHEMBL4035084	Inhibition of CaMK2delta (unknown origin)	B	CCN(CC)CCCC(C)Nc1nc(/C=C/c2c(Cl)cc(Cl)cc2Cl)nc2ccc(N)cc12		CHEMBL4090364	=	IC50	nM	9100.0	CHEMBL2801	Homo sapiens	IC50	uM	9.1
	18203565	CHEMBL4043852	Inhibition of wild-type human partial length CAMK2D (M1 to E329 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL2801	Homo sapiens	Activity	%	100.0
	18211595	CHEMBL4045647	Inhibition of CaMK2d labeling at conserved Lys2 (DLKPENLLLASK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-0.4	CHEMBL2801	Homo sapiens	INH	%	-0.4
	18211695	CHEMBL4045649	Inhibition of CaMK2d labeling at conserved Lys1 (IPTGQEYAAKIINTKK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-34.2	CHEMBL2801	Homo sapiens	INH	%	-34.2
	18211794	CHEMBL4045890	Inhibition of CaMK2d labeling at conserved Lys2 (DLKPENLLLASK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-7.5	CHEMBL2801	Homo sapiens	INH	%	-7.5
	18211796	CHEMBL4045892	Inhibition of CaMK2d labeling at conserved Lys1 (IPTGQEYAAKIINTKK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-13.3	CHEMBL2801	Homo sapiens	INH	%	-13.3
	18253749	CHEMBL4055159	Inhibition of wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL2801	Homo sapiens	Activity	%	100.0
	18253750	CHEMBL4055159	Inhibition of wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL2801	Homo sapiens	Activity	%	100.0
	18274797	CHEMBL4118311	Inhibition of CaMK2d in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENLLLASK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-32.3	CHEMBL2801	Homo sapiens	INH	%	-32.3
	18274798	CHEMBL4118311	Inhibition of CaMK2d in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENLLLASK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-33.8	CHEMBL2801	Homo sapiens	INH	%	-33.8
	18274799	CHEMBL4118311	Inhibition of CaMK2d in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPENLLLASK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-52.4	CHEMBL2801	Homo sapiens	INH	%	-52.4
	18274803	CHEMBL4118313	Inhibition of CaMK2d in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled IPTGQEYAAKIINTKK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-44.9	CHEMBL2801	Homo sapiens	INH	%	-44.9
	18274804	CHEMBL4118313	Inhibition of CaMK2d in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled IPTGQEYAAKIINTKK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-43.3	CHEMBL2801	Homo sapiens	INH	%	-43.3
	18274805	CHEMBL4118313	Inhibition of CaMK2d in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled IPTGQEYAAKIINTKK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-41.2	CHEMBL2801	Homo sapiens	INH	%	-41.2
	18440107	CHEMBL4156931	Binding affinity to wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	78.0	CHEMBL2801	Homo sapiens	Activity	%	78.0
	18449495	CHEMBL4177940	Inhibition of CAMK2D (unknown origin) at 1 uM	B	CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=NC1c1ccc(F)cc1Br		CHEMBL3742114	=	Inhibition	%	11.0	CHEMBL2801	Homo sapiens	INH	%	11.0
	18477350	CHEMBL4183786	Inhibition of full length human N-terminal GST-tagged CaMK2delta expressed in baculovirus expression system at 10 nM relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373	>	Inhibition	%	90.0	CHEMBL2801	Homo sapiens	INH	%	90.0
	18478401	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CN(C)CCNC(=O)c1cccc(-c2cnc3ccc(-c4cccs4)nn23)c1		CHEMBL4215541	=	IC50	nM	37.0	CHEMBL2801	Homo sapiens	IC50	nM	37.0
	18478408	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN1CCC[C@H]1CNC(=O)c1ccnc(-c2cnn3ccc(-c4cccs4)nc23)c1		CHEMBL4209840	=	IC50	nM	3.4	CHEMBL2801	Homo sapiens	IC50	nM	3.4
	18478409	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)CCCNC(=O)c1ccnc(-c2cnn3ccc(-c4cccs4)nc23)c1		CHEMBL4214345	=	IC50	nM	9.1	CHEMBL2801	Homo sapiens	IC50	nM	9.1
	18478410	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCCCNC(=O)c1cccc(-c2cnc3ccc(-c4cccs4)nn23)c1		CHEMBL4211047	=	IC50	nM	4436.0	CHEMBL2801	Homo sapiens	IC50	nM	4436.0
	18478411	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	O=C(NCCO)c1cccc(-c2cnc3ccc(-c4cccs4)nn23)c1		CHEMBL4211112	=	IC50	nM	454.0	CHEMBL2801	Homo sapiens	IC50	nM	454.0
	18478412	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)CCNC(=O)c1cccc(-c2cnc3ccc(-c4cccs4)nn23)c1		CHEMBL4216080	=	IC50	nM	5.8	CHEMBL2801	Homo sapiens	IC50	nM	5.8
	18478413	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CC(C)N(CCNC(=O)c1cccc(-c2cnc3ccc(-c4cccs4)nn23)c1)C(C)C		CHEMBL4211934	=	IC50	nM	41.0	CHEMBL2801	Homo sapiens	IC50	nM	41.0
	18478414	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	O=C(NCCN1CCOCC1)c1cccc(-c2cnc3ccc(-c4cccs4)nn23)c1		CHEMBL4205811	=	IC50	nM	474.0	CHEMBL2801	Homo sapiens	IC50	nM	474.0
	18478415	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	O=C(NCCN1CCCC1)c1cccc(-c2cnc3ccc(-c4cccs4)nn23)c1		CHEMBL4218994	=	IC50	nM	191.0	CHEMBL2801	Homo sapiens	IC50	nM	191.0
	18478416	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	O=C(NCCN1CCNCC1)c1cccc(-c2cnc3ccc(-c4cccs4)nn23)c1		CHEMBL4207271	=	IC50	nM	325.0	CHEMBL2801	Homo sapiens	IC50	nM	325.0
	18478417	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CN(C)CCNC(=O)c1cccc(-c2cnc3ccc(-c4ccsc4)nn23)c1		CHEMBL4209139	=	IC50	nM	65.0	CHEMBL2801	Homo sapiens	IC50	nM	65.0
	18478418	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CN(C)CCNC(=O)c1cccc(-c2cnc3ccc(-n4cccc4)nn23)c1		CHEMBL4205405	=	IC50	nM	57.0	CHEMBL2801	Homo sapiens	IC50	nM	57.0
	18478454	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CN(C)CCNC(=O)c1cccc(-c2cnc3ccc(-c4ccccc4)nn23)c1		CHEMBL4214991	=	IC50	nM	245.0	CHEMBL2801	Homo sapiens	IC50	nM	245.0
	18478455	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)CCNC(=O)c1cccc(-c2cnc3ccc(-c4ccccc4)nn23)c1		CHEMBL4210073	=	IC50	nM	44.0	CHEMBL2801	Homo sapiens	IC50	nM	44.0
	18478456	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)CCNC(=O)c1cccc(-c2cnn3ccc(-c4cccs4)nc23)c1		CHEMBL4210568	=	IC50	nM	3.5	CHEMBL2801	Homo sapiens	IC50	nM	3.5
	18478457	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)CCNC(=O)c1ccnc(-c2cnn3ccc(-c4cccs4)nc23)c1		CHEMBL4205708	=	IC50	nM	1.6	CHEMBL2801	Homo sapiens	IC50	nM	1.6
	18478461	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)CCNC(=O)c1cc(-c2cnn3ccc(-c4cccs4)nc23)c2ncn(C)c2c1		CHEMBL4208717	=	IC50	nM	4.0	CHEMBL2801	Homo sapiens	IC50	nM	4.0
	18478462	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)CCNC(=O)c1cc(-c2cnn3ccc(-c4cccs4)nc23)c2nccn2c1		CHEMBL4213305	=	IC50	nM	3.3	CHEMBL2801	Homo sapiens	IC50	nM	3.3
	18478463	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)CCNC(=O)c1cc(-c2cnn3ccc(-c4cccs4)nc23)n2ccnc2c1		CHEMBL4215635	=	IC50	nM	254.0	CHEMBL2801	Homo sapiens	IC50	nM	254.0
	18478464	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)[C@H](C)CNC(=O)c1ccnc(-c2cnn3ccc(-c4cccs4)nc23)c1		CHEMBL4213540	=	IC50	nM	7.2	CHEMBL2801	Homo sapiens	IC50	nM	7.2
	18478465	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)[C@@H](C)CNC(=O)c1ccnc(-c2cnn3ccc(-c4cccs4)nc23)c1		CHEMBL4217261	=	IC50	nM	0.09	CHEMBL2801	Homo sapiens	IC50	nM	0.09
	18478469	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)C[C@@H](C)NC(=O)c1ccnc(-c2cnn3ccc(-c4cccs4)nc23)c1		CHEMBL4204410	=	IC50	nM	125.0	CHEMBL2801	Homo sapiens	IC50	nM	125.0
	18478470	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)C[C@H](C)NC(=O)c1ccnc(-c2cnn3ccc(-c4cccs4)nc23)c1		CHEMBL4211430	=	IC50	nM	2.17	CHEMBL2801	Homo sapiens	IC50	nM	2.17
	18478471	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)CCN(C)C(=O)c1ccnc(-c2cnn3ccc(-c4cccs4)nc23)c1		CHEMBL4209789	=	IC50	nM	53.0	CHEMBL2801	Homo sapiens	IC50	nM	53.0
	18478472	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCc1cc(C(=O)NC[C@H](C)N(CC)CC)cc(-c2cnn3ccc(-c4cccs4)nc23)n1		CHEMBL4209443	=	IC50	nM	0.92	CHEMBL2801	Homo sapiens	IC50	nM	0.92
	18478476	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)[C@@H](C)CNC(=O)c1cc(NC)nc(-c2cnn3ccc(-c4cccs4)nc23)c1		CHEMBL4218769	=	IC50	nM	0.05	CHEMBL2801	Homo sapiens	IC50	nM	0.05
	18478479	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)[C@@H](C)CNC(=O)c1cc(-c2cnn3ccc(-c4cccs4)nc23)nc(N(C)C)c1		CHEMBL4213838	=	IC50	nM	0.23	CHEMBL2801	Homo sapiens	IC50	nM	0.23
	18478482	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)[C@@H](C)CNC(=O)c1cc(NCCO)nc(-c2cnn3ccc(-c4cccs4)nc23)c1		CHEMBL4206514	=	IC50	nM	0.1	CHEMBL2801	Homo sapiens	IC50	nM	0.1
	18478485	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)[C@@H](C)CNC(=O)c1cc(NCCOC)nc(-c2cnn3ccc(-c4cccs4)nc23)c1		CHEMBL4218245	=	IC50	nM	0.08	CHEMBL2801	Homo sapiens	IC50	nM	0.08
	18478488	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)[C@@H](C)CNC(=O)c1cc(OCCOC)nc(-c2cnn3ccc(-c4cccs4)nc23)c1		CHEMBL4210881	=	IC50	nM	0.28	CHEMBL2801	Homo sapiens	IC50	nM	0.28
	18478491	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)[C@@H](C)CNC(=O)c1cc(-c2cnn3ccc(-c4cccs4)nc23)nc(N2CCOCC2)c1		CHEMBL4205997	=	IC50	nM	0.3	CHEMBL2801	Homo sapiens	IC50	nM	0.3
	18478494	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)[C@@H](C)CNC(=O)c1cc(-c2cnn3ccc(-c4cccs4)nc23)nc(N2CC(OC)C2)c1		CHEMBL4215300	=	IC50	nM	0.1	CHEMBL2801	Homo sapiens	IC50	nM	0.1
	18478599	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)[C@@H](C)CNC(=O)c1cc(-c2cnn3ccc(-c4cccs4)nc23)nc(N2CC(O)C2)c1		CHEMBL4210359	=	IC50	nM	0.1	CHEMBL2801	Homo sapiens	IC50	nM	0.1
	18478699	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)[C@@H](C)CNC(=O)c1cc(-c2cnn3ccc(-c4cccs4)nc23)nc(N2CC[C@@H](O)C2)c1		CHEMBL4208018	=	IC50	nM	0.06	CHEMBL2801	Homo sapiens	IC50	nM	0.06
	18478702	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)[C@@H](C)CNC(=O)c1cc(-c2cnn3ccc(-c4cccs4)nc23)nc(N2CC[C@H](O)C2)c1		CHEMBL4215817	=	IC50	nM	0.07	CHEMBL2801	Homo sapiens	IC50	nM	0.07
	18478705	CHEMBL4184342	Inhibition of recombinant human full length His-tagged CaMK2delta expressed in baculovirus using Biotin labelled STK1 as substrate after 1 hr in presence of ATP by fluorescence assay	B	CCN(CC)[C@@H](C)CNC(=O)c1cc(-c2cnn3ccc(-c4cccs4)nc23)nc(N2CCC(O)CC2)c1		CHEMBL4209816	=	IC50	nM	0.22	CHEMBL2801	Homo sapiens	IC50	nM	0.22
	18484547	CHEMBL4185710	Binding affinity to wild-type human partial length CAMK2D (M1 to E329 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	99.0	CHEMBL2801	Homo sapiens	Activity	%	99.0
	18485074	CHEMBL4185710	Binding affinity to wild-type human partial length CAMK2D (M1 to E329 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL2801	Homo sapiens	Activity	%	100.0
	18507874	CHEMBL4190893	Inhibition of recombinant full-length human CAMK2delta at 1 uM using calmodulin as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	3.0	CHEMBL2801	Homo sapiens	INH	%	3.0
	18653733	CHEMBL4230037	Inhibition of CAMK2D (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-1.0	CHEMBL2801	Homo sapiens	INH	%	-1.0
	18653734	CHEMBL4230037	Inhibition of CAMK2D (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	18655625	CHEMBL4230610	Binding affinity to wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL2801	Homo sapiens	Activity	%	100.0
	18751054	CHEMBL4263751	Inhibition of CAMK2D (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	-3.0	CHEMBL2801	Homo sapiens	INH	%	-3.0
	18751704	CHEMBL4264199	Binding affinity to wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	83.0	CHEMBL2801	Homo sapiens	Activity	%	83.0
	18857869	CHEMBL4307715	Binding affinity to wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	98.0	CHEMBL2801	Homo sapiens	Activity	%	98.0
Not Active	18883562	CHEMBL4312660	Activity at human CAMK2D at 10 uM	B	CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F		CHEMBL4585668		Activity			CHEMBL2801	Homo sapiens	Activity		
	18892567	CHEMBL4314742	Inhibition of recombinant full-length human CaMK2delta assessed as residual activity at 10 uM using calmodulin as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	120.5	CHEMBL2801	Homo sapiens	Activity	%	120.5
	18919424	CHEMBL4322783	Binding affinity to recombinant human full-length N-terminal GST-tagged CAMK2D expressed in baculovirus expression system using GS peptide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	4.0	CHEMBL2801	Homo sapiens	Kd	nM	4.0
	18919612	CHEMBL4322783	Binding affinity to recombinant human full-length N-terminal GST-tagged CAMK2D expressed in baculovirus expression system using GS peptide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	6.0	CHEMBL2801	Homo sapiens	Kd	nM	6.0
	18937761	CHEMBL4327610	Inhibition of human CAMK2D assessed as residual activity at 1 uM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	97.62	CHEMBL2801	Homo sapiens	Activity	%	97.62
	18937762	CHEMBL4327610	Inhibition of human CAMK2D assessed as residual activity at 1 uM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	98.2	CHEMBL2801	Homo sapiens	Activity	%	98.2
	18938451	CHEMBL4327971	Inhibition of human CAMK2D assessed as residual activity at 100 uM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2801	Homo sapiens	Activity	%	65.0
	18938824	CHEMBL4328335	Inhibition of human CAMK2D using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.0311	CHEMBL2801	Homo sapiens	IC50	10'-11M	3.11
	18958787	CHEMBL4333306	Binding affinity to wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	79.0	CHEMBL2801	Homo sapiens	Activity	%	79.0
	18964117	CHEMBL4334993	Inhibition of recombinant full length human CaMK2delta assessed as residual activity at 1 uM using calmodulin as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	92.0	CHEMBL2801	Homo sapiens	Activity	%	92.0
	18964118	CHEMBL4334993	Inhibition of recombinant full length human CaMK2delta assessed as residual activity at 1 uM using calmodulin as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	65.0	CHEMBL2801	Homo sapiens	Activity	%	65.0
	18971811	CHEMBL4336821	Inhibition of recombinant full length human CaMK2delta assessed as residual activity at 10 uM using calmodulin as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	68.0	CHEMBL2801	Homo sapiens	Activity	%	68.0
	19032179	CHEMBL4349773	Inhibition of CAMK2D (unknown origin) at 20 nM using calmodulin as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
Not Active	19039870	CHEMBL4351774	Inhibition of recombinant full-length human CaMK2delta at 10 uM using calmodulin as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2801	Homo sapiens	INH		
Active	19041036	CHEMBL4352297	Inhibition of human CAMK2D at 10 uM using KKLNRTLSFAEPG as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2801	Homo sapiens	INH		
	19059487	CHEMBL4357788	Binding affinity to wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2801	Homo sapiens	Activity	%	100.0
	19090059	CHEMBL4365633	Inhibition of wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	78.0	CHEMBL2801	Homo sapiens	Activity	%	78.0
	19091839	CHEMBL4366313	Inhibition of human CAMK2D at 100 nM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	22.55	CHEMBL2801	Homo sapiens	INH	%	22.55
	19144676	CHEMBL4377692	Inhibition of recombinant full-length human CaMK2delta at 1 uM using calmodulin as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	36.0	CHEMBL2801	Homo sapiens	INH	%	36.0
	19147767	CHEMBL4379163	Inhibition of recombinant full length human CaMK2delta using calmodulin as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2801	Homo sapiens	IC50	uM	10.0
	19159315	CHEMBL4382419	Binding affinity to wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	41.0	CHEMBL2801	Homo sapiens	Activity	%	41.0
	19191692	CHEMBL4389138	Inhibition of wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL2801	Homo sapiens	INH	%	100.0
	19191801	CHEMBL4389615	Inhibition of wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL2801	Homo sapiens	INH	%	100.0
	19199981	CHEMBL4391241	Binding affinity to wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	80.0	CHEMBL2801	Homo sapiens	Activity	%	80.0
	19266336	CHEMBL4405286	Inhibition of wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2801	Homo sapiens	INH	%	50.0
	20600477	CHEMBL4603272	Inhibition of recombinant full length human His-tagged CAMK2D expressed in baculovirus expression system using serine/threonine-04 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2801	Homo sapiens	IC50	uM	100.0
	22423781	CHEMBL4674466	Inhibition of human CAMK2D using KKLNRTLSFAEPG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	87.44	CHEMBL2801	Homo sapiens	Activity	%	87.44
	22423782	CHEMBL4674466	Inhibition of human CAMK2D using KKLNRTLSFAEPG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	49.18	CHEMBL2801	Homo sapiens	Activity	%	49.18
	22843474	CHEMBL4720471	Inhibition of human CAMK2D assessed as residual activity using KKLNRTLSFAEPG as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	96.95	CHEMBL2801	Homo sapiens	Activity	%	96.95
	22843824	CHEMBL4720810	Inhibition of human CAMK2D using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.0645	CHEMBL2801	Homo sapiens	IC50	10^-11M	6.45
	22844643	CHEMBL4721318	Inhibition of wild-type human partial length CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	86.33	CHEMBL2801	Homo sapiens	Activity	%	86.33
Active	22946975	CHEMBL4765539	Inhibition of wild-type human CAMK2delta at 10 uM using KKLNRTLSFAEPG peptide as substrate in presence of Ca2+ calmodulin and [gamma-33P]-ATP by radiometric hotspot kinase assay	B	CCCCCn1cc(-c2ccccc2OCc2ccccc2)nc1N.Cl		CHEMBL4795714		Inhibition	%		CHEMBL2801	Homo sapiens	INH		
	22946986	CHEMBL4765550	Inhibition of wild-type human CAMK2delta using KKLNRTLSFAEPG peptide as substrate in presence of Ca2+ calmodulin and [gamma-33P]-ATP by radiometric hotspot kinase assay	B	CCCCCn1cc(-c2ccccc2OCc2ccccc2)nc1N.Cl		CHEMBL4795714	=	IC50	nM	3000.0	CHEMBL2801	Homo sapiens	IC50	uM	3.0
	22952775	CHEMBL4766712	Inhibition of recombinant full length human CaMK2delta assessed as residual activity at 10 uM using calmodulin as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	85.0	CHEMBL2801	Homo sapiens	Activity	%	85.0
	23120235	CHEMBL4804353	Inhibition of CAMK2D in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855542	=	IC50	nM	-4100.0	CHEMBL2801	Homo sapiens	IC50	uM	-4.1
	23120236	CHEMBL4804353	Inhibition of CAMK2D in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-31000.0	CHEMBL2801	Homo sapiens	IC50	uM	-31.0
	23120237	CHEMBL4804353	Inhibition of CAMK2D in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	15900.0	CHEMBL2801	Homo sapiens	IC50	uM	15.9
	23120238	CHEMBL4804353	Inhibition of CAMK2D in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	2300.0	CHEMBL2801	Homo sapiens	IC50	uM	2.3
	23120239	CHEMBL4804353	Inhibition of CAMK2D in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	4200.0	CHEMBL2801	Homo sapiens	IC50	uM	4.2
	23120240	CHEMBL4804353	Inhibition of CAMK2D in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4859660	=	IC50	nM	-5700.0	CHEMBL2801	Homo sapiens	IC50	uM	-5.7
	23121279	CHEMBL4804535	Inhibition of CAMK2D in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	23121280	CHEMBL4804535	Inhibition of CAMK2D in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	23121281	CHEMBL4804535	Inhibition of CAMK2D in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	23121282	CHEMBL4804535	Inhibition of CAMK2D in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	23121283	CHEMBL4804535	Inhibition of CAMK2D in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	23121284	CHEMBL4804535	Inhibition of CAMK2D in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL2801	Homo sapiens	INH	%	0.0
	23122473	CHEMBL4804824	Inhibition of human CAMK2D assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	94.0	CHEMBL2801	Homo sapiens	Activity	%	94.0
	23123168	CHEMBL4805412	Inhibition of human CAMK2D assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	89.0	CHEMBL2801	Homo sapiens	Activity	%	89.0
	23123721	CHEMBL4805965	Inhibition of DNA-tagged human CAMK2D assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	80.0	CHEMBL2801	Homo sapiens	Activity	%	80.0
	23124426	CHEMBL4806429	Inhibition of human CAMK2D assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL2801	Homo sapiens	Activity	%	99.0
	23124427	CHEMBL4806429	Inhibition of human CAMK2D assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	92.0	CHEMBL2801	Homo sapiens	Activity	%	92.0
	23127867	CHEMBL4807764	Inhibition of CAMK2D (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL2801	Homo sapiens	Activity	%	75.0
	23127868	CHEMBL4807764	Inhibition of CAMK2D (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2801	Homo sapiens	Activity	%	75.0
	23127869	CHEMBL4807764	Inhibition of CAMK2D (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2801	Homo sapiens	Activity	%	75.0
	23252305	CHEMBL4831387	Inhibition of wild type human CAMK2D (M1 to E329 residues) expressed in bacterial expression system assessed as protein activity at 0.5 uM relative to control	B	CC(C)(N)CCNc1nc(Nc2ccc(C#N)nc2)ncc1C(F)(F)F		CHEMBL4861256	=	Activity	%	19.0	CHEMBL2801	Homo sapiens	Activity	%	19.0
Not Active	23317308	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	99.0	CHEMBL2801	Homo sapiens	% Control	%	99.0
Not Active	23317776	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23318447	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23318926	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	95.0	CHEMBL2801	Homo sapiens	% Control	%	95.0
Not Active	23319565	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23320038	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	99.9	CHEMBL2801	Homo sapiens	% Control	%	99.9
Not Active	23320716	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	91.0	CHEMBL2801	Homo sapiens	% Control	%	91.0
Not Active	23321184	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23321814	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	93.0	CHEMBL2801	Homo sapiens	% Control	%	93.0
Not Active	23322282	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	88.0	CHEMBL2801	Homo sapiens	% Control	%	88.0
Not Active	23322971	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	91.0	CHEMBL2801	Homo sapiens	% Control	%	91.0
Not Active	23323439	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23323963	CHEMBL4880582	CaMKIIdelta (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	3.0	CHEMBL2801	Homo sapiens	% inhibition	%	3.0
Not Active	23324293	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	82.1	CHEMBL2801	Homo sapiens	% Control	%	82.1
Not Active	23324928	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	86.0	CHEMBL2801	Homo sapiens	% Control	%	86.0
Not Active	23325396	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23326043	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	97.0	CHEMBL2801	Homo sapiens	% Control	%	97.0
Not Active	23326511	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23327211	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23327679	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23328266	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	90.0	CHEMBL2801	Homo sapiens	% Control	%	90.0
Not Active	23328734	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	84.0	CHEMBL2801	Homo sapiens	% Control	%	84.0
Not Active	23329270	CHEMBL4880977	CaMKIIdelta (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	95.0	CHEMBL2801	Homo sapiens	% residual kinase activity	%	95.0
Not Active	23329680	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23330148	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23330904	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23331372	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23331959	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	89.1	CHEMBL2801	Homo sapiens	% Control	%	89.1
Not Active	23332427	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	80.0	CHEMBL2801	Homo sapiens	% Control	%	80.0
Not Active	23333143	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23333782	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	99.0	CHEMBL2801	Homo sapiens	% Control	%	99.0
Not Active	23334250	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	97.0	CHEMBL2801	Homo sapiens	% Control	%	97.0
Not Active	23335229	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	90.0	CHEMBL2801	Homo sapiens	% Control	%	90.0
Not Active	23335697	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	95.0	CHEMBL2801	Homo sapiens	% Control	%	95.0
Not Active	23336324	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23336792	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23337531	CHEMBL4881902	CAMK2D Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	94.5	CHEMBL2801	Homo sapiens	% Ctrl	%	94.5
Not Active	23337873	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23338341	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	99.0	CHEMBL2801	Homo sapiens	% Control	%	99.0
Not Active	23338953	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23339421	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	81.0	CHEMBL2801	Homo sapiens	% Control	%	81.0
Not Active	23340058	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	76.0	CHEMBL2801	Homo sapiens	% Control	%	76.0
Not Active	23340526	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23341183	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23341651	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23342267	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	91.0	CHEMBL2801	Homo sapiens	% Control	%	91.0
Not Active	23342735	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23343365	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	91.0	CHEMBL2801	Homo sapiens	% Control	%	91.0
Not Active	23343833	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	83.0	CHEMBL2801	Homo sapiens	% Control	%	83.0
Not Active	23344471	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23345044	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23345512	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	87.0	CHEMBL2801	Homo sapiens	% Control	%	87.0
Not Active	23346089	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	84.6	CHEMBL2801	Homo sapiens	% Control	%	84.6
Not Active	23346558	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	87.2	CHEMBL2801	Homo sapiens	% Control	%	87.2
Not Active	23347168	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	77.7	CHEMBL2801	Homo sapiens	% Control	%	77.7
Not Active	23347649	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	81.0	CHEMBL2801	Homo sapiens	% Control	%	81.0
Not Active	23348228	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23348696	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23349283	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23349901	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23350369	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23350974	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23351442	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23351980	CHEMBL4882673	CAMK2D (CaMKII delta) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	23.95	CHEMBL2801	Homo sapiens	% Inhibition	%	23.9456
Not Active	23352466	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23352934	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	88.0	CHEMBL2801	Homo sapiens	% Control	%	88.0
Not Active	23353816	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23354284	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23355016	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23355484	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23356120	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23356588	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23357197	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23357844	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	82.0	CHEMBL2801	Homo sapiens	% Control	%	82.0
Not Active	23358312	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23358898	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23359496	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23359964	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23360549	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	99.0	CHEMBL2801	Homo sapiens	% Control	%	99.0
Not Active	23361017	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23361590	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23362126	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23362594	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23364236	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	96.0	CHEMBL2801	Homo sapiens	% Control	%	96.0
Not Active	23364704	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23365443	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	72.0	CHEMBL2801	Homo sapiens	% Control	%	72.0
Not Active	23365986	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	99.0	CHEMBL2801	Homo sapiens	% Control	%	99.0
Not Active	23366576	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23367044	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23367489	CHEMBL4883842	CAMK2D ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	43.0	CHEMBL2801	Homo sapiens	% Residual activity with Skepinone-L	%	43.0
Not Active	23367922	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	92.0	CHEMBL2801	Homo sapiens	% Control	%	92.0
Not Active	23368390	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	89.0	CHEMBL2801	Homo sapiens	% Control	%	89.0
Not Active	23368989	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	70.0	CHEMBL2801	Homo sapiens	% Control	%	70.0
Not Active	23369457	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	90.0	CHEMBL2801	Homo sapiens	% Control	%	90.0
Not Active	23369998	CHEMBL4884242	CaMKIIdelta(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	75.0	CHEMBL2801	Homo sapiens	% residual kinase activity	%	75.0
Not Active	23370425	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	78.0	CHEMBL2801	Homo sapiens	% Control	%	78.0
Not Active	23370893	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23371702	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	84.0	CHEMBL2801	Homo sapiens	% Control	%	84.0
Not Active	23372170	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	93.0	CHEMBL2801	Homo sapiens	% Control	%	93.0
	23373711	CHEMBL4885488	CaMK2delta(CA2DCGT1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2801	Homo sapiens	pIC50		6.0
Not Active	23375597	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23376065	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23376643	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	90.0	CHEMBL2801	Homo sapiens	% Control	%	90.0
Not Active	23377112	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	75.0	CHEMBL2801	Homo sapiens	% Control	%	75.0
Not Active	23377970	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	91.0	CHEMBL2801	Homo sapiens	% Control	%	91.0
Not Active	23378438	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23379605	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23380073	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	97.0	CHEMBL2801	Homo sapiens	% Control	%	97.0
Not Active	23380767	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23381415	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23381883	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23382507	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	83.0	CHEMBL2801	Homo sapiens	% Control	%	83.0
Not Active	23382975	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
Not Active	23383719	CHEMBL4887368	CAMK2D Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	96.0	CHEMBL2801	Homo sapiens	% Ctrl	%	96.0
Not Active	23384204	CHEMBL4887799	CaMKIIdelta(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O	Outside typical range	CHEMBL4802045		Inhibition	%	-21.46	CHEMBL2801	Homo sapiens	% inhibition	%	-21.46
Not Active	23384890	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	86.0	CHEMBL2801	Homo sapiens	% Control	%	86.0
Not Active	23385357	CHEMBL4879614	KinomeScan assay: inhibition of CAMK2D	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL2801	Homo sapiens	% Control	%	100.0
